,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1916,GO:0042446,0.00965643897287177,0.999175182271272,5,7,hormone biosynthetic process,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11;DHCR7
1098,GO:0016229,0.0134474092385171,0.99945506472175,3,4,steroid dehydrogenase activity,MF,HSD3B2;HSD17B3;HSD17B11
1691,GO:0033764,0.0134474092385171,0.99945506472175,3,4,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD3B2;HSD17B3;HSD17B11
950,GO:0010817,0.0141121922228709,0.998390462880758,5,8,regulation of hormone levels,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11;DHCR7
1915,GO:0042445,0.0141121922228709,0.998390462880758,5,8,hormone metabolic process,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11;DHCR7
718,GO:0008209,0.0276472602931249,0.998492610545968,3,4,androgen metabolic process,BP,HSD3B2;HSD17B3;HSD17B11
1135,GO:0016614,0.030587590647074,0.994807965354884,5,10,oxidoreductase activity, acting on CH-OH group of donors,MF,HSD3B2;HSD17B3;AOX1;HSD17B11;BDH2
9,GO:0000122,0.0307138469634184,1,1,1,negative regulation of transcription from RNA polymerase II promoter,BP,IFI27
49,GO:0001085,0.0307138469634184,1,1,1,RNA polymerase II transcription factor binding,MF,IFI27
51,GO:0001102,0.0307138469634184,1,1,1,RNA polymerase II activating transcription factor binding,MF,IFI27
349,GO:0005521,0.0307138469634184,1,1,1,lamin binding,MF,IFI27
368,GO:0005637,0.0307138469634184,1,1,1,nuclear inner membrane,CC,IFI27
507,GO:0006611,0.0307138469634184,1,1,1,protein export from nucleus,BP,IFI27
702,GO:0008134,0.0307138469634184,1,1,1,transcription factor binding,MF,IFI27
1687,GO:0033613,0.0307138469634184,1,1,1,activating transcription factor binding,MF,IFI27
2251,GO:0045892,0.0307138469634184,1,1,1,negative regulation of transcription, DNA-templated,BP,IFI27
2341,GO:0046825,0.0307138469634184,1,1,1,regulation of protein export from nucleus,BP,IFI27
2577,GO:0051168,0.0307138469634184,1,1,1,nuclear export,BP,IFI27
3297,GO:1903507,0.0307138469634184,1,1,1,negative regulation of nucleic acid-templated transcription,BP,IFI27
1527,GO:0031965,0.0320002145146991,1,2,2,nuclear membrane,CC,DHCR7;IFI27
533,GO:0006694,0.0340970660929942,0.99440848279166,5,9,steroid biosynthetic process,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11;DHCR7
1766,GO:0034754,0.0363035370307512,0.995249775802999,4,7,cellular hormone metabolic process,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11
1137,GO:0016616,0.0364451470641733,0.994742506762358,4,8,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD3B2;HSD17B3;HSD17B11;BDH2
777,GO:0009058,0.041901811656178,0.985124423576501,16,56,biosynthetic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;ACCS;RBMS3;HSD17B3;PDK4;HSD17B11;DHCR7;BDH2;IFI27;RNASEL
3170,GO:1901362,0.0581305982085281,0.979924202848579,10,30,organic cyclic compound biosynthetic process,BP,PNP;HEXB;CYP11A1;HSD3B2;TICAM1;HSD17B3;HSD17B11;DHCR7;IFI27;RNASEL
3179,GO:1901576,0.0692060299885727,0.972839465320816,15,54,organic substance biosynthetic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;RBMS3;HSD17B3;PDK4;HSD17B11;DHCR7;BDH2;IFI27;RNASEL
714,GO:0008202,0.070435946005885,0.98377138940405,5,11,steroid metabolic process,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11;DHCR7
423,GO:0006026,0.0743302949094096,1,2,2,aminoglycan catabolic process,BP,HEXB;IDUA
424,GO:0006027,0.0743302949094096,1,2,2,glycosaminoglycan catabolic process,BP,HEXB;IDUA
1385,GO:0030204,0.0743302949094096,1,2,2,chondroitin sulfate metabolic process,BP,HEXB;IDUA
1387,GO:0030207,0.0743302949094096,1,2,2,chondroitin sulfate catabolic process,BP,HEXB;IDUA
2470,GO:0050654,0.0743302949094096,1,2,2,chondroitin sulfate proteoglycan metabolic process,BP,HEXB;IDUA
3300,GO:1903510,0.0743302949094096,1,2,2,mucopolysaccharide metabolic process,BP,HEXB;IDUA
907,GO:0010557,0.0764041212542204,0.986853398810942,4,7,positive regulation of macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;RNASEL
367,GO:0005635,0.0799917790904698,0.99320587788894,2,4,nuclear envelope,CC,DHCR7;IFI27
1168,GO:0016787,0.0836201264040822,0.972803043571058,7,21,hydrolase activity,MF,HEXB;CMBL;CASP4;PON2;RNASEL;ASAH2;IDUA
386,GO:0005773,0.0899728390086922,0.980849581743827,4,9,vacuole,CC,HEXB;TICAM1;PON2;IDUA
2582,GO:0051173,0.0912070960999699,0.981597265757003,4,8,positive regulation of nitrogen compound metabolic process,BP,HEXB;TICAM1;RBMS3;RNASEL
1419,GO:0030539,0.0920668231999927,1,1,1,male genitalia development,BP,HSD17B3
2373,GO:0047035,0.0920668231999927,1,1,1,testosterone dehydrogenase (NAD+) activity,MF,HSD17B3
2374,GO:0047045,0.0920668231999927,1,1,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B3
1995,GO:0043094,0.0928943388370117,1,2,2,cellular metabolic compound salvage,BP,PNP;MRI1
537,GO:0006702,0.0937789967331049,0.993638586265629,2,3,androgen biosynthetic process,BP,HSD3B2;HSD17B3
609,GO:0006955,0.0948020038773264,0.970837674088225,6,17,immune response,BP,PNP;HEXB;TICAM1;CASP4;IFI27;RNASEL
2100,GO:0044249,0.105390874947372,0.954879869566582,14,51,cellular biosynthetic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;RBMS3;HSD17B3;PDK4;HSD17B11;BDH2;IFI27;RNASEL
1719,GO:0034340,0.105486974650374,0.992294641416421,2,3,response to type I interferon,BP,IFI27;RNASEL
2746,GO:0060337,0.105486974650374,0.992294641416421,2,3,type I interferon signaling pathway,BP,IFI27;RNASEL
2908,GO:0071357,0.105486974650374,0.992294641416421,2,3,cellular response to type I interferon,BP,IFI27;RNASEL
232,GO:0003824,0.10555527194328,0.956158633736101,18,69,catalytic activity,MF,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;CASP4;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;RNASEL;ASAH2;IDUA
27,GO:0000323,0.106320069390124,0.98097914927357,3,7,lytic vacuole,CC,HEXB;PON2;IDUA
381,GO:0005764,0.106320069390124,0.98097914927357,3,7,lysosome,CC,HEXB;PON2;IDUA
600,GO:0006915,0.106884550384948,0.96939497189815,5,14,apoptotic process,BP,TICAM1;CASP4;PDK4;IFI27;ASAH2
463,GO:0006357,0.10765459542322,0.982175919425563,3,6,regulation of transcription from RNA polymerase II promoter,BP,HEXB;IFI27;RNASEL
2998,GO:0072593,0.12095607383485,0.98168131005321,3,5,reactive oxygen species metabolic process,BP,TICAM1;PDK4;AOX1
2921,GO:0071417,0.129005171346969,0.979821769580017,3,5,cellular response to organonitrogen compound,BP,CASP4;PDK4;RNASEL
3187,GO:1901653,0.129005171346969,0.979821769580017,3,5,cellular response to peptide,BP,CASP4;PDK4;RNASEL
3198,GO:1901699,0.129005171346969,0.979821769580017,3,5,cellular response to nitrogen compound,BP,CASP4;PDK4;RNASEL
2810,GO:0070059,0.129050910303005,1,1,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CASP4
2994,GO:0072557,0.129050910303005,1,1,1,IPAF inflammasome complex,CC,CASP4
3061,GO:0097194,0.129050910303005,1,1,1,execution phase of apoptosis,BP,CASP4
3062,GO:0097200,0.129050910303005,1,1,1,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
3339,GO:1904645,0.129050910303005,1,1,1,response to beta-amyloid,BP,CASP4
3340,GO:1904646,0.129050910303005,1,1,1,cellular response to beta-amyloid,BP,CASP4
279,GO:0004553,0.137879282156831,0.988021469501676,2,3,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,HEXB;IDUA
827,GO:0009311,0.137879282156831,0.988021469501676,2,3,oligosaccharide metabolic process,BP,HEXB;IDUA
1172,GO:0016798,0.137879282156831,0.988021469501676,2,3,hydrolase activity, acting on glycosyl bonds,MF,HEXB;IDUA
2990,GO:0072523,0.139031156582891,0.987854655018062,2,3,purine-containing compound catabolic process,BP,PNP;AOX1
526,GO:0006665,0.142058888178047,0.987411332391567,2,3,sphingolipid metabolic process,BP,HEXB;ASAH2
527,GO:0006672,0.142058888178047,0.987411332391567,2,3,ceramide metabolic process,BP,HEXB;ASAH2
2588,GO:0051188,0.145242081404759,0.962572652807655,4,9,cofactor biosynthetic process,BP,ACSF2;PNP;PDK4;BDH2
2457,GO:0048806,0.146714505095076,0.994441682130031,1,2,genitalia development,BP,HSD17B3
465,GO:0006366,0.149630873529381,0.968464788446834,3,7,transcription from RNA polymerase II promoter,BP,HEXB;IFI27;RNASEL
3057,GO:0097190,0.14973582368115,0.965509336934898,3,9,apoptotic signaling pathway,BP,TICAM1;CASP4;IFI27
2185,GO:0045087,0.15057668659465,0.956882638098403,4,12,innate immune response,BP,TICAM1;CASP4;IFI27;RNASEL
723,GO:0008219,0.155284030512193,0.948523615532121,5,15,cell death,BP,TICAM1;CASP4;PDK4;IFI27;ASAH2
994,GO:0012501,0.155284030512193,0.948523615532121,5,15,programmed cell death,BP,TICAM1;CASP4;PDK4;IFI27;ASAH2
1289,GO:0019867,0.15625958246162,0.979848673892199,2,4,outer membrane,CC,DHCR7;IFI27
1530,GO:0031968,0.15625958246162,0.979848673892199,2,4,organelle outer membrane,CC,DHCR7;IFI27
3156,GO:1901136,0.156505713956837,0.966272302786637,3,7,carbohydrate derivative catabolic process,BP,PNP;HEXB;IDUA
3186,GO:1901652,0.160839823586285,0.967553577986686,3,6,response to peptide,BP,CASP4;PDK4;RNASEL
517,GO:0006643,0.161643532504351,0.978685455763232,2,4,membrane lipid metabolic process,BP,HEXB;ASAH2
888,GO:0010008,0.162128448543534,0.984295265140493,2,3,endosome membrane,CC,SNX21;TICAM1
2138,GO:0044440,0.162128448543534,0.984295265140493,2,3,endosomal part,CC,SNX21;TICAM1
2140,GO:0044445,0.164779368499595,0.977994772098096,2,4,cytosolic part,CC,TICAM1;CASP4
598,GO:0006913,0.16605369401669,0.992797743510099,1,2,nucleocytoplasmic transport,BP,IFI27
1573,GO:0032386,0.16605369401669,0.992797743510099,1,2,regulation of intracellular transport,BP,IFI27
1671,GO:0033157,0.16605369401669,0.992797743510099,1,2,regulation of intracellular protein transport,BP,IFI27
2340,GO:0046822,0.16605369401669,0.992797743510099,1,2,regulation of nucleocytoplasmic transport,BP,IFI27
2578,GO:0051169,0.16605369401669,0.992797743510099,1,2,nuclear transport,BP,IFI27
2749,GO:0060341,0.16605369401669,0.992797743510099,1,2,regulation of cellular localization,BP,IFI27
3327,GO:1903827,0.16605369401669,0.992797743510099,1,2,regulation of cellular protein localization,BP,IFI27
2703,GO:0055080,0.169273853079404,0.964943148117741,3,6,cation homeostasis,BP,HEXB;PDK4;BDH2
3103,GO:0098771,0.169273853079404,0.964943148117741,3,6,inorganic ion homeostasis,BP,HEXB;PDK4;BDH2
607,GO:0006952,0.16951599668819,0.941976803443363,5,15,defense response,BP,TICAM1;CASP4;AOX1;IFI27;RNASEL
3197,GO:1901698,0.170161009647111,0.951276514217288,4,10,response to nitrogen compound,BP,TICAM1;CASP4;PDK4;RNASEL
290,GO:0004672,0.172089060628272,0.98263409458997,2,3,protein kinase activity,MF,PDK4;RNASEL
2009,GO:0043202,0.175530767803631,0.975553124722382,2,4,lysosomal lumen,CC,HEXB;IDUA
256,GO:0004197,0.177678583363069,0.991696276718933,1,2,cysteine-type endopeptidase activity,MF,CASP4
725,GO:0008234,0.177678583363069,0.991696276718933,1,2,cysteine-type peptidase activity,MF,CASP4
2801,GO:0061702,0.177678583363069,0.991696276718933,1,2,inflammasome complex,CC,CASP4
2996,GO:0072559,0.177678583363069,0.991696276718933,1,2,NLRP3 inflammasome complex,CC,CASP4
3053,GO:0097153,0.177678583363069,0.991696276718933,1,2,cysteine-type endopeptidase activity involved in apoptotic process,MF,CASP4
3056,GO:0097169,0.177678583363069,0.991696276718933,1,2,AIM2 inflammasome complex,CC,CASP4
2928,GO:0071495,0.180439762654085,0.961367243148645,3,6,cellular response to endogenous stimulus,BP,CASP4;PDK4;RNASEL
2161,GO:0044711,0.19112962054186,0.910251820447638,10,35,single-organism biosynthetic process,BP,PNP;HEXB;MRI1;CYP11A1;HSD3B2;HSD17B3;PDK4;HSD17B11;DHCR7;BDH2
3071,GO:0097367,0.191162454710711,0.944558870757336,4,9,carbohydrate derivative binding,MF,ACSF2;PNP;PDK4;RNASEL
706,GO:0008152,0.192650868150976,0.930311318002144,23,99,metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;ACCS;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;WDR45;ASAH2;IDUA
599,GO:0006914,0.193527361610005,0.978799306606287,2,3,autophagy,BP,TICAM1;WDR45
420,GO:0006022,0.198148930429395,0.977925915990358,2,3,aminoglycan metabolic process,BP,HEXB;IDUA
425,GO:0006029,0.198148930429395,0.977925915990358,2,3,proteoglycan metabolic process,BP,HEXB;IDUA
1384,GO:0030203,0.198148930429395,0.977925915990358,2,3,glycosaminoglycan metabolic process,BP,HEXB;IDUA
246,GO:0004064,0.199034109743147,1,1,1,arylesterase activity,MF,PON2
1257,GO:0019372,0.199034109743147,1,1,1,lipoxygenase pathway,BP,PON2
2322,GO:0046573,0.199034109743147,1,1,1,lactonohydrolase activity,MF,PON2
3129,GO:0102007,0.199034109743147,1,1,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,PON2
144,GO:0002376,0.19938110736264,0.918728413464382,6,22,immune system process,BP,PNP;HEXB;TICAM1;CASP4;IFI27;RNASEL
1265,GO:0019439,0.199706215740316,0.948753519239213,3,8,aromatic compound catabolic process,BP,PNP;AOX1;PON2
387,GO:0005775,0.203278923855094,0.964457954451044,2,5,vacuolar lumen,CC,HEXB;IDUA
2135,GO:0044437,0.203278923855094,0.964457954451044,2,5,vacuolar part,CC,HEXB;IDUA
137,GO:0002263,0.204437870889348,0.949475267713486,3,7,cell activation involved in immune response,BP,PNP;HEXB;TICAM1
139,GO:0002275,0.204437870889348,0.949475267713486,3,7,myeloid cell activation involved in immune response,BP,PNP;HEXB;TICAM1
143,GO:0002366,0.204437870889348,0.949475267713486,3,7,leukocyte activation involved in immune response,BP,PNP;HEXB;TICAM1
3174,GO:1901565,0.206259470833082,0.932580584411877,4,12,organonitrogen compound catabolic process,BP,PNP;HEXB;AOX1;IDUA
1187,GO:0016860,0.206989979744777,0.967753298438579,2,4,intramolecular oxidoreductase activity,MF,MRI1;HSD3B2
12,GO:0000166,0.213510929349646,0.916654054574287,6,15,nucleotide binding,MF,ACSF2;PDK4;AOX1;DHCR7;BDH2;RNASEL
3163,GO:1901265,0.213510929349646,0.916654054574287,6,15,nucleoside phosphate binding,MF,ACSF2;PDK4;AOX1;DHCR7;BDH2;RNASEL
3169,GO:1901361,0.21481029279633,0.942741109386747,3,8,organic cyclic compound catabolic process,BP,PNP;AOX1;HSD17B11
1122,GO:0016491,0.216204367841613,0.904909611574349,7,24,oxidoreductase activity,MF,CYP11A1;HSD3B2;HSD17B3;AOX1;HSD17B11;DHCR7;BDH2
919,GO:0010629,0.221947623784567,0.982500943103925,1,3,negative regulation of gene expression,BP,IFI27
233,GO:0003854,0.223784165249077,1,1,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,HSD3B2
394,GO:0005790,0.223784165249077,1,1,1,smooth endoplasmic reticulum,CC,HSD3B2
540,GO:0006705,0.223784165249077,1,1,1,mineralocorticoid biosynthetic process,BP,HSD3B2
721,GO:0008212,0.223784165249077,1,1,1,mineralocorticoid metabolic process,BP,HSD3B2
1449,GO:0030868,0.223784165249077,1,1,1,smooth endoplasmic reticulum membrane,CC,HSD3B2
3073,GO:0097425,0.223784165249077,1,1,1,smooth endoplasmic reticulum part,CC,HSD3B2
1647,GO:0032869,0.226592253987315,0.972181271247305,2,3,cellular response to insulin stimulus,BP,PDK4;RNASEL
2111,GO:0044273,0.23133519992504,0.96104223316974,2,4,sulfur compound catabolic process,BP,HEXB;IDUA
2066,GO:0043603,0.232540298919216,0.919846708361757,4,12,cellular amide metabolic process,BP,HEXB;RBMS3;BDH2;ASAH2
182,GO:0002696,0.235888457800367,0.959721041092197,2,4,positive regulation of leukocyte activation,BP,PNP;TICAM1
1655,GO:0032943,0.235888457800367,0.959721041092197,2,4,mononuclear cell proliferation,BP,PNP;TICAM1
1656,GO:0032944,0.235888457800367,0.959721041092197,2,4,regulation of mononuclear cell proliferation,BP,PNP;TICAM1
1657,GO:0032946,0.235888457800367,0.959721041092197,2,4,positive regulation of mononuclear cell proliferation,BP,PNP;TICAM1
2331,GO:0046649,0.235888457800367,0.959721041092197,2,4,lymphocyte activation,BP,PNP;TICAM1
2332,GO:0046651,0.235888457800367,0.959721041092197,2,4,lymphocyte proliferation,BP,PNP;TICAM1
2476,GO:0050670,0.235888457800367,0.959721041092197,2,4,regulation of lymphocyte proliferation,BP,PNP;TICAM1
2477,GO:0050671,0.235888457800367,0.959721041092197,2,4,positive regulation of lymphocyte proliferation,BP,PNP;TICAM1
2532,GO:0050867,0.235888457800367,0.959721041092197,2,4,positive regulation of cell activation,BP,PNP;TICAM1
2606,GO:0051249,0.235888457800367,0.959721041092197,2,4,regulation of lymphocyte activation,BP,PNP;TICAM1
2607,GO:0051251,0.235888457800367,0.959721041092197,2,4,positive regulation of lymphocyte activation,BP,PNP;TICAM1
2856,GO:0070661,0.235888457800367,0.959721041092197,2,4,leukocyte proliferation,BP,PNP;TICAM1
2857,GO:0070663,0.235888457800367,0.959721041092197,2,4,regulation of leukocyte proliferation,BP,PNP;TICAM1
2858,GO:0070665,0.235888457800367,0.959721041092197,2,4,positive regulation of leukocyte proliferation,BP,PNP;TICAM1
846,GO:0009615,0.237618451709167,0.959213568517816,2,4,response to virus,BP,TICAM1;RNASEL
2661,GO:0051607,0.237618451709167,0.959213568517816,2,4,defense response to virus,BP,TICAM1;RNASEL
3085,GO:0098542,0.237618451709167,0.959213568517816,2,4,defense response to other organism,BP,TICAM1;RNASEL
1829,GO:0036094,0.23790712656863,0.88932914062387,8,24,small molecule binding,MF,ACSF2;PNP;ACCS;PDK4;AOX1;DHCR7;BDH2;RNASEL
1484,GO:0031328,0.23796004729999,0.918807845937339,4,11,positive regulation of cellular biosynthetic process,BP,HEXB;TICAM1;RBMS3;RNASEL
134,GO:0002252,0.238178299819017,0.918699313245036,4,11,immune effector process,BP,PNP;HEXB;TICAM1;RNASEL
3088,GO:0098588,0.238446543107194,0.906937666102361,5,15,bounding membrane of organelle,CC,SNX21;HSD3B2;TICAM1;DHCR7;IFI27
3168,GO:1901360,0.239253293499087,0.87588908425995,12,48,organic cyclic compound metabolic process,BP,PNP;HEXB;CYP11A1;HSD3B2;TICAM1;HSD17B3;AOX1;HSD17B11;DHCR7;BDH2;IFI27;RNASEL
995,GO:0012505,0.245047312016756,0.877725309118333,9,37,endomembrane system,CC,PNP;HEXB;SNX21;HSD3B2;TICAM1;CASP4;HSD17B3;DHCR7;IFI27
260,GO:0004303,0.251095468229799,1,1,1,estradiol 17-beta-dehydrogenase activity,MF,HSD17B11
541,GO:0006706,0.251095468229799,1,1,1,steroid catabolic process,BP,HSD17B11
542,GO:0006710,0.251095468229799,1,1,1,androgen catabolic process,BP,HSD17B11
1917,GO:0042447,0.251095468229799,1,1,1,hormone catabolic process,BP,HSD17B11
759,GO:0008610,0.255236845270328,0.881307286805537,7,24,lipid biosynthetic process,BP,HEXB;CYP11A1;HSD3B2;HSD17B3;PDK4;HSD17B11;DHCR7
915,GO:0010604,0.255337316202498,0.895361941492011,5,17,positive regulation of macromolecule metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
3200,GO:1901701,0.255710871289698,0.912133855003501,4,10,cellular response to oxygen-containing compound,BP,TICAM1;CASP4;PDK4;RNASEL
3171,GO:1901363,0.25653564870764,0.869252405619969,10,34,heterocyclic compound binding,MF,ACSF2;PNP;CYP11A1;ACCS;RBMS3;PDK4;AOX1;DHCR7;BDH2;RNASEL
66,GO:0001573,0.257320327663885,1,1,1,ganglioside metabolic process,BP,HEXB
77,GO:0001669,0.257320327663885,1,1,1,acrosomal vesicle,CC,HEXB
281,GO:0004563,0.257320327663885,1,1,1,beta-N-acetylhexosaminidase activity,MF,HEXB
530,GO:0006689,0.257320327663885,1,1,1,ganglioside catabolic process,BP,HEXB
624,GO:0007040,0.257320327663885,1,1,1,lysosome organization,BP,HEXB
648,GO:0007272,0.257320327663885,1,1,1,ensheathment of neurons,BP,HEXB
654,GO:0007338,0.257320327663885,1,1,1,single fertilization,BP,HEXB
655,GO:0007341,0.257320327663885,1,1,1,penetration of zona pellucida,BP,HEXB
681,GO:0007617,0.257320327663885,1,1,1,mating behavior,BP,HEXB
682,GO:0007618,0.257320327663885,1,1,1,mating,BP,HEXB
683,GO:0007619,0.257320327663885,1,1,1,courtship behavior,BP,HEXB
686,GO:0007626,0.257320327663885,1,1,1,locomotory behavior,BP,HEXB
692,GO:0008049,0.257320327663885,1,1,1,male courtship behavior,BP,HEXB
739,GO:0008347,0.257320327663885,1,1,1,glial cell migration,BP,HEXB
742,GO:0008366,0.257320327663885,1,1,1,axon ensheathment,BP,HEXB
828,GO:0009313,0.257320327663885,1,1,1,oligosaccharide catabolic process,BP,HEXB
840,GO:0009566,0.257320327663885,1,1,1,fertilization,BP,HEXB
1064,GO:0015929,0.257320327663885,1,1,1,hexosaminidase activity,MF,HEXB
1238,GO:0019098,0.257320327663885,1,1,1,reproductive behavior,BP,HEXB
1389,GO:0030212,0.257320327663885,1,1,1,hyaluronan metabolic process,BP,HEXB
1390,GO:0030214,0.257320327663885,1,1,1,hyaluronan catabolic process,BP,HEXB
1902,GO:0042339,0.257320327663885,1,1,1,keratan sulfate metabolic process,BP,HEXB
1903,GO:0042340,0.257320327663885,1,1,1,keratan sulfate catabolic process,BP,HEXB
1931,GO:0042552,0.257320327663885,1,1,1,myelination,BP,HEXB
2068,GO:0043615,0.257320327663885,1,1,1,astrocyte cell migration,BP,HEXB
2157,GO:0044706,0.257320327663885,1,1,1,multi-multicellular organism process,BP,HEXB
2731,GO:0060179,0.257320327663885,1,1,1,male mating behavior,BP,HEXB
3009,GO:0080171,0.257320327663885,1,1,1,lytic vacuole organization,BP,HEXB
3064,GO:0097223,0.257320327663885,1,1,1,sperm part,CC,HEXB
1140,GO:0016628,0.260242045371821,0.952296890756571,2,4,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DHCR7;BDH2
351,GO:0005524,0.266224974348974,0.929383234848387,3,6,ATP binding,MF,ACSF2;PDK4;RNASEL
1206,GO:0017076,0.266224974348974,0.929383234848387,3,6,purine nucleotide binding,MF,ACSF2;PDK4;RNASEL
1421,GO:0030554,0.266224974348974,0.929383234848387,3,6,adenyl nucleotide binding,MF,ACSF2;PDK4;RNASEL
1596,GO:0032553,0.266224974348974,0.929383234848387,3,6,ribonucleotide binding,MF,ACSF2;PDK4;RNASEL
1597,GO:0032555,0.266224974348974,0.929383234848387,3,6,purine ribonucleotide binding,MF,ACSF2;PDK4;RNASEL
1598,GO:0032559,0.266224974348974,0.929383234848387,3,6,adenyl ribonucleotide binding,MF,ACSF2;PDK4;RNASEL
1809,GO:0035639,0.266224974348974,0.929383234848387,3,6,purine ribonucleoside triphosphate binding,MF,ACSF2;PDK4;RNASEL
918,GO:0010628,0.267088015941902,0.923604697557016,3,7,positive regulation of gene expression,BP,HEXB;RBMS3;RNASEL
359,GO:0005576,0.267429366626392,0.862934376300024,9,37,extracellular region,CC,PNP;HEXB;CMBL;CASP4;AOX1;PON2;HSD17B11;BDH2;IDUA
791,GO:0009100,0.267795161882096,0.943291269305078,2,5,glycoprotein metabolic process,BP,HEXB;IDUA
559,GO:0006775,0.268240895022899,1,1,1,fat-soluble vitamin metabolic process,BP,CYP11A1
747,GO:0008386,0.268240895022899,1,1,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,CYP11A1
1151,GO:0016713,0.268240895022899,1,1,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,CYP11A1
1906,GO:0042359,0.268240895022899,1,1,1,vitamin D metabolic process,BP,CYP11A1
2134,GO:0044433,0.272206885716278,0.901116531378437,4,11,cytoplasmic vesicle part,CC,PNP;HEXB;SNX21;TICAM1
1073,GO:0016032,0.272502738231157,0.94156600966101,2,5,viral process,BP,TICAM1;RNASEL
2122,GO:0044403,0.272502738231157,0.94156600966101,2,5,symbiosis, encompassing mutualism through parasitism,BP,TICAM1;RNASEL
2123,GO:0044419,0.272502738231157,0.94156600966101,2,5,interspecies interaction between organisms,BP,TICAM1;RNASEL
2167,GO:0044764,0.272502738231157,0.94156600966101,2,5,multi-organism cellular process,BP,TICAM1;RNASEL
1161,GO:0016757,0.273415776530913,0.941228502642979,2,5,transferase activity, transferring glycosyl groups,MF,PNP;HEXB
1646,GO:0032868,0.276034881082814,0.947156386467366,2,4,response to insulin,BP,PDK4;RNASEL
1377,GO:0030170,0.277593065330257,1,1,1,pyridoxal phosphate binding,MF,ACCS
2832,GO:0070279,0.277593065330257,1,1,1,vitamin B6 binding,MF,ACCS
793,GO:0009108,0.280361639227553,0.91360144114649,3,8,coenzyme biosynthetic process,BP,ACSF2;PNP;PDK4
561,GO:0006790,0.280432716270424,0.884536903715897,5,14,sulfur compound metabolic process,BP,ACSF2;HEXB;MRI1;PDK4;IDUA
2805,GO:0065008,0.283024402583088,0.85319082337761,9,34,regulation of biological quality,BP,HEXB;CYP11A1;HSD3B2;HSD17B3;PDK4;HSD17B11;DHCR7;BDH2;RNASEL
2259,GO:0045934,0.283969621929518,0.977309777672461,1,2,negative regulation of nucleobase-containing compound metabolic process,BP,IFI27
2609,GO:0051253,0.283969621929518,0.977309777672461,1,2,negative regulation of RNA metabolic process,BP,IFI27
3250,GO:1902679,0.283969621929518,0.977309777672461,1,2,negative regulation of RNA biosynthetic process,BP,IFI27
2873,GO:0070887,0.284147233333779,0.868418895663791,6,22,cellular response to chemical stimulus,BP,CMBL;TICAM1;CASP4;PDK4;IFI27;RNASEL
2621,GO:0051287,0.284413236872657,0.944323534327608,2,4,NAD binding,MF,AOX1;BDH2
2110,GO:0044272,0.287800995873286,0.914076142393159,3,7,sulfur compound biosynthetic process,BP,ACSF2;MRI1;PDK4
917,GO:0010608,0.287941240415902,0.935732072763985,2,5,posttranscriptional regulation of gene expression,BP,RBMS3;RNASEL
2988,GO:0072521,0.288467222942923,0.935528535224621,2,5,purine-containing compound metabolic process,BP,PNP;AOX1
608,GO:0006954,0.289731688876612,0.909030791802659,3,8,inflammatory response,BP,TICAM1;CASP4;AOX1
3060,GO:0097193,0.293250478318548,0.968174174974943,1,3,intrinsic apoptotic signaling pathway,BP,CASP4
1186,GO:0016853,0.293922789475235,0.933398727292403,2,5,isomerase activity,MF,MRI1;HSD3B2
237,GO:0003940,0.294547608866284,1,1,1,L-iduronidase activity,MF,IDUA
415,GO:0005984,0.294547608866284,1,1,1,disaccharide metabolic process,BP,IDUA
1367,GO:0030135,0.294547608866284,1,1,1,coated vesicle,CC,IDUA
1386,GO:0030205,0.294547608866284,1,1,1,dermatan sulfate metabolic process,BP,IDUA
1388,GO:0030209,0.294547608866284,1,1,1,dermatan sulfate catabolic process,BP,IDUA
2471,GO:0050655,0.294547608866284,1,1,1,dermatan sulfate proteoglycan metabolic process,BP,IDUA
2515,GO:0050801,0.297104838505228,0.90536235156172,3,8,ion homeostasis,BP,HEXB;PDK4;BDH2
297,GO:0004769,0.298076547210436,0.974760940966206,1,2,steroid delta-isomerase activity,MF,HSD3B2
1481,GO:0031325,0.298154366435565,0.867008052686253,5,20,positive regulation of cellular metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2109,GO:0044271,0.298361308459084,0.851185941719087,7,28,cellular nitrogen compound biosynthetic process,BP,PNP;HEXB;TICAM1;RBMS3;BDH2;IFI27;RNASEL
397,GO:0005811,0.299586656233927,0.974478432013528,1,2,lipid particle,CC,HSD17B11
556,GO:0006766,0.301576566974028,0.930353051836608,2,5,vitamin metabolic process,BP,CYP11A1;AOX1
138,GO:0002274,0.30168183356284,0.903053163418285,3,8,myeloid leukocyte activation,BP,PNP;HEXB;TICAM1
1174,GO:0016810,0.305211650292441,1,1,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ASAH2
1175,GO:0016811,0.305211650292441,1,1,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,ASAH2
1204,GO:0017040,0.305211650292441,1,1,1,ceramidase activity,MF,ASAH2
86,GO:0001816,0.306355631995393,0.928416943820104,2,5,cytokine production,BP,PNP;TICAM1
122,GO:0002054,0.30644637252999,1,1,1,nucleobase binding,MF,PNP
123,GO:0002060,0.30644637252999,1,1,1,purine nucleobase binding,MF,PNP
295,GO:0004731,0.30644637252999,1,1,1,purine-nucleoside phosphorylase activity,MF,PNP
449,GO:0006148,0.30644637252999,1,1,1,inosine catabolic process,BP,PNP
450,GO:0006152,0.30644637252999,1,1,1,purine nucleoside catabolic process,BP,PNP
550,GO:0006738,0.30644637252999,1,1,1,nicotinamide riboside catabolic process,BP,PNP
704,GO:0008144,0.30644637252999,1,1,1,drug binding,MF,PNP
800,GO:0009119,0.30644637252999,1,1,1,ribonucleoside metabolic process,BP,PNP
1163,GO:0016763,0.30644637252999,1,1,1,transferase activity, transferring pentosyl groups,MF,PNP
1609,GO:0032623,0.30644637252999,1,1,1,interleukin-2 production,BP,PNP
1737,GO:0034418,0.30644637252999,1,1,1,urate biosynthetic process,BP,PNP
1893,GO:0042278,0.30644637252999,1,1,1,purine nucleoside metabolic process,BP,PNP
1894,GO:0042301,0.30644637252999,1,1,1,phosphate ion binding,MF,PNP
1919,GO:0042454,0.30644637252999,1,1,1,ribonucleoside catabolic process,BP,PNP
1996,GO:0043101,0.30644637252999,1,1,1,purine-containing compound salvage,BP,PNP
2217,GO:0045580,0.30644637252999,1,1,1,regulation of T cell differentiation,BP,PNP
2218,GO:0045582,0.30644637252999,1,1,1,positive regulation of T cell differentiation,BP,PNP
2222,GO:0045619,0.30644637252999,1,1,1,regulation of lymphocyte differentiation,BP,PNP
2223,GO:0045621,0.30644637252999,1,1,1,positive regulation of lymphocyte differentiation,BP,PNP
2268,GO:0046102,0.30644637252999,1,1,1,inosine metabolic process,BP,PNP
2272,GO:0046128,0.30644637252999,1,1,1,purine ribonucleoside metabolic process,BP,PNP
2273,GO:0046130,0.30644637252999,1,1,1,purine ribonucleoside catabolic process,BP,PNP
2292,GO:0046415,0.30644637252999,1,1,1,urate metabolic process,BP,PNP
2314,GO:0046495,0.30644637252999,1,1,1,nicotinamide riboside metabolic process,BP,PNP
2325,GO:0046631,0.30644637252999,1,1,1,alpha-beta T cell activation,BP,PNP
2326,GO:0046632,0.30644637252999,1,1,1,alpha-beta T cell differentiation,BP,PNP
2327,GO:0046634,0.30644637252999,1,1,1,regulation of alpha-beta T cell activation,BP,PNP
2328,GO:0046635,0.30644637252999,1,1,1,positive regulation of alpha-beta T cell activation,BP,PNP
2329,GO:0046637,0.30644637252999,1,1,1,regulation of alpha-beta T cell differentiation,BP,PNP
2330,GO:0046638,0.30644637252999,1,1,1,positive regulation of alpha-beta T cell differentiation,BP,PNP
2852,GO:0070637,0.30644637252999,1,1,1,pyridine nucleoside metabolic process,BP,PNP
2853,GO:0070638,0.30644637252999,1,1,1,pyridine nucleoside catabolic process,BP,PNP
2879,GO:0070970,0.30644637252999,1,1,1,interleukin-2 secretion,BP,PNP
2993,GO:0072526,0.30644637252999,1,1,1,pyridine-containing compound catabolic process,BP,PNP
651,GO:0007281,0.307294623340685,0.973006820511509,1,2,germ cell development,BP,HEXB
653,GO:0007292,0.307294623340685,0.973006820511509,1,2,female gamete generation,BP,HEXB
1313,GO:0022412,0.307294623340685,0.973006820511509,1,2,cellular process involved in reproduction in multicellular organism,BP,HEXB
2408,GO:0048477,0.307294623340685,0.973006820511509,1,2,oogenesis,BP,HEXB
3054,GO:0097159,0.308711307734786,0.83298164889209,10,35,organic cyclic compound binding,MF,ACSF2;PNP;CYP11A1;ACCS;RBMS3;PDK4;AOX1;DHCR7;BDH2;RNASEL
369,GO:0005640,0.310070141814514,1,1,1,nuclear outer membrane,CC,DHCR7
860,GO:0009791,0.310070141814514,1,1,1,post-embryonic development,BP,DHCR7
877,GO:0009918,0.310070141814514,1,1,1,sterol delta7 reductase activity,MF,DHCR7
1088,GO:0016128,0.310070141814514,1,1,1,phytosteroid metabolic process,BP,DHCR7
1089,GO:0016129,0.310070141814514,1,1,1,phytosteroid biosynthetic process,BP,DHCR7
1090,GO:0016131,0.310070141814514,1,1,1,brassinosteroid metabolic process,BP,DHCR7
1091,GO:0016132,0.310070141814514,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
2376,GO:0047598,0.310070141814514,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
141,GO:0002281,0.310175575511586,1,1,1,macrophage activation involved in immune response,BP,TICAM1
902,GO:0010508,0.310175575511586,1,1,1,positive regulation of autophagy,BP,TICAM1
1364,GO:0030101,0.310175575511586,1,1,1,natural killer cell activation,BP,TICAM1
1450,GO:0030888,0.310175575511586,1,1,1,regulation of B cell proliferation,BP,TICAM1
1451,GO:0030890,0.310175575511586,1,1,1,positive regulation of B cell proliferation,BP,TICAM1
1512,GO:0031663,0.310175575511586,1,1,1,lipopolysaccharide-mediated signaling pathway,BP,TICAM1
1542,GO:0032092,0.310175575511586,1,1,1,positive regulation of protein binding,BP,TICAM1
1585,GO:0032481,0.310175575511586,1,1,1,positive regulation of type I interferon production,BP,TICAM1
1626,GO:0032728,0.310175575511586,1,1,1,positive regulation of interferon-beta production,BP,TICAM1
1642,GO:0032814,0.310175575511586,1,1,1,regulation of natural killer cell activation,BP,TICAM1
1643,GO:0032816,0.310175575511586,1,1,1,positive regulation of natural killer cell activation,BP,TICAM1
1706,GO:0034121,0.310175575511586,1,1,1,regulation of toll-like receptor signaling pathway,BP,TICAM1
1707,GO:0034122,0.310175575511586,1,1,1,negative regulation of toll-like receptor signaling pathway,BP,TICAM1
1708,GO:0034127,0.310175575511586,1,1,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
1709,GO:0034128,0.310175575511586,1,1,1,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
1860,GO:0042033,0.310175575511586,1,1,1,chemokine biosynthetic process,BP,TICAM1
1868,GO:0042100,0.310175575511586,1,1,1,B cell proliferation,BP,TICAM1
1872,GO:0042108,0.310175575511586,1,1,1,positive regulation of cytokine biosynthetic process,BP,TICAM1
1874,GO:0042113,0.310175575511586,1,1,1,B cell activation,BP,TICAM1
2036,GO:0043330,0.310175575511586,1,1,1,response to exogenous dsRNA,BP,TICAM1
2037,GO:0043331,0.310175575511586,1,1,1,response to dsRNA,BP,TICAM1
2183,GO:0045073,0.310175575511586,1,1,1,regulation of chemokine biosynthetic process,BP,TICAM1
2184,GO:0045080,0.310175575511586,1,1,1,positive regulation of chemokine biosynthetic process,BP,TICAM1
2208,GO:0045359,0.310175575511586,1,1,1,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
2210,GO:0045429,0.310175575511586,1,1,1,positive regulation of nitric oxide biosynthetic process,BP,TICAM1
2496,GO:0050755,0.310175575511586,1,1,1,chemokine metabolic process,BP,TICAM1
2530,GO:0050864,0.310175575511586,1,1,1,regulation of B cell activation,BP,TICAM1
2534,GO:0050871,0.310175575511586,1,1,1,positive regulation of B cell activation,BP,TICAM1
2572,GO:0051099,0.310175575511586,1,1,1,positive regulation of binding,BP,TICAM1
3295,GO:1903428,0.310175575511586,1,1,1,positive regulation of reactive oxygen species biosynthetic process,BP,TICAM1
3336,GO:1904407,0.310175575511586,1,1,1,positive regulation of nitric oxide metabolic process,BP,TICAM1
227,GO:0003729,0.310214379380877,1,1,1,mRNA binding,MF,RBMS3
228,GO:0003730,0.310214379380877,1,1,1,mRNA 3'-UTR binding,MF,RBMS3
1713,GO:0034250,0.310214379380877,1,1,1,positive regulation of cellular amide metabolic process,BP,RBMS3
2234,GO:0045727,0.310214379380877,1,1,1,positive regulation of translation,BP,RBMS3
235,GO:0003858,0.310214570320066,1,1,1,3-hydroxybutyrate dehydrogenase activity,MF,BDH2
560,GO:0006778,0.310214570320066,1,1,1,porphyrin-containing compound metabolic process,BP,BDH2
813,GO:0009237,0.310214570320066,1,1,1,siderophore metabolic process,BP,BDH2
1248,GO:0019290,0.310214570320066,1,1,1,siderophore biosynthetic process,BP,BDH2
1667,GO:0033013,0.310214570320066,1,1,1,tetrapyrrole metabolic process,BP,BDH2
1883,GO:0042168,0.310214570320066,1,1,1,heme metabolic process,BP,BDH2
1914,GO:0042440,0.310214570320066,1,1,1,pigment metabolic process,BP,BDH2
2152,GO:0044550,0.310214570320066,1,1,1,secondary metabolite biosynthetic process,BP,BDH2
2700,GO:0055072,0.310214570320066,1,1,1,iron ion homeostasis,BP,BDH2
8,GO:0000097,0.310214570320151,1,1,1,sulfur amino acid biosynthetic process,BP,MRI1
69,GO:0001650,0.310214570320151,1,1,1,fibrillar center,CC,MRI1
784,GO:0009067,0.310214570320151,1,1,1,aspartate family amino acid biosynthetic process,BP,MRI1
790,GO:0009086,0.310214570320151,1,1,1,methionine biosynthetic process,BP,MRI1
1188,GO:0016861,0.310214570320151,1,1,1,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MRI1
1266,GO:0019509,0.310214570320151,1,1,1,L-methionine salvage from methylthioadenosine,BP,MRI1
1997,GO:0043102,0.310214570320151,1,1,1,amino acid salvage,BP,MRI1
2144,GO:0044452,0.310214570320151,1,1,1,nucleolar part,CC,MRI1
2318,GO:0046523,0.310214570320151,1,1,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,MRI1
2893,GO:0071265,0.310214570320151,1,1,1,L-methionine biosynthetic process,BP,MRI1
2894,GO:0071267,0.310214570320151,1,1,1,L-methionine salvage,BP,MRI1
244,GO:0004031,0.310214570320175,1,1,1,aldehyde oxidase activity,MF,AOX1
298,GO:0004854,0.310214570320175,1,1,1,xanthine dehydrogenase activity,MF,AOX1
447,GO:0006144,0.310214570320175,1,1,1,purine nucleobase metabolic process,BP,AOX1
448,GO:0006145,0.310214570320175,1,1,1,purine nucleobase catabolic process,BP,AOX1
796,GO:0009112,0.310214570320175,1,1,1,nucleobase metabolic process,BP,AOX1
797,GO:0009115,0.310214570320175,1,1,1,xanthine catabolic process,BP,AOX1
1138,GO:0016623,0.310214570320175,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
1155,GO:0016725,0.310214570320175,1,1,1,oxidoreductase activity, acting on CH or CH2 groups,MF,AOX1
1156,GO:0016726,0.310214570320175,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,AOX1
1197,GO:0016903,0.310214570320175,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AOX1
1963,GO:0042816,0.310214570320175,1,1,1,vitamin B6 metabolic process,BP,AOX1
2061,GO:0043546,0.310214570320175,1,1,1,molybdopterin cofactor binding,MF,AOX1
2269,GO:0046110,0.310214570320175,1,1,1,xanthine metabolic process,BP,AOX1
2270,GO:0046113,0.310214570320175,1,1,1,nucleobase catabolic process,BP,AOX1
2653,GO:0051537,0.310214570320175,1,1,1,2 iron, 2 sulfur cluster binding,MF,AOX1
356,GO:0005546,0.310214570320176,1,1,1,phosphatidylinositol-4,5-bisphosphate binding,MF,SNX21
384,GO:0005769,0.310214570320176,1,1,1,early endosome,CC,SNX21
1522,GO:0031901,0.310214570320176,1,1,1,early endosome membrane,CC,SNX21
1548,GO:0032266,0.310214570320176,1,1,1,phosphatidylinositol-3-phosphate binding,MF,SNX21
3207,GO:1901981,0.310214570320176,1,1,1,phosphatidylinositol phosphate binding,MF,SNX21
3267,GO:1902936,0.310214570320176,1,1,1,phosphatidylinositol bisphosphate binding,MF,SNX21
296,GO:0004740,0.310214570320304,1,1,1,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK4
431,GO:0006086,0.310214570320304,1,1,1,acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
432,GO:0006090,0.310214570320304,1,1,1,pyruvate metabolic process,BP,PDK4
588,GO:0006885,0.310214570320304,1,1,1,regulation of pH,BP,PDK4
735,GO:0008286,0.310214570320304,1,1,1,insulin receptor signaling pathway,BP,PDK4
903,GO:0010510,0.310214570320304,1,1,1,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
1705,GO:0034103,0.310214570320304,1,1,1,regulation of tissue remodeling,BP,PDK4
1958,GO:0042762,0.310214570320304,1,1,1,regulation of sulfur metabolic process,BP,PDK4
2028,GO:0043276,0.310214570320304,1,1,1,anoikis,BP,PDK4
2191,GO:0045124,0.310214570320304,1,1,1,regulation of bone resorption,BP,PDK4
2212,GO:0045453,0.310214570320304,1,1,1,bone resorption,BP,PDK4
2343,GO:0046849,0.310214570320304,1,1,1,bone remodeling,BP,PDK4
2344,GO:0046850,0.310214570320304,1,1,1,regulation of bone remodeling,BP,PDK4
2520,GO:0050812,0.310214570320304,1,1,1,regulation of acyl-CoA biosynthetic process,BP,PDK4
2589,GO:0051193,0.310214570320304,1,1,1,regulation of cofactor metabolic process,BP,PDK4
2590,GO:0051196,0.310214570320304,1,1,1,regulation of coenzyme metabolic process,BP,PDK4
2698,GO:0055067,0.310214570320304,1,1,1,monovalent inorganic cation homeostasis,BP,PDK4
2888,GO:0071229,0.310214570320304,1,1,1,cellular response to acid chemical,BP,PDK4
2919,GO:0071398,0.310214570320304,1,1,1,cellular response to fatty acid,BP,PDK4
3391,GO:2000209,0.310214570320304,1,1,1,regulation of anoikis,BP,PDK4
3415,GO:2000811,0.310214570320304,1,1,1,negative regulation of anoikis,BP,PDK4
277,GO:0004521,0.310214570320314,1,1,1,endoribonuclease activity,MF,RNASEL
464,GO:0006364,0.310214570320314,1,1,1,rRNA processing,BP,RNASEL
954,GO:0010827,0.310214570320314,1,1,1,regulation of glucose transport,BP,RNASEL
955,GO:0010828,0.310214570320314,1,1,1,positive regulation of glucose transport,BP,RNASEL
1110,GO:0016363,0.310214570320314,1,1,1,nuclear matrix,CC,RNASEL
1236,GO:0019058,0.310214570320314,1,1,1,viral life cycle,BP,RNASEL
1237,GO:0019079,0.310214570320314,1,1,1,viral genome replication,BP,RNASEL
1736,GO:0034399,0.310214570320314,1,1,1,nuclear periphery,CC,RNASEL
1891,GO:0042254,0.310214570320314,1,1,1,ribosome biogenesis,BP,RNASEL
1978,GO:0043021,0.310214570320314,1,1,1,ribonucleoprotein complex binding,MF,RNASEL
2081,GO:0043900,0.310214570320314,1,1,1,regulation of multi-organism process,BP,RNASEL
2082,GO:0043901,0.310214570320314,1,1,1,negative regulation of multi-organism process,BP,RNASEL
2083,GO:0043903,0.310214570320314,1,1,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,RNASEL
2120,GO:0044381,0.310214570320314,1,1,1,glucose import in response to insulin stimulus,BP,RNASEL
2181,GO:0045069,0.310214570320314,1,1,1,regulation of viral genome replication,BP,RNASEL
2182,GO:0045071,0.310214570320314,1,1,1,negative regulation of viral genome replication,BP,RNASEL
2280,GO:0046324,0.310214570320314,1,1,1,regulation of glucose import,BP,RNASEL
2281,GO:0046326,0.310214570320314,1,1,1,positive regulation of glucose import,BP,RNASEL
2417,GO:0048525,0.310214570320314,1,1,1,negative regulation of viral process,BP,RNASEL
2510,GO:0050792,0.310214570320314,1,1,1,regulation of viral process,BP,RNASEL
3042,GO:0090502,0.310214570320314,1,1,1,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,RNASEL
3137,GO:1900076,0.310214570320314,1,1,1,regulation of cellular response to insulin stimulus,BP,RNASEL
3138,GO:1900078,0.310214570320314,1,1,1,positive regulation of cellular response to insulin stimulus,BP,RNASEL
3328,GO:1903900,0.310214570320314,1,1,1,regulation of viral life cycle,BP,RNASEL
3329,GO:1903901,0.310214570320314,1,1,1,negative regulation of viral life cycle,BP,RNASEL
3438,GO:2001273,0.310214570320314,1,1,1,regulation of glucose import in response to insulin stimulus,BP,RNASEL
3439,GO:2001275,0.310214570320314,1,1,1,positive regulation of glucose import in response to insulin stimulus,BP,RNASEL
3381,GO:2000112,0.312854915409457,0.860435262184928,5,17,regulation of cellular macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
893,GO:0010243,0.314060231632897,0.893344627008778,3,9,response to organonitrogen compound,BP,CASP4;PDK4;RNASEL
2264,GO:0045944,0.314788719914453,0.933426462987988,2,4,positive regulation of transcription from RNA polymerase II promoter,BP,HEXB;RNASEL
2163,GO:0044723,0.314904682948428,0.890348676542033,3,10,single-organism carbohydrate metabolic process,BP,HEXB;PDK4;IDUA
868,GO:0009891,0.319931371852912,0.871831666073408,4,12,positive regulation of biosynthetic process,BP,HEXB;TICAM1;RBMS3;RNASEL
2896,GO:0071310,0.323601136959356,0.852385732384477,5,18,cellular response to organic substance,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL
3184,GO:1901617,0.324868902643128,0.920664699124953,2,5,organic hydroxy compound biosynthetic process,BP,HSD17B3;DHCR7
740,GO:0008360,0.325634734890964,0.969302021961474,1,2,regulation of cell shape,BP,HEXB
1865,GO:0042063,0.325634734890964,0.969302021961474,1,2,gliogenesis,BP,HEXB
2004,GO:0043168,0.32648354697262,0.835811315008603,7,22,anion binding,MF,ACSF2;PNP;SNX21;ACCS;PDK4;AOX1;RNASEL
2129,GO:0044428,0.331654049676878,0.844426652006862,5,21,nuclear part,CC,MRI1;AOX1;DHCR7;IFI27;RNASEL
3382,GO:2000113,0.332274638284773,0.958162116808652,1,3,negative regulation of cellular macromolecule biosynthetic process,BP,IFI27
508,GO:0006629,0.333397834135773,0.8110854360703,11,44,lipid metabolic process,BP,ACSF2;HEXB;CYP11A1;HSD3B2;HSD17B3;PDK4;PON2;HSD17B11;DHCR7;BDH2;ASAH2
2105,GO:0044262,0.33422224020646,0.925927467281166,2,4,cellular carbohydrate metabolic process,BP,PDK4;IDUA
400,GO:0005829,0.339208169547297,0.808708954716307,10,42,cytosol,CC,PNP;MRI1;CMBL;TICAM1;CASP4;AOX1;HSD17B11;DHCR7;BDH2;RNASEL
1240,GO:0019184,0.341478931360034,0.965863463013133,1,2,nonribosomal peptide biosynthetic process,BP,BDH2
1984,GO:0043043,0.344918404068691,0.90189996122273,2,7,peptide biosynthetic process,BP,RBMS3;BDH2
2067,GO:0043604,0.344918404068691,0.90189996122273,2,7,amide biosynthetic process,BP,RBMS3;BDH2
2475,GO:0050663,0.345574137112848,0.964937760602487,1,2,cytokine secretion,BP,PNP
1015,GO:0015031,0.348253722566888,0.867326207104061,3,12,protein transport,BP,PNP;SNX21;IFI27
1055,GO:0015833,0.348253722566888,0.867326207104061,3,12,peptide transport,BP,PNP;SNX21;IFI27
1964,GO:0042886,0.348253722566888,0.867326207104061,3,12,amide transport,BP,PNP;SNX21;IFI27
2193,GO:0045184,0.348253722566888,0.867326207104061,3,12,establishment of protein localization,BP,PNP;SNX21;IFI27
2697,GO:0055065,0.348864676686623,0.910009823647825,2,5,metal ion homeostasis,BP,HEXB;BDH2
1601,GO:0032602,0.349102487762208,0.964127796481051,1,2,chemokine production,BP,TICAM1
1610,GO:0032635,0.349102487762208,0.964127796481051,1,2,interleukin-6 production,BP,TICAM1
1613,GO:0032642,0.349102487762208,0.964127796481051,1,2,regulation of chemokine production,BP,TICAM1
1620,GO:0032675,0.349102487762208,0.964127796481051,1,2,regulation of interleukin-6 production,BP,TICAM1
1625,GO:0032722,0.349102487762208,0.964127796481051,1,2,positive regulation of chemokine production,BP,TICAM1
1631,GO:0032755,0.349102487762208,0.964127796481051,1,2,positive regulation of interleukin-6 production,BP,TICAM1
980,GO:0010941,0.34924693791764,0.866726961161484,3,12,regulation of cell death,BP,CASP4;PDK4;IFI27
1968,GO:0042981,0.34924693791764,0.866726961161484,3,12,regulation of apoptotic process,BP,CASP4;PDK4;IFI27
1987,GO:0043067,0.34924693791764,0.866726961161484,3,12,regulation of programmed cell death,BP,CASP4;PDK4;IFI27
1529,GO:0031967,0.34961561802888,0.834989573743257,5,18,organelle envelope,CC,CYP11A1;HSD3B2;PDK4;DHCR7;IFI27
1533,GO:0031975,0.34961561802888,0.834989573743257,5,18,envelope,CC,CYP11A1;HSD3B2;PDK4;DHCR7;IFI27
906,GO:0010556,0.351661397469884,0.833589827775285,5,18,regulation of macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1794,GO:0035384,0.351751895938447,0.918799682636872,2,4,thioester biosynthetic process,BP,ACSF2;PDK4
2936,GO:0071616,0.351751895938447,0.918799682636872,2,4,acyl-CoA biosynthetic process,BP,ACSF2;PDK4
97,GO:0001894,0.352241014814317,0.963397593943806,1,2,tissue homeostasis,BP,PDK4
2737,GO:0060249,0.352241014814317,0.963397593943806,1,2,anatomical structure homeostasis,BP,PDK4
776,GO:0009057,0.352520106193565,0.902190788508627,2,6,macromolecule catabolic process,BP,HEXB;IDUA
2252,GO:0045893,0.353155474509425,0.908031014781858,2,5,positive regulation of transcription, DNA-templated,BP,HEXB;RNASEL
2610,GO:0051254,0.353155474509425,0.908031014781858,2,5,positive regulation of RNA metabolic process,BP,HEXB;RNASEL
3251,GO:1902680,0.353155474509425,0.908031014781858,2,5,positive regulation of RNA biosynthetic process,BP,HEXB;RNASEL
3298,GO:1903508,0.353155474509425,0.908031014781858,2,5,positive regulation of nucleic acid-templated transcription,BP,HEXB;RNASEL
2164,GO:0044724,0.355110404237697,0.96272193428426,1,2,single-organism carbohydrate catabolic process,BP,HEXB
732,GO:0008283,0.355427339921437,0.862970763558804,3,12,cell proliferation,BP,PNP;TICAM1;DHCR7
1877,GO:0042127,0.355427339921437,0.862970763558804,3,12,regulation of cell proliferation,BP,PNP;TICAM1;DHCR7
866,GO:0009889,0.355797451580184,0.811185843168665,7,27,regulation of biosynthetic process,BP,HEXB;TICAM1;RBMS3;PDK4;DHCR7;IFI27;RNASEL
454,GO:0006195,0.356683498408215,0.962348222308563,1,2,purine nucleotide catabolic process,BP,PNP
275,GO:0004518,0.356775805007693,0.962326220798122,1,2,nuclease activity,MF,RNASEL
276,GO:0004519,0.356775805007693,0.962326220798122,1,2,endonuclease activity,MF,RNASEL
278,GO:0004540,0.356775805007693,0.962326220798122,1,2,ribonuclease activity,MF,RNASEL
1084,GO:0016072,0.356775805007693,0.962326220798122,1,2,rRNA metabolic process,BP,RNASEL
3037,GO:0090305,0.356775805007693,0.962326220798122,1,2,nucleic acid phosphodiester bond hydrolysis,BP,RNASEL
3041,GO:0090501,0.356775805007693,0.962326220798122,1,2,RNA phosphodiester bond hydrolysis,BP,RNASEL
345,GO:0005506,0.356860932568135,0.906303949829162,2,5,iron ion binding,MF,CYP11A1;AOX1
2050,GO:0043487,0.35726726660199,0.962208943772369,1,2,regulation of RNA stability,BP,RNASEL
2051,GO:0043488,0.35726726660199,0.962208943772369,1,2,regulation of mRNA stability,BP,RNASEL
2038,GO:0043393,0.359538829004803,0.961663902689082,1,2,regulation of protein binding,BP,TICAM1
2054,GO:0043496,0.359538829004803,0.961663902689082,1,2,regulation of protein homodimerization activity,BP,TICAM1
2571,GO:0051098,0.359538829004803,0.961663902689082,1,2,regulation of binding,BP,TICAM1
375,GO:0005741,0.363823942952522,0.948835029735071,1,3,mitochondrial outer membrane,CC,IFI27
697,GO:0008104,0.365082388729828,0.85541583359406,3,13,protein localization,BP,PNP;SNX21;IFI27
1648,GO:0032870,0.36611945048402,0.91269424339646,2,4,cellular response to hormone stimulus,BP,PDK4;RNASEL
2913,GO:0071375,0.36611945048402,0.91269424339646,2,4,cellular response to peptide hormone stimulus,BP,PDK4;RNASEL
529,GO:0006687,0.368360009127262,0.959500438123028,1,2,glycosphingolipid metabolic process,BP,HEXB
1258,GO:0019377,0.368360009127262,0.959500438123028,1,2,glycolipid catabolic process,BP,HEXB
1371,GO:0030149,0.368360009127262,0.959500438123028,1,2,sphingolipid catabolic process,BP,HEXB
2302,GO:0046466,0.368360009127262,0.959500438123028,1,2,membrane lipid catabolic process,BP,HEXB
2308,GO:0046479,0.368360009127262,0.959500438123028,1,2,glycosphingolipid catabolic process,BP,HEXB
2317,GO:0046514,0.368360009127262,0.959500438123028,1,2,ceramide catabolic process,BP,HEXB
2847,GO:0070542,0.369475608256776,0.959221462185921,1,2,response to fatty acid,BP,PDK4
181,GO:0002694,0.370076872610442,0.9000055154756,2,5,regulation of leukocyte activation,BP,PNP;TICAM1
2531,GO:0050865,0.370076872610442,0.9000055154756,2,5,regulation of cell activation,BP,PNP;TICAM1
1104,GO:0016301,0.370925206280452,0.899593760469465,2,5,kinase activity,MF,PDK4;RNASEL
1166,GO:0016773,0.370925206280452,0.899593760469465,2,5,phosphotransferase activity, alcohol group as acceptor,MF,PDK4;RNASEL
870,GO:0009893,0.372122778090517,0.816337717021603,5,21,positive regulation of metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
393,GO:0005789,0.372896285206785,0.830074493288614,4,17,endoplasmic reticulum membrane,CC,HSD3B2;CASP4;HSD17B3;DHCR7
1884,GO:0042175,0.372896285206785,0.830074493288614,4,17,nuclear outer membrane-endoplasmic reticulum membrane network,CC,HSD3B2;CASP4;HSD17B3;DHCR7
2133,GO:0044432,0.372896285206785,0.830074493288614,4,17,endoplasmic reticulum part,CC,HSD3B2;CASP4;HSD17B3;DHCR7
1887,GO:0042181,0.374602510378058,0.957923701459616,1,2,ketone biosynthetic process,BP,HSD17B3
2334,GO:0046661,0.374602510378058,0.957923701459616,1,2,male sex differentiation,BP,HSD17B3
2793,GO:0061370,0.374602510378058,0.957923701459616,1,2,testosterone biosynthetic process,BP,HSD17B3
1680,GO:0033489,0.376399628271423,0.957462662352716,1,2,cholesterol biosynthetic process via desmosterol,BP,DHCR7
1681,GO:0033490,0.376399628271423,0.957462662352716,1,2,cholesterol biosynthetic process via lathosterol,BP,DHCR7
2260,GO:0045935,0.378462464549353,0.889053086122759,2,6,positive regulation of nucleobase-containing compound metabolic process,BP,HEXB;RNASEL
2096,GO:0044238,0.379026254284478,0.791595697896796,20,90,primary metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
525,GO:0006664,0.379592346213319,0.943734529004039,1,3,glycolipid metabolic process,BP,HEXB
3299,GO:1903509,0.379592346213319,0.943734529004039,1,3,liposaccharide metabolic process,BP,HEXB
462,GO:0006355,0.380194915049209,0.829268007437716,4,14,regulation of transcription, DNA-templated,BP,HEXB;TICAM1;IFI27;RNASEL
733,GO:0008284,0.380351975879598,0.883450866695381,2,7,positive regulation of cell proliferation,BP,PNP;TICAM1
1505,GO:0031410,0.38095655801113,0.814368347393479,5,17,cytoplasmic vesicle,CC,PNP;HEXB;SNX21;TICAM1;IDUA
3082,GO:0097708,0.38095655801113,0.814368347393479,5,17,intracellular vesicle,CC,PNP;HEXB;SNX21;TICAM1;IDUA
84,GO:0001775,0.381095166909094,0.854710823513833,3,9,cell activation,BP,PNP;HEXB;TICAM1
2199,GO:0045321,0.381095166909094,0.854710823513833,3,9,leukocyte activation,BP,PNP;HEXB;TICAM1
843,GO:0009607,0.385555524591979,0.851943773608153,3,9,response to biotic stimulus,BP,TICAM1;PRRT1;RNASEL
775,GO:0009056,0.386018644908323,0.776457047809476,9,37,catabolic process,BP,PNP;HEXB;TICAM1;AOX1;PON2;HSD17B11;BDH2;WDR45;IDUA
3199,GO:1901700,0.388642195650085,0.823459852218628,4,14,response to oxygen-containing compound,BP,TICAM1;CASP4;PDK4;RNASEL
1139,GO:0016627,0.389780164681759,0.890206333425662,2,5,oxidoreductase activity, acting on the CH-CH group of donors,MF,DHCR7;BDH2
2211,GO:0045444,0.390159513129338,0.940145756266408,1,3,fat cell differentiation,BP,RNASEL
1551,GO:0032270,0.390181126923636,0.840963146030118,3,12,positive regulation of cellular protein metabolic process,BP,TICAM1;RBMS3;IFI27
2604,GO:0051247,0.390181126923636,0.840963146030118,3,12,positive regulation of protein metabolic process,BP,TICAM1;RBMS3;IFI27
2099,GO:0044248,0.390625417866352,0.778032108709242,8,32,cellular catabolic process,BP,PNP;HEXB;TICAM1;AOX1;PON2;BDH2;WDR45;IDUA
1269,GO:0019538,0.391142115187271,0.776080971026814,8,36,protein metabolic process,BP,HEXB;TICAM1;CASP4;RBMS3;PDK4;IFI27;RNASEL;IDUA
1772,GO:0034976,0.391411268831343,0.953484741654821,1,2,response to endoplasmic reticulum stress,BP,CASP4
142,GO:0002283,0.394063417320272,0.880730292893432,2,6,neutrophil activation involved in immune response,BP,PNP;HEXB
149,GO:0002444,0.394063417320272,0.880730292893432,2,6,myeloid leukocyte mediated immunity,BP,PNP;HEXB
150,GO:0002446,0.394063417320272,0.880730292893432,2,6,neutrophil mediated immunity,BP,PNP;HEXB
1536,GO:0031983,0.394063417320272,0.880730292893432,2,6,vesicle lumen,CC,PNP;HEXB
1771,GO:0034774,0.394063417320272,0.880730292893432,2,6,secretory granule lumen,CC,PNP;HEXB
1836,GO:0036230,0.394063417320272,0.880730292893432,2,6,granulocyte activation,BP,PNP;HEXB
1876,GO:0042119,0.394063417320272,0.880730292893432,2,6,neutrophil activation,BP,PNP;HEXB
2034,GO:0043299,0.394063417320272,0.880730292893432,2,6,leukocyte degranulation,BP,PNP;HEXB
2035,GO:0043312,0.394063417320272,0.880730292893432,2,6,neutrophil degranulation,BP,PNP;HEXB
2735,GO:0060205,0.394063417320272,0.880730292893432,2,6,cytoplasmic vesicle lumen,CC,PNP;HEXB
1668,GO:0033036,0.39409625150185,0.814175940270491,4,18,macromolecule localization,BP,PNP;HEXB;SNX21;IFI27
2114,GO:0044283,0.394162129437176,0.792726629826831,6,21,small molecule biosynthetic process,BP,PNP;MRI1;HSD17B3;PDK4;DHCR7;BDH2
2108,GO:0044270,0.397648170859039,0.878772193013348,2,6,cellular nitrogen compound catabolic process,BP,PNP;AOX1
2338,GO:0046700,0.397648170859039,0.878772193013348,2,6,heterocycle catabolic process,BP,PNP;AOX1
382,GO:0005766,0.404184280238914,0.935164713048092,1,3,primary lysosome,CC,HEXB
1800,GO:0035578,0.404184280238914,0.935164713048092,1,3,azurophil granule lumen,CC,HEXB
1938,GO:0042582,0.404184280238914,0.935164713048092,1,3,azurophil granule,CC,HEXB
2456,GO:0048771,0.407650500876523,0.948919302258057,1,2,tissue remodeling,BP,PDK4
1321,GO:0022613,0.407650500876531,0.948919302258054,1,2,ribonucleoprotein complex biogenesis,BP,RNASEL
50,GO:0001101,0.40808424040654,0.933734443874926,1,3,response to acid chemical,BP,PDK4
2047,GO:0043434,0.410124079126699,0.879561289804593,2,5,response to peptide hormone,BP,PDK4;RNASEL
2095,GO:0044237,0.412576981708335,0.766067022127768,20,90,cellular metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;BDH2;IFI27;RNASEL;WDR45;ASAH2;IDUA
2714,GO:0055114,0.413335302125117,0.760008181444715,8,32,oxidation-reduction process,BP,CYP11A1;HSD3B2;HSD17B3;PDK4;AOX1;HSD17B11;DHCR7;BDH2
3175,GO:1901566,0.415979130943106,0.79939959200673,4,17,organonitrogen compound biosynthetic process,BP,PNP;MRI1;RBMS3;BDH2
209,GO:0003006,0.419467754663839,0.861136932139065,2,7,developmental process involved in reproduction,BP,HEXB;HSD17B3
539,GO:0006704,0.419688877558007,0.945352318216734,1,2,glucocorticoid biosynthetic process,BP,HSD3B2
1285,GO:0019843,0.421887863844337,0.928510320468275,1,3,rRNA binding,MF,RNASEL
1861,GO:0042035,0.423332814641023,0.944241102891674,1,2,regulation of cytokine biosynthetic process,BP,TICAM1
1866,GO:0042089,0.423332814641023,0.944241102891674,1,2,cytokine biosynthetic process,BP,TICAM1
1871,GO:0042107,0.423332814641023,0.944241102891674,1,2,cytokine metabolic process,BP,TICAM1
2202,GO:0045350,0.423332814641023,0.944241102891674,1,2,interferon-beta biosynthetic process,BP,TICAM1
2203,GO:0045351,0.423332814641023,0.944241102891674,1,2,type I interferon biosynthetic process,BP,TICAM1
2206,GO:0045357,0.423332814641023,0.944241102891674,1,2,regulation of interferon-beta biosynthetic process,BP,TICAM1
7,GO:0000096,0.423526023314325,0.944181769462669,1,2,sulfur amino acid metabolic process,BP,MRI1
497,GO:0006555,0.423526023314325,0.944181769462669,1,2,methionine metabolic process,BP,MRI1
783,GO:0009066,0.423526023314325,0.944181769462669,1,2,aspartate family amino acid metabolic process,BP,MRI1
2155,GO:0044702,0.424028696149768,0.858397368975611,2,7,single organism reproductive process,BP,HEXB;HSD17B3
601,GO:0006919,0.424128931882527,0.919848221995389,1,4,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI27
983,GO:0010950,0.424128931882527,0.919848221995389,1,4,positive regulation of endopeptidase activity,BP,IFI27
985,GO:0010952,0.424128931882527,0.919848221995389,1,4,positive regulation of peptidase activity,BP,IFI27
2031,GO:0043280,0.424128931882527,0.919848221995389,1,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI27
3420,GO:2001056,0.424128931882527,0.919848221995389,1,4,positive regulation of cysteine-type endopeptidase activity,BP,IFI27
3296,GO:1903506,0.42419191551139,0.796221963854706,4,15,regulation of nucleic acid-templated transcription,BP,HEXB;TICAM1;IFI27;RNASEL
1165,GO:0016772,0.426275187710406,0.86250824623722,2,6,transferase activity, transferring phosphorus-containing groups,MF,PDK4;RNASEL
3183,GO:1901615,0.427075463787331,0.818273612233209,3,11,organic hydroxy compound metabolic process,BP,CYP11A1;HSD17B3;DHCR7
176,GO:0002684,0.430249767497216,0.854613147262787,2,7,positive regulation of immune system process,BP,PNP;TICAM1
2580,GO:0051171,0.432496737117529,0.770124165483818,5,22,regulation of nitrogen compound metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2804,GO:0065007,0.432732064992766,0.729681742717286,15,66,biological regulation,BP,PNP;HEXB;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2
3112,GO:0098805,0.434870490974812,0.788244961674103,4,15,whole membrane,CC,SNX21;TICAM1;DHCR7;IFI27
835,GO:0009435,0.435673984670745,0.940366130624267,1,2,NAD biosynthetic process,BP,PNP
1252,GO:0019359,0.435673984670745,0.940366130624267,1,2,nicotinamide nucleotide biosynthetic process,BP,PNP
1254,GO:0019363,0.435673984670745,0.940366130624267,1,2,pyridine nucleotide biosynthetic process,BP,PNP
1721,GO:0034356,0.435673984670745,0.940366130624267,1,2,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PNP
2992,GO:0072525,0.435673984670745,0.940366130624267,1,2,pyridine-containing compound biosynthetic process,BP,PNP
908,GO:0010558,0.442125605718176,0.911886193979242,1,4,negative regulation of macromolecule biosynthetic process,BP,IFI27
2581,GO:0051172,0.443322071067887,0.906354631246347,1,5,negative regulation of nitrogen compound metabolic process,BP,IFI27
2016,GO:0043230,0.444253036919109,0.748463895653419,6,27,extracellular organelle,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
2811,GO:0070062,0.444253036919109,0.748463895653419,6,27,extracellular exosome,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
3308,GO:1903561,0.444253036919109,0.748463895653419,6,27,extracellular vesicle,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
459,GO:0006351,0.44478226425122,0.779059259057749,4,16,transcription, DNA-templated,BP,HEXB;TICAM1;IFI27;RNASEL
3080,GO:0097659,0.44478226425122,0.779059259057749,4,16,nucleic acid-templated transcription,BP,HEXB;TICAM1;IFI27;RNASEL
2939,GO:0071705,0.447365209840925,0.799338909312852,3,13,nitrogen compound transport,BP,PNP;SNX21;IFI27
1532,GO:0031974,0.448053753491533,0.721352237900342,10,43,membrane-enclosed lumen,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;PDK4;AOX1;RNASEL;IDUA
2019,GO:0043233,0.448053753491533,0.721352237900342,10,43,organelle lumen,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;PDK4;AOX1;RNASEL;IDUA
2809,GO:0070013,0.448053753491533,0.721352237900342,10,43,intracellular organelle lumen,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;PDK4;AOX1;RNASEL;IDUA
748,GO:0008395,0.453242871228368,0.934543352171004,1,2,steroid hydroxylase activity,MF,CYP11A1
1583,GO:0032479,0.456174745808926,0.914395948814106,1,3,regulation of type I interferon production,BP,TICAM1
1602,GO:0032606,0.456174745808926,0.914395948814106,1,3,type I interferon production,BP,TICAM1
1604,GO:0032608,0.456174745808926,0.914395948814106,1,3,interferon-beta production,BP,TICAM1
1615,GO:0032648,0.456174745808926,0.914395948814106,1,3,regulation of interferon-beta production,BP,TICAM1
2566,GO:0051090,0.456174745808926,0.914395948814106,1,3,regulation of sequence-specific DNA binding transcription factor activity,BP,TICAM1
2567,GO:0051091,0.456174745808926,0.914395948814106,1,3,positive regulation of sequence-specific DNA binding transcription factor activity,BP,TICAM1
2568,GO:0051092,0.456174745808926,0.914395948814106,1,3,positive regulation of NF-kappaB transcription factor activity,BP,TICAM1
798,GO:0009116,0.460568807650477,0.932005289641258,1,2,nucleoside metabolic process,BP,PNP
806,GO:0009164,0.460568807650477,0.932005289641258,1,2,nucleoside catabolic process,BP,PNP
1189,GO:0016863,0.461289808321934,0.912145018135635,1,3,intramolecular oxidoreductase activity, transposing C=C bonds,MF,HSD3B2
1129,GO:0016567,0.463009379905644,0.911379537738069,1,3,protein ubiquitination,BP,TICAM1
1498,GO:0031396,0.463009379905644,0.911379537738069,1,3,regulation of protein ubiquitination,BP,TICAM1
1500,GO:0031398,0.463009379905644,0.911379537738069,1,3,positive regulation of protein ubiquitination,BP,TICAM1
1582,GO:0032446,0.463009379905644,0.911379537738069,1,3,protein modification by small protein conjugation,BP,TICAM1
2855,GO:0070647,0.463009379905644,0.911379537738069,1,3,protein modification by small protein conjugation or removal,BP,TICAM1
3287,GO:1903320,0.463009379905644,0.911379537738069,1,3,regulation of protein modification by small protein conjugation or removal,BP,TICAM1
3289,GO:1903322,0.463009379905644,0.911379537738069,1,3,positive regulation of protein modification by small protein conjugation or removal,BP,TICAM1
1403,GO:0030323,0.463572515324612,0.911127888741029,1,3,respiratory tube development,BP,DHCR7
1404,GO:0030324,0.463572515324612,0.911127888741029,1,3,lung development,BP,DHCR7
2767,GO:0060541,0.463572515324612,0.911127888741029,1,3,respiratory system development,BP,DHCR7
377,GO:0005758,0.466367442821124,0.929949084379827,1,2,mitochondrial intermembrane space,CC,HSD3B2
1531,GO:0031970,0.466367442821124,0.929949084379827,1,2,organelle envelope lumen,CC,HSD3B2
2387,GO:0048037,0.466727636123176,0.76811096201067,4,13,cofactor binding,MF,ACCS;AOX1;DHCR7;BDH2
65,GO:0001568,0.46735298456651,0.909426114932921,1,3,blood vessel development,BP,DHCR7
112,GO:0001944,0.46735298456651,0.909426114932921,1,3,vasculature development,BP,DHCR7
2981,GO:0072358,0.46735298456651,0.909426114932921,1,3,cardiovascular system development,BP,DHCR7
2160,GO:0044710,0.468072217229147,0.699536114104729,15,69,single-organism metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;ASAH2;IDUA
490,GO:0006518,0.469095347073117,0.82521915894347,2,8,peptide metabolic process,BP,RBMS3;BDH2
374,GO:0005740,0.469152993994248,0.761670812536726,4,15,mitochondrial envelope,CC,CYP11A1;HSD3B2;PDK4;IFI27
1528,GO:0031966,0.469152993994248,0.761670812536726,4,15,mitochondrial membrane,CC,CYP11A1;HSD3B2;PDK4;IFI27
2702,GO:0055076,0.470550608204468,0.928439355486959,1,2,transition metal ion homeostasis,BP,BDH2
252,GO:0004175,0.473370661170949,0.896875800259024,1,4,endopeptidase activity,MF,CASP4
531,GO:0006690,0.474488912608005,0.906154518073031,1,3,icosanoid metabolic process,BP,PON2
3176,GO:1901568,0.474488912608005,0.906154518073031,1,3,fatty acid derivative metabolic process,BP,PON2
1169,GO:0016788,0.475751469285461,0.817202835718823,2,9,hydrolase activity, acting on ester bonds,MF,PON2;RNASEL
1758,GO:0034654,0.479133786465258,0.733137376774134,5,21,nucleobase-containing compound biosynthetic process,BP,PNP;HEXB;TICAM1;IFI27;RNASEL
1361,GO:0030098,0.479153027308798,0.9252639606943,1,2,lymphocyte differentiation,BP,PNP
1392,GO:0030217,0.479153027308798,0.9252639606943,1,2,T cell differentiation,BP,PNP
3219,GO:1902107,0.479153027308798,0.9252639606943,1,2,positive regulation of leukocyte differentiation,BP,PNP
3321,GO:1903708,0.479153027308798,0.9252639606943,1,2,positive regulation of hemopoiesis,BP,PNP
1301,GO:0020037,0.479626127130083,0.903750541851977,1,3,heme binding,MF,CYP11A1
2357,GO:0046906,0.479626127130083,0.903750541851977,1,3,tetrapyrrole binding,MF,CYP11A1
2415,GO:0048522,0.481270565979328,0.716745006086736,6,28,positive regulation of cellular process,BP,PNP;HEXB;TICAM1;RBMS3;IFI27;RNASEL
2130,GO:0044429,0.481745018470488,0.71928060626754,6,24,mitochondrial part,CC,ACSF2;CYP11A1;HSD3B2;PDK4;IFI27;RNASEL
129,GO:0002221,0.481980677455812,0.92419909002629,1,2,pattern recognition receptor signaling pathway,BP,TICAM1
131,GO:0002224,0.481980677455812,0.92419909002629,1,2,toll-like receptor signaling pathway,BP,TICAM1
193,GO:0002756,0.481980677455812,0.92419909002629,1,2,MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
1810,GO:0035666,0.481980677455812,0.92419909002629,1,2,TRIF-dependent toll-like receptor signaling pathway,BP,TICAM1
3070,GO:0097342,0.481980677455812,0.92419909002629,1,2,ripoptosome,CC,TICAM1
2139,GO:0044444,0.483071371046401,0.722570665028739,21,101,cytoplasmic part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
538,GO:0006703,0.485372336326129,0.92290784034561,1,2,estrogen biosynthetic process,BP,HSD17B11
719,GO:0008210,0.485372336326129,0.92290784034561,1,2,estrogen metabolic process,BP,HSD17B11
1890,GO:0042221,0.485752378496233,0.697153665036824,8,36,response to chemical,BP,PNP;CMBL;TICAM1;CASP4;PDK4;PON2;IFI27;RNASEL
2938,GO:0071704,0.488285852504376,0.705418115127723,20,93,organic substance metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
469,GO:0006397,0.489768256320302,0.89888235195594,1,3,mRNA processing,BP,RNASEL
1297,GO:0019915,0.489775877535002,0.921208364395457,1,2,lipid storage,BP,HEXB
622,GO:0007033,0.489775877535073,0.921208364395429,1,2,vacuole organization,BP,HEXB
677,GO:0007605,0.489775877535153,0.921208364395397,1,2,sensory perception of sound,BP,HEXB
2538,GO:0050885,0.489775877535153,0.921208364395397,1,2,neuromuscular process controlling balance,BP,HEXB
2542,GO:0050905,0.489775877535153,0.921208364395397,1,2,neuromuscular process,BP,HEXB
2546,GO:0050954,0.489775877535153,0.921208364395397,1,2,sensory perception of mechanical stimulus,BP,HEXB
744,GO:0008375,0.489775877535168,0.921208364395392,1,2,acetylglucosaminyltransferase activity,MF,HEXB
650,GO:0007276,0.490197924819267,0.898672481690308,1,3,gamete generation,BP,HEXB
1300,GO:0019953,0.490197924819267,0.898672481690308,1,3,sexual reproduction,BP,HEXB
1589,GO:0032504,0.490197924819267,0.898672481690308,1,3,multicellular organism reproduction,BP,HEXB
2156,GO:0044703,0.490197924819267,0.898672481690308,1,3,multi-organism reproductive process,BP,HEXB
2434,GO:0048609,0.490197924819267,0.898672481690308,1,3,multicellular organismal reproductive process,BP,HEXB
148,GO:0002443,0.490966547912443,0.814690903187195,2,7,leukocyte mediated immunity,BP,PNP;HEXB
414,GO:0005975,0.491705791279774,0.765375340394631,3,13,carbohydrate metabolic process,BP,HEXB;PDK4;IDUA
3397,GO:2000379,0.49218710774161,0.920266670547102,1,2,positive regulation of reactive oxygen species metabolic process,BP,TICAM1
444,GO:0006109,0.492216109609051,0.920255295795921,1,2,regulation of carbohydrate metabolic process,BP,PDK4
938,GO:0010675,0.492216109609051,0.920255295795921,1,2,regulation of cellular carbohydrate metabolic process,BP,PDK4
972,GO:0010906,0.492216109609051,0.920255295795921,1,2,regulation of glucose metabolic process,BP,PDK4
3173,GO:1901564,0.492775770351522,0.690547999749267,8,37,organonitrogen compound metabolic process,BP,PNP;HEXB;MRI1;RBMS3;AOX1;BDH2;ASAH2;IDUA
272,GO:0004497,0.492788817933663,0.897400638327952,1,3,monooxygenase activity,MF,CYP11A1
2608,GO:0051252,0.493430686056363,0.740096066718558,4,16,regulation of RNA metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
3422,GO:2001141,0.493430686056363,0.740096066718558,4,16,regulation of RNA biosynthetic process,BP,HEXB;TICAM1;IFI27;RNASEL
1482,GO:0031326,0.494332872128514,0.706740522058146,6,26,regulation of cellular biosynthetic process,BP,HEXB;TICAM1;RBMS3;PDK4;IFI27;RNASEL
1221,GO:0018130,0.495840219765914,0.717902827925148,5,22,heterocycle biosynthetic process,BP,PNP;HEXB;TICAM1;IFI27;RNASEL
1264,GO:0019438,0.495840219765914,0.717902827925148,5,22,aromatic compound biosynthetic process,BP,PNP;HEXB;TICAM1;IFI27;RNASEL
2586,GO:0051186,0.497009656005798,0.738963511812687,4,15,cofactor metabolic process,BP,ACSF2;PNP;PDK4;BDH2
536,GO:0006700,0.497298953503102,0.918243927774303,1,2,C21-steroid hormone biosynthetic process,BP,CYP11A1
1078,GO:0016052,0.49885823186962,0.894378359876766,1,3,carbohydrate catabolic process,BP,HEXB
3155,GO:1901135,0.499789843095566,0.758884462886974,3,13,carbohydrate derivative metabolic process,BP,PNP;HEXB;IDUA
2107,GO:0044267,0.499803345046973,0.699980770545329,6,29,cellular protein metabolic process,BP,HEXB;TICAM1;RBMS3;PDK4;IFI27;RNASEL
808,GO:0009166,0.500091236016418,0.893756973722465,1,3,nucleotide catabolic process,BP,PNP
3164,GO:1901292,0.500091236016418,0.893756973722465,1,3,nucleoside phosphate catabolic process,BP,PNP
2982,GO:0072359,0.500247631802629,0.882682735734384,1,4,circulatory system development,BP,DHCR7
1271,GO:0019674,0.50303103701185,0.892265239052887,1,3,NAD metabolic process,BP,PNP
1246,GO:0019221,0.503130699655854,0.794450914248802,2,10,cytokine-mediated signaling pathway,BP,IFI27;RNASEL
1774,GO:0035091,0.504338732667591,0.915398842587138,1,2,phosphatidylinositol binding,MF,SNX21
2032,GO:0043281,0.506208316601868,0.872825619639708,1,5,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI27
3383,GO:2000116,0.506208316601868,0.872825619639708,1,5,regulation of cysteine-type endopeptidase activity,BP,IFI27
1244,GO:0019219,0.508666478956225,0.72562964036623,4,17,regulation of nucleobase-containing compound metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
628,GO:0007155,0.508952888880269,0.889216334157,1,3,cell adhesion,BP,PNP
629,GO:0007159,0.508952888880269,0.889216334157,1,3,leukocyte cell-cell adhesion,BP,PNP
1109,GO:0016337,0.508952888880269,0.889216334157,1,3,single organismal cell-cell adhesion,BP,PNP
1309,GO:0022407,0.508952888880269,0.889216334157,1,3,regulation of cell-cell adhesion,BP,PNP
1310,GO:0022409,0.508952888880269,0.889216334157,1,3,positive regulation of cell-cell adhesion,BP,PNP
1320,GO:0022610,0.508952888880269,0.889216334157,1,3,biological adhesion,BP,PNP
1373,GO:0030155,0.508952888880269,0.889216334157,1,3,regulation of cell adhesion,BP,PNP
1867,GO:0042098,0.508952888880269,0.889216334157,1,3,T cell proliferation,BP,PNP
1869,GO:0042102,0.508952888880269,0.889216334157,1,3,positive regulation of T cell proliferation,BP,PNP
1873,GO:0042110,0.508952888880269,0.889216334157,1,3,T cell activation,BP,PNP
1878,GO:0042129,0.508952888880269,0.889216334157,1,3,regulation of T cell proliferation,BP,PNP
2238,GO:0045785,0.508952888880269,0.889216334157,1,3,positive regulation of cell adhesion,BP,PNP
2529,GO:0050863,0.508952888880269,0.889216334157,1,3,regulation of T cell activation,BP,PNP
2533,GO:0050870,0.508952888880269,0.889216334157,1,3,positive regulation of T cell activation,BP,PNP
3092,GO:0098602,0.508952888880269,0.889216334157,1,3,single organism cell adhesion,BP,PNP
3093,GO:0098609,0.508952888880269,0.889216334157,1,3,cell-cell adhesion,BP,PNP
3271,GO:1903037,0.508952888880269,0.889216334157,1,3,regulation of leukocyte cell-cell adhesion,BP,PNP
3272,GO:1903039,0.508952888880269,0.889216334157,1,3,positive regulation of leukocyte cell-cell adhesion,BP,PNP
898,GO:0010468,0.51009699419819,0.707712905434498,5,20,regulation of gene expression,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
89,GO:0001819,0.511626044134262,0.887820571987026,1,3,positive regulation of cytokine production,BP,TICAM1
1612,GO:0032640,0.511626044134262,0.887820571987026,1,3,tumor necrosis factor production,BP,TICAM1
1622,GO:0032680,0.511626044134262,0.887820571987026,1,3,regulation of tumor necrosis factor production,BP,TICAM1
1633,GO:0032760,0.511626044134262,0.887820571987026,1,3,positive regulation of tumor necrosis factor production,BP,TICAM1
2940,GO:0071706,0.511626044134262,0.887820571987026,1,3,tumor necrosis factor superfamily cytokine production,BP,TICAM1
3306,GO:1903555,0.511626044134262,0.887820571987026,1,3,regulation of tumor necrosis factor superfamily cytokine production,BP,TICAM1
3307,GO:1903557,0.511626044134262,0.887820571987026,1,3,positive regulation of tumor necrosis factor superfamily cytokine production,BP,TICAM1
2366,GO:0046950,0.51224007255892,0.91212177985081,1,2,cellular ketone body metabolic process,BP,BDH2
2367,GO:0046951,0.51224007255892,0.91212177985081,1,2,ketone body biosynthetic process,BP,BDH2
3227,GO:1902224,0.51224007255892,0.91212177985081,1,2,ketone body metabolic process,BP,BDH2
430,GO:0006085,0.512240072559089,0.912121779850739,1,2,acetyl-CoA biosynthetic process,BP,PDK4
981,GO:0010942,0.512273925282679,0.864852198582852,1,6,positive regulation of cell death,BP,IFI27
1985,GO:0043065,0.512273925282679,0.864852198582852,1,6,positive regulation of apoptotic process,BP,IFI27
1988,GO:0043068,0.512273925282679,0.864852198582852,1,6,positive regulation of programmed cell death,BP,IFI27
632,GO:0007166,0.512925445814242,0.720550842610566,4,18,cell surface receptor signaling pathway,BP,TICAM1;PDK4;IFI27;RNASEL
1636,GO:0032774,0.513151405982514,0.721776719656919,4,17,RNA biosynthetic process,BP,HEXB;TICAM1;IFI27;RNASEL
513,GO:0006637,0.514400661635783,0.804968991976128,2,6,acyl-CoA metabolic process,BP,ACSF2;PDK4
1793,GO:0035383,0.514400661635783,0.804968991976128,2,6,thioester metabolic process,BP,ACSF2;PDK4
2667,GO:0051704,0.516067215250457,0.747936812161458,3,12,multi-organism process,BP,HEXB;TICAM1;RNASEL
243,GO:0003996,0.516096449973803,0.910489538764609,1,2,acyl-CoA ligase activity,MF,ACSF2
1111,GO:0016405,0.516096449973803,0.910489538764609,1,2,CoA-ligase activity,MF,ACSF2
1192,GO:0016877,0.516096449973803,0.910489538764609,1,2,ligase activity, forming carbon-sulfur bonds,MF,ACSF2
1193,GO:0016878,0.516096449973803,0.910489538764609,1,2,acid-thiol ligase activity,MF,ACSF2
1495,GO:0031347,0.516513240843712,0.791028351533523,2,8,regulation of defense response,BP,TICAM1;CASP4
1457,GO:0031090,0.516640887075794,0.678748364940367,7,28,organelle membrane,CC,SNX21;CYP11A1;HSD3B2;TICAM1;PDK4;DHCR7;IFI27
590,GO:0006887,0.517137009078132,0.795719435719874,2,7,exocytosis,BP,PNP;HEXB
1369,GO:0030141,0.517137009078132,0.795719435719874,2,7,secretory granule,CC,PNP;HEXB
2180,GO:0045055,0.517137009078132,0.795719435719874,2,7,regulated exocytosis,BP,PNP;HEXB
3120,GO:0099503,0.517137009078132,0.795719435719874,2,7,secretory vesicle,CC,PNP;HEXB
194,GO:0002757,0.517783724740079,0.884558675672568,1,3,immune response-activating signal transduction,BP,TICAM1
195,GO:0002758,0.517783724740079,0.884558675672568,1,3,innate immune response-activating signal transduction,BP,TICAM1
198,GO:0002764,0.517783724740079,0.884558675672568,1,3,immune response-regulating signaling pathway,BP,TICAM1
1790,GO:0035336,0.518523836429411,0.90945092271573,1,2,long-chain fatty-acyl-CoA metabolic process,BP,ACSF2
1791,GO:0035337,0.518523836429411,0.90945092271573,1,2,fatty-acyl-CoA metabolic process,BP,ACSF2
1792,GO:0035338,0.518523836429411,0.90945092271573,1,2,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSF2
2365,GO:0046949,0.518523836429411,0.90945092271573,1,2,fatty-acyl-CoA biosynthetic process,BP,ACSF2
1,GO:0000003,0.51947699180578,0.788770380288495,2,8,reproduction,BP,HEXB;HSD17B3
1314,GO:0022414,0.51947699180578,0.788770380288495,2,8,reproductive process,BP,HEXB;HSD17B3
383,GO:0005768,0.519539090689574,0.80123963862593,2,6,endosome,CC,SNX21;TICAM1
160,GO:0002521,0.519689998024113,0.883535526231159,1,3,leukocyte differentiation,BP,PNP
3217,GO:1902105,0.519689998024113,0.883535526231159,1,3,regulation of leukocyte differentiation,BP,PNP
3319,GO:1903706,0.519689998024113,0.883535526231159,1,3,regulation of hemopoiesis,BP,PNP
778,GO:0009059,0.521189634385753,0.693823130030104,5,24,macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1757,GO:0034645,0.521189634385753,0.693823130030104,5,24,cellular macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2369,GO:0046982,0.521310620726269,0.882660686182855,1,3,protein heterodimerization activity,MF,HEXB
675,GO:0007600,0.521310620726411,0.882660686182778,1,3,sensory perception,BP,HEXB
93,GO:0001882,0.521530417511374,0.908152361727665,1,2,nucleoside binding,MF,PNP
2166,GO:0044763,0.521712623408235,0.668090500737792,19,89,single-organism cellular process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2652,GO:0051536,0.522407205385652,0.907771128060219,1,2,iron-sulfur cluster binding,MF,AOX1
2655,GO:0051540,0.522407205385652,0.907771128060219,1,2,metal cluster binding,MF,AOX1
2918,GO:0071396,0.523616695425889,0.798248929677922,2,6,cellular response to lipid,BP,TICAM1;PDK4
372,GO:0005737,0.525830090699682,0.70195980930216,22,105,cytoplasm,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2215,GO:0045540,0.526449711205209,0.905998434420441,1,2,regulation of cholesterol biosynthetic process,BP,DHCR7
3265,GO:1902930,0.526449711205209,0.905998434420441,1,2,regulation of alcohol biosynthetic process,BP,DHCR7
1779,GO:0035264,0.526449711205346,0.905998434420381,1,2,multicellular organism growth,BP,DHCR7
1279,GO:0019748,0.526482137268326,0.905984115062618,1,2,secondary metabolic process,BP,BDH2
388,GO:0005776,0.526522980084978,0.905966076587363,1,2,autophagosome,CC,TICAM1
900,GO:0010506,0.526522980084978,0.905966076587363,1,2,regulation of autophagy,BP,TICAM1
1875,GO:0042116,0.526522980085063,0.905966076587325,1,2,macrophage activation,BP,TICAM1
766,GO:0008652,0.526550078654255,0.905954106940503,1,2,cellular amino acid biosynthetic process,BP,MRI1
3182,GO:1901607,0.526550078654255,0.905954106940503,1,2,alpha-amino acid biosynthetic process,BP,MRI1
764,GO:0008643,0.5265500786543,0.905954106940483,1,2,carbohydrate transport,BP,RNASEL
765,GO:0008645,0.5265500786543,0.905954106940483,1,2,hexose transport,BP,RNASEL
1049,GO:0015749,0.5265500786543,0.905954106940483,1,2,monosaccharide transport,BP,RNASEL
1050,GO:0015758,0.5265500786543,0.905954106940483,1,2,glucose transport,BP,RNASEL
2279,GO:0046323,0.5265500786543,0.905954106940483,1,2,glucose import,BP,RNASEL
821,GO:0009267,0.526550078654353,0.905954106940459,1,2,cellular response to starvation,BP,PDK4
1514,GO:0031668,0.526550078654353,0.905954106940459,1,2,cellular response to extracellular stimulus,BP,PDK4
1515,GO:0031669,0.526550078654353,0.905954106940459,1,2,cellular response to nutrient levels,BP,PDK4
1652,GO:0032880,0.52706193298468,0.855523754982826,1,6,regulation of protein localization,BP,IFI27
2596,GO:0051223,0.52706193298468,0.855523754982826,1,6,regulation of protein transport,BP,IFI27
2819,GO:0070201,0.52706193298468,0.855523754982826,1,6,regulation of establishment of protein localization,BP,IFI27
3015,GO:0090087,0.52706193298468,0.855523754982826,1,6,regulation of peptide transport,BP,IFI27
873,GO:0009896,0.52731415695483,0.8793794080555,1,3,positive regulation of catabolic process,BP,TICAM1
1487,GO:0031331,0.52731415695483,0.8793794080555,1,3,positive regulation of cellular catabolic process,BP,TICAM1
715,GO:0008203,0.528456298476711,0.787164079882314,2,7,cholesterol metabolic process,BP,CYP11A1;DHCR7
3247,GO:1902652,0.528456298476711,0.787164079882314,2,7,secondary alcohol metabolic process,BP,CYP11A1;DHCR7
2141,GO:0044446,0.529399215523537,0.646396138551465,16,74,intracellular organelle part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;DHCR7;IFI27;RNASEL;IDUA
585,GO:0006874,0.530831253879391,0.877427188512602,1,3,cellular calcium ion homeostasis,BP,HEXB
2701,GO:0055074,0.530831253879391,0.877427188512602,1,3,calcium ion homeostasis,BP,HEXB
2985,GO:0072503,0.530831253879391,0.877427188512602,1,3,cellular divalent inorganic cation homeostasis,BP,HEXB
2986,GO:0072507,0.530831253879391,0.877427188512602,1,3,divalent inorganic cation homeostasis,BP,HEXB
2989,GO:0072522,0.532819034996302,0.87631395098289,1,3,purine-containing compound biosynthetic process,BP,PNP
475,GO:0006417,0.534214507315843,0.875528134827468,1,3,regulation of translation,BP,RBMS3
1711,GO:0034248,0.534214507315843,0.875528134827468,1,3,regulation of cellular amide metabolic process,BP,RBMS3
1378,GO:0030176,0.535072269871089,0.875043347174066,1,3,integral component of endoplasmic reticulum membrane,CC,DHCR7
1470,GO:0031227,0.535072269871089,0.875043347174066,1,3,intrinsic component of endoplasmic reticulum membrane,CC,DHCR7
1318,GO:0022604,0.537434800303515,0.873701116868463,1,3,regulation of cell morphogenesis,BP,HEXB
1535,GO:0031982,0.540041921320458,0.647185993514135,8,37,vesicle,CC,PNP;HEXB;SNX21;CMBL;TICAM1;AOX1;BDH2;IDUA
606,GO:0006950,0.5405530766864,0.655982248295954,7,29,response to stress,BP,TICAM1;CASP4;PDK4;AOX1;PON2;IFI27;RNASEL
710,GO:0008194,0.540881974726222,0.871724162831176,1,3,UDP-glycosyltransferase activity,MF,HEXB
3190,GO:1901657,0.542162532252475,0.870984130518717,1,3,glycosyl compound metabolic process,BP,PNP
3191,GO:1901658,0.542162532252475,0.870984130518717,1,3,glycosyl compound catabolic process,BP,PNP
1684,GO:0033554,0.543025723940774,0.766172741763666,2,9,cellular response to stress,BP,CASP4;PDK4
127,GO:0002218,0.545500825786104,0.855862495979614,1,4,activation of innate immune response,BP,TICAM1
1497,GO:0031349,0.545500825786104,0.855862495979614,1,4,positive regulation of defense response,BP,TICAM1
2187,GO:0045089,0.545500825786104,0.855862495979614,1,4,positive regulation of innate immune response,BP,TICAM1
545,GO:0006725,0.546264619319073,0.640922225350992,8,38,cellular aromatic compound metabolic process,BP,PNP;HEXB;TICAM1;AOX1;PON2;BDH2;IFI27;RNASEL
429,GO:0006084,0.548125433253922,0.867497560095302,1,3,acetyl-CoA metabolic process,BP,PDK4
565,GO:0006805,0.548371812000993,0.867352050287199,1,3,xenobiotic metabolic process,BP,CMBL
833,GO:0009410,0.548371812000993,0.867352050287199,1,3,response to xenobiotic stimulus,BP,CMBL
2927,GO:0071466,0.548371812000993,0.867352050287199,1,3,cellular response to xenobiotic stimulus,BP,CMBL
2464,GO:0048871,0.549128592459506,0.86690437586371,1,3,multicellular organismal homeostasis,BP,PDK4
1162,GO:0016758,0.54927656569666,0.853447358230073,1,4,transferase activity, transferring hexosyl groups,MF,HEXB
1133,GO:0016604,0.549682770936118,0.866575856537806,1,3,nuclear body,CC,AOX1
2143,GO:0044451,0.549682770936118,0.866575856537806,1,3,nucleoplasm part,CC,AOX1
631,GO:0007165,0.549721998758291,0.655676370339953,6,27,signal transduction,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
1372,GO:0030154,0.549886201863968,0.671808378627619,5,20,cell differentiation,BP,PNP;HEXB;DHCR7;BDH2;RNASEL
2462,GO:0048869,0.549886201863968,0.671808378627619,5,20,cellular developmental process,BP,PNP;HEXB;DHCR7;BDH2;RNASEL
1852,GO:0040007,0.55581356016786,0.862902029353702,1,3,growth,BP,DHCR7
2428,GO:0048589,0.55581356016786,0.862902029353702,1,3,developmental growth,BP,DHCR7
1644,GO:0032844,0.555962787591021,0.862811697133225,1,3,regulation of homeostatic process,BP,PDK4
1886,GO:0042180,0.557347324839839,0.754317285205028,2,9,cellular ketone metabolic process,BP,HSD17B3;PDK4
2937,GO:0071702,0.559369353543819,0.677563078621972,4,19,organic substance transport,BP,PNP;SNX21;IFI27;RNASEL
1071,GO:0016020,0.559711988451867,0.614108771555905,14,65,membrane,CC,HEXB;SNX21;CYP11A1;HSD3B2;TICAM1;CASP4;TMEM164;HSD17B3;PDK4;PRRT1;PON2;DHCR7;IFI27;ASAH2
2277,GO:0046320,0.561267071903152,0.859572450027105,1,3,regulation of fatty acid oxidation,BP,PDK4
2003,GO:0043167,0.561855320158557,0.621687255372661,9,39,ion binding,MF,ACSF2;PNP;SNX21;CYP11A1;ACCS;PDK4;AOX1;PON2;RNASEL
2598,GO:0051235,0.562657017827601,0.858714433417299,1,3,maintenance of location,BP,HEXB
1961,GO:0042802,0.56518416734628,0.672120568218965,4,19,identical protein binding,MF,HEXB;MRI1;ACCS;PON2
1288,GO:0019866,0.565332023874634,0.705306863087757,3,12,organelle inner membrane,CC,HSD3B2;PDK4;IFI27
2536,GO:0050877,0.566179192819314,0.842279543513539,1,4,neurological system process,BP,HEXB
373,GO:0005739,0.566509988457362,0.615657767850494,9,44,mitochondrion,CC,ACSF2;CYP11A1;HSD3B2;CASP4;PDK4;PON2;IFI27;RNASEL;ASAH2
159,GO:0002520,0.566596921360442,0.841996019732639,1,4,immune system development,BP,PNP
1360,GO:0030097,0.566596921360442,0.841996019732639,1,4,hemopoiesis,BP,PNP
2418,GO:0048534,0.566596921360442,0.841996019732639,1,4,hematopoietic or lymphoid organ development,BP,PNP
451,GO:0006163,0.567288693222045,0.841525682840103,1,4,purine nucleotide metabolic process,BP,PNP
2829,GO:0070266,0.567831701152107,0.855486092207144,1,3,necroptotic process,BP,TICAM1
3066,GO:0097300,0.567831701152107,0.855486092207144,1,3,programmed necrotic cell death,BP,TICAM1
567,GO:0006809,0.569153217647554,0.854652971095818,1,3,nitric oxide biosynthetic process,BP,TICAM1
2209,GO:0045428,0.569153217647554,0.854652971095818,1,3,regulation of nitric oxide biosynthetic process,BP,TICAM1
2276,GO:0046209,0.569153217647554,0.854652971095818,1,3,nitric oxide metabolic process,BP,TICAM1
3292,GO:1903409,0.569153217647554,0.854652971095818,1,3,reactive oxygen species biosynthetic process,BP,TICAM1
3293,GO:1903426,0.569153217647554,0.854652971095818,1,3,regulation of reactive oxygen species biosynthetic process,BP,TICAM1
3395,GO:2000377,0.569153217647554,0.854652971095818,1,3,regulation of reactive oxygen species metabolic process,BP,TICAM1
3421,GO:2001057,0.569153217647554,0.854652971095818,1,3,reactive nitrogen species metabolic process,BP,TICAM1
2991,GO:0072524,0.569562471411007,0.754219126775248,2,7,pyridine-containing compound metabolic process,BP,PNP;AOX1
1317,GO:0022603,0.569592948657662,0.83995168322196,1,4,regulation of anatomical structure morphogenesis,BP,HEXB
534,GO:0006695,0.572673773719501,0.852416126636665,1,3,cholesterol biosynthetic process,BP,DHCR7
1087,GO:0016126,0.572673773719501,0.852416126636665,1,3,sterol biosynthetic process,BP,DHCR7
2275,GO:0046165,0.572673773719501,0.852416126636665,1,3,alcohol biosynthetic process,BP,DHCR7
3248,GO:1902653,0.572673773719501,0.852416126636665,1,3,secondary alcohol biosynthetic process,BP,DHCR7
2473,GO:0050661,0.57754603488513,0.849278309228076,1,3,NADP binding,MF,DHCR7
417,GO:0006006,0.580868032461235,0.832084886022714,1,4,glucose metabolic process,BP,PDK4
478,GO:0006468,0.584096162220199,0.73117076833795,2,9,protein phosphorylation,BP,PDK4;RNASEL
378,GO:0005759,0.584206524299866,0.656957708380651,4,17,mitochondrial matrix,CC,ACSF2;CYP11A1;PDK4;RNASEL
2126,GO:0044422,0.586053906957786,0.592087416802032,16,75,organelle part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;DHCR7;IFI27;RNASEL;IDUA
774,GO:0009055,0.58629691386845,0.828197457398505,1,4,electron carrier activity,MF,AOX1
2493,GO:0050727,0.58924367362695,0.841540663979584,1,3,regulation of inflammatory response,BP,CASP4
87,GO:0001817,0.592795287860944,0.823457002624783,1,4,regulation of cytokine production,BP,TICAM1
3233,GO:1902494,0.592898991071895,0.804408192401387,1,7,catalytic complex,CC,TICAM1
1083,GO:0016071,0.597175130848151,0.820207453746868,1,4,mRNA metabolic process,BP,RNASEL
472,GO:0006412,0.600277944230124,0.808633174257106,1,5,translation,BP,RBMS3
175,GO:0002683,0.601757782815306,0.816759652323954,1,4,negative regulation of immune system process,BP,TICAM1
720,GO:0008211,0.60263878903585,0.832314182609953,1,3,glucocorticoid metabolic process,BP,HSD3B2
2250,GO:0045862,0.606823804062961,0.797315393213838,1,6,positive regulation of proteolysis,BP,IFI27
589,GO:0006886,0.607226774134579,0.812580051686302,1,4,intracellular protein transport,BP,IFI27
392,GO:0005783,0.607294432934579,0.626119651417703,4,24,endoplasmic reticulum,CC,HSD3B2;CASP4;HSD17B3;DHCR7
2466,GO:0048878,0.60738606264874,0.665789417122662,3,12,chemical homeostasis,BP,HEXB;PDK4;BDH2
200,GO:0002790,0.607989634401519,0.802505932112483,1,5,peptide secretion,BP,PNP
824,GO:0009306,0.607989634401519,0.802505932112483,1,5,protein secretion,BP,PNP
1999,GO:0043123,0.608498097948763,0.811598210030594,1,4,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
557,GO:0006767,0.608740593270551,0.811410488756762,1,4,water-soluble vitamin metabolic process,BP,AOX1
2474,GO:0050662,0.610012929349327,0.666739796695244,3,11,coenzyme binding,MF,AOX1;DHCR7;BDH2
724,GO:0008233,0.610595719306265,0.800402508682213,1,5,peptidase activity,MF,CASP4
2808,GO:0070011,0.610595719306265,0.800402508682213,1,5,peptidase activity, acting on L-amino acid peptides,MF,CASP4
2601,GO:0051240,0.61181623777091,0.710561065580903,2,8,positive regulation of multicellular organismal process,BP,PNP;TICAM1
2685,GO:0052689,0.612314561616725,0.808627263795596,1,4,carboxylic ester hydrolase activity,MF,PON2
1086,GO:0016125,0.613365689478342,0.709108875122899,2,8,sterol metabolic process,BP,CYP11A1;DHCR7
1745,GO:0034470,0.613809403855435,0.80745391839417,1,4,ncRNA processing,BP,RNASEL
850,GO:0009636,0.614414122940485,0.806977698935151,1,4,response to toxic substance,BP,PON2
1284,GO:0019842,0.615123920701802,0.806417581106738,1,4,vitamin binding,MF,ACCS
2413,GO:0048518,0.621100685965907,0.582404353607673,6,31,positive regulation of biological process,BP,PNP;HEXB;TICAM1;RBMS3;IFI27;RNASEL
807,GO:0009165,0.621118878585167,0.801636943329948,1,4,nucleotide biosynthetic process,BP,PNP
3165,GO:1901293,0.621118878585167,0.801636943329948,1,4,nucleoside phosphate biosynthetic process,BP,PNP
2186,GO:0045088,0.621289205637093,0.791594258224976,1,5,regulation of innate immune response,BP,TICAM1
1783,GO:0035295,0.62204650791851,0.800889174327938,1,4,tube development,BP,DHCR7
2433,GO:0048608,0.622168212058282,0.790857340436721,1,5,reproductive structure development,BP,HSD17B3
2798,GO:0061458,0.622168212058282,0.790857340436721,1,5,reproductive system development,BP,HSD17B3
3006,GO:0080090,0.625871678784564,0.569545739615028,7,32,regulation of primary metabolic process,BP,HEXB;TICAM1;RBMS3;PDK4;DHCR7;IFI27;RNASEL
717,GO:0008207,0.625894179179976,0.815315038508733,1,3,C21-steroid hormone metabolic process,BP,CYP11A1
1749,GO:0034613,0.626114266571784,0.787524638739556,1,5,cellular protein localization,BP,IFI27
2863,GO:0070727,0.626114266571784,0.787524638739556,1,5,cellular macromolecule localization,BP,IFI27
2010,GO:0043207,0.626405168373094,0.696688405746449,2,8,response to external biotic stimulus,BP,TICAM1;RNASEL
2668,GO:0051707,0.626405168373094,0.696688405746449,2,8,response to other organism,BP,TICAM1;RNASEL
174,GO:0002682,0.626785399699076,0.687496123633812,2,10,regulation of immune system process,BP,PNP;TICAM1
3128,GO:0101002,0.627256182324842,0.814279096472387,1,3,ficolin-1-rich granule,CC,PNP
3345,GO:1904813,0.627256182324842,0.814279096472387,1,3,ficolin-1-rich granule lumen,CC,PNP
2828,GO:0070265,0.629970789314952,0.794412059916528,1,4,necrotic cell death,BP,TICAM1
2540,GO:0050896,0.630941112996578,0.542626319154029,12,54,response to stimulus,BP,PNP;HEXB;CMBL;TICAM1;CASP4;PDK4;PRRT1;AOX1;PON2;IFI27;RNASEL;ASAH2
2162,GO:0044712,0.633697030596382,0.570390422206273,6,29,single-organism catabolic process,BP,PNP;HEXB;AOX1;HSD17B11;BDH2;IDUA
426,GO:0006066,0.634185104343607,0.6840515695145,2,9,alcohol metabolic process,BP,CYP11A1;DHCR7
1249,GO:0019318,0.63732084546486,0.777837383272854,1,5,hexose metabolic process,BP,PDK4
488,GO:0006508,0.639508581663163,0.671665460605881,2,11,proteolysis,BP,CASP4;IFI27
566,GO:0006807,0.640138054707897,0.533840455655313,11,55,nitrogen compound metabolic process,BP,PNP;HEXB;MRI1;TICAM1;RBMS3;AOX1;BDH2;IFI27;RNASEL;ASAH2;IDUA
1760,GO:0034660,0.640612890381342,0.774927787417785,1,5,ncRNA metabolic process,BP,RNASEL
584,GO:0006873,0.641335609976493,0.784837050481762,1,4,cellular ion homeostasis,BP,HEXB
586,GO:0006875,0.641335609976493,0.784837050481762,1,4,cellular metal ion homeostasis,BP,HEXB
1344,GO:0030003,0.641335609976493,0.784837050481762,1,4,cellular cation homeostasis,BP,HEXB
2929,GO:0071496,0.645869655289376,0.799649975259474,1,3,cellular response to external stimulus,BP,PDK4
2194,GO:0045202,0.649994256476729,0.796285626822933,1,3,synapse,CC,PRRT1
1896,GO:0042304,0.654467899786171,0.773337248233026,1,4,regulation of fatty acid biosynthetic process,BP,PDK4
2112,GO:0044281,0.654565871960003,0.517119109412219,12,57,small molecule metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD17B3;PDK4;AOX1;PON2;DHCR7;BDH2;IDUA
416,GO:0005996,0.65523811856555,0.754528720187481,1,6,monosaccharide metabolic process,BP,PDK4
1756,GO:0034641,0.656285895370995,0.522582736656099,9,46,cellular nitrogen compound metabolic process,BP,PNP;HEXB;TICAM1;RBMS3;AOX1;BDH2;IFI27;RNASEL;ASAH2
1191,GO:0016874,0.659345078893013,0.788486633649585,1,3,ligase activity,MF,ACSF2
226,GO:0003723,0.659387333463369,0.648354856788637,2,12,RNA binding,MF,RBMS3;RNASEL
1549,GO:0032268,0.661283986715432,0.60081024858415,3,16,regulation of cellular protein metabolic process,BP,TICAM1;RBMS3;IFI27
2295,GO:0046434,0.661765977797355,0.755511079392082,1,5,organophosphate catabolic process,BP,PNP
1448,GO:0030855,0.661800300027818,0.786398528010003,1,3,epithelial cell differentiation,BP,BDH2
889,GO:0010033,0.66239571992685,0.550934205293408,5,27,response to organic substance,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL
2682,GO:0052547,0.662431013384779,0.747619651284689,1,6,regulation of peptidase activity,BP,IFI27
2683,GO:0052548,0.662431013384779,0.747619651284689,1,6,regulation of endopeptidase activity,BP,IFI27
1942,GO:0042594,0.666789248549417,0.782102682453798,1,3,response to starvation,BP,PDK4
2669,GO:0051716,0.669892713040688,0.521511164674098,7,33,cellular response to stimulus,BP,CMBL;TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
2091,GO:0044093,0.670798987083393,0.633801692704508,2,13,positive regulation of molecular function,BP,TICAM1;IFI27
3021,GO:0090181,0.671632263580368,0.777863569148417,1,3,regulation of cholesterol metabolic process,BP,DHCR7
2359,GO:0046914,0.672692920549432,0.636639941329961,2,11,transition metal ion binding,MF,CYP11A1;AOX1
3039,GO:0090407,0.676279033533701,0.632699970521,2,11,organophosphate biosynthetic process,BP,PNP;HEXB
996,GO:0012506,0.676428664634451,0.773596965800169,1,3,vesicle membrane,CC,SNX21
1425,GO:0030659,0.676428664634451,0.773596965800169,1,3,cytoplasmic vesicle membrane,CC,SNX21
2519,GO:0050810,0.676570187263374,0.773470029008344,1,3,regulation of steroid biosynthetic process,BP,DHCR7
1295,GO:0019901,0.676667845653469,0.773382400424556,1,3,protein kinase binding,MF,TICAM1
547,GO:0006732,0.677490673849627,0.586944161735678,3,14,coenzyme metabolic process,BP,ACSF2;PNP;PDK4
852,GO:0009719,0.677619281101307,0.584599053358252,3,15,response to endogenous stimulus,BP,CASP4;PDK4;RNASEL
867,GO:0009890,0.678551317801418,0.726270997348751,1,7,negative regulation of biosynthetic process,BP,IFI27
1483,GO:0031327,0.678551317801418,0.726270997348751,1,7,negative regulation of cellular biosynthetic process,BP,IFI27
1654,GO:0032940,0.680268077857226,0.628280342948494,2,11,secretion by cell,BP,PNP;HEXB
2356,GO:0046903,0.680268077857226,0.628280342948494,2,11,secretion,BP,PNP;HEXB
1157,GO:0016740,0.681502554739171,0.552018684729587,4,19,transferase activity,MF,PNP;HEXB;PDK4;RNASEL
1759,GO:0034655,0.68304311217147,0.734650124049075,1,5,nucleobase-containing compound catabolic process,BP,PNP
640,GO:0007249,0.684653668504618,0.725286652151864,1,6,I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
1998,GO:0043122,0.684653668504618,0.725286652151864,1,6,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
1242,GO:0019217,0.685060717274055,0.732598809172525,1,5,regulation of fatty acid metabolic process,BP,PDK4
2128,GO:0044425,0.688009642511234,0.492006658177648,8,43,membrane part,CC,HSD3B2;CASP4;TMEM164;HSD17B3;PRRT1;DHCR7;IFI27;ASAH2
135,GO:0002253,0.689926036132991,0.727598144762162,1,5,activation of immune response,BP,TICAM1
2506,GO:0050778,0.689926036132991,0.727598144762162,1,5,positive regulation of immune response,BP,TICAM1
2125,GO:0044421,0.690864302129728,0.505658987573029,6,32,extracellular region part,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
842,GO:0009605,0.691944272851552,0.543434520480474,4,17,response to external stimulus,BP,TICAM1;CASP4;PDK4;RNASEL
1534,GO:0031981,0.692622779333979,0.563970785811279,3,17,nuclear lumen,CC,MRI1;AOX1;RNASEL
1082,GO:0016070,0.694632759450761,0.533303637458468,4,22,RNA metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
2560,GO:0051049,0.694791406964774,0.60676573093951,2,13,regulation of transport,BP,IFI27;RNASEL
2707,GO:0055086,0.697715845921747,0.61192222182464,2,10,nucleobase-containing small molecule metabolic process,BP,PNP;AOX1
1962,GO:0042803,0.701743197951515,0.603797120791887,2,11,protein homodimerization activity,MF,HEXB;ACCS
370,GO:0005654,0.703731910995807,0.601469165529332,2,11,nucleoplasm,CC,MRI1;AOX1
2221,GO:0045597,0.70636531619007,0.722852913070731,1,4,positive regulation of cell differentiation,BP,PNP
3178,GO:1901575,0.706487694340641,0.487530849538953,6,32,organic substance catabolic process,BP,PNP;HEXB;AOX1;HSD17B11;BDH2;IDUA
633,GO:0007167,0.71109654375802,0.717811505800825,1,4,enzyme linked receptor protein signaling pathway,BP,PDK4
634,GO:0007169,0.71109654375802,0.717811505800825,1,4,transmembrane receptor protein tyrosine kinase signaling pathway,BP,PDK4
3036,GO:0090304,0.713452077380964,0.51012639105025,4,23,nucleic acid metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
897,GO:0010467,0.713484967864307,0.492382076209989,5,27,gene expression,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1241,GO:0019216,0.71545390742833,0.595509996202886,2,9,regulation of lipid metabolic process,BP,PDK4;DHCR7
2354,GO:0046890,0.71545390742833,0.595509996202886,2,9,regulation of lipid biosynthetic process,BP,PDK4;DHCR7
1107,GO:0016310,0.716113383113429,0.586734674178866,2,11,phosphorylation,BP,PDK4;RNASEL
468,GO:0006396,0.716465568807279,0.690511179128724,1,6,RNA processing,BP,RNASEL
668,GO:0007548,0.719878500912803,0.686568666371796,1,6,sex differentiation,BP,HSD17B3
366,GO:0005634,0.721366269285081,0.460059199738268,7,38,nucleus,CC,PNP;MRI1;AOX1;PON2;DHCR7;IFI27;RNASEL
2175,GO:0044877,0.723118705030557,0.691327820092458,1,5,macromolecular complex binding,MF,RNASEL
1119,GO:0016477,0.724295427476796,0.681402065246864,1,6,cell migration,BP,HEXB
1353,GO:0030054,0.72448413223456,0.689750747260207,1,5,cell junction,CC,PRRT1
1149,GO:0016705,0.727176347037958,0.686620458832699,1,5,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP11A1
1294,GO:0019900,0.73113179088805,0.695556103237871,1,4,kinase binding,MF,TICAM1
2603,GO:0051246,0.731680989494442,0.517019862030261,3,17,regulation of protein metabolic process,BP,TICAM1;RBMS3;IFI27
3007,GO:0080134,0.732493482907883,0.566579686459417,2,11,regulation of response to stress,BP,TICAM1;CASP4
1503,GO:0031401,0.735190088395067,0.66222534283888,1,7,positive regulation of protein modification process,BP,TICAM1
884,GO:0009987,0.736582604788366,0.492681692076075,22,107,cellular process,BP,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;WDR45;ASAH2;IDUA
53,GO:0001501,0.739685834967279,0.662813000851867,1,6,skeletal system development,BP,HEXB
2504,GO:0050776,0.742328932538891,0.659525745278035,1,6,regulation of immune response,BP,TICAM1
2411,GO:0048513,0.746794347372348,0.49507592721737,3,19,animal organ development,BP,PNP;HSD17B3;DHCR7
445,GO:0006139,0.749109909326786,0.434906261907919,6,34,nucleobase-containing compound metabolic process,BP,PNP;HEXB;TICAM1;AOX1;IFI27;RNASEL
1940,GO:0042592,0.751280909976582,0.495769609940479,3,15,homeostatic process,BP,HEXB;PDK4;BDH2
477,GO:0006464,0.753401126872879,0.486509730431304,3,19,cellular protein modification process,BP,TICAM1;PDK4;RNASEL
1835,GO:0036211,0.753401126872879,0.486509730431304,3,19,protein modification process,BP,TICAM1;PDK4;RNASEL
2104,GO:0044260,0.754638592405697,0.418709316884325,7,40,cellular macromolecule metabolic process,BP,HEXB;TICAM1;RBMS3;PDK4;IFI27;RNASEL;IDUA
1278,GO:0019725,0.756083204213611,0.651181409600363,1,5,cellular homeostasis,BP,HEXB
2705,GO:0055082,0.756083204213611,0.651181409600363,1,5,cellular chemical homeostasis,BP,HEXB
854,GO:0009725,0.757770301771599,0.53759480747676,2,10,response to hormone,BP,PDK4;RNASEL
2472,GO:0050660,0.763993374123267,0.655570718528079,1,4,flavin adenine dinucleotide binding,MF,AOX1
678,GO:0007610,0.764934875534204,0.639615394635976,1,5,behavior,BP,HEXB
32,GO:0000902,0.767440437086893,0.636276513766836,1,5,cell morphogenesis,BP,HEXB
1662,GO:0032989,0.767440437086893,0.636276513766836,1,5,cellular component morphogenesis,BP,HEXB
1247,GO:0019222,0.767607317727348,0.403673061373983,7,36,regulation of metabolic process,BP,HEXB;TICAM1;RBMS3;PDK4;DHCR7;IFI27;RNASEL
1543,GO:0032101,0.769672580954846,0.633277252719349,1,5,regulation of response to external stimulus,BP,CASP4
767,GO:0008654,0.770922183415558,0.6154415452152,1,7,phospholipid biosynthetic process,BP,HEXB
2309,GO:0046483,0.772116584978787,0.396798634141019,7,39,heterocycle metabolic process,BP,PNP;HEXB;TICAM1;AOX1;BDH2;IFI27;RNASEL
1479,GO:0031323,0.772736065389909,0.405697818514137,6,32,regulation of cellular metabolic process,BP,HEXB;TICAM1;RBMS3;PDK4;IFI27;RNASEL
1094,GO:0016192,0.772774021319657,0.507962479562768,2,13,vesicle-mediated transport,BP,PNP;HEXB
885,GO:0009991,0.773519369305221,0.643081523496407,1,4,response to extracellular stimulus,BP,PDK4
1513,GO:0031667,0.773519369305221,0.643081523496407,1,4,response to nutrient levels,BP,PDK4
354,GO:0005543,0.774254343936737,0.6270466424088,1,5,phospholipid binding,MF,SNX21
1072,GO:0016021,0.774357752191146,0.401837531592168,6,36,integral component of membrane,CC,HSD3B2;TMEM164;PRRT1;DHCR7;IFI27;ASAH2
1704,GO:0034097,0.776801233944164,0.502341779531228,2,13,response to cytokine,BP,IFI27;RNASEL
2903,GO:0071345,0.776801233944164,0.502341779531228,2,13,cellular response to cytokine stimulus,BP,IFI27;RNASEL
2630,GO:0051345,0.779946377460761,0.597784730532848,1,8,positive regulation of hydrolase activity,BP,IFI27
1243,GO:0019218,0.781367581745835,0.617170652334808,1,5,regulation of steroid metabolic process,BP,DHCR7
916,GO:0010605,0.782841567787369,0.589804137764879,1,9,negative regulation of macromolecule metabolic process,BP,IFI27
871,GO:0009894,0.783109336948613,0.60493369090826,1,6,regulation of catabolic process,BP,TICAM1
1485,GO:0031329,0.783109336948613,0.60493369090826,1,6,regulation of cellular catabolic process,BP,TICAM1
1696,GO:0033993,0.784466818119742,0.494011987438882,2,12,response to lipid,BP,TICAM1;PDK4
562,GO:0006793,0.784513313717334,0.400146242374411,5,31,phosphorus metabolic process,BP,ACSF2;PNP;HEXB;PDK4;RNASEL
616,GO:0006996,0.784710893460802,0.587061712269002,1,9,organelle organization,BP,HEXB
705,GO:0008150,0.785031405794781,0.621461404540134,25,120,biological_process,BP,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;ACCS;CASP4;RBMS3;HSD17B3;PDK4;PRRT1;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;WDR45;ASAH2;IDUA
211,GO:0003008,0.786929038680216,0.587599893113201,1,8,system process,BP,HEXB
563,GO:0006796,0.787929271931935,0.41154503973203,4,27,phosphate-containing compound metabolic process,BP,PNP;HEXB;PDK4;RNASEL
2370,GO:0046983,0.788315246281567,0.485952010948745,2,13,protein dimerization activity,MF,HEXB;ACCS
1339,GO:0023052,0.788467285760054,0.384457275948031,6,33,signaling,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
2154,GO:0044700,0.788467285760054,0.384457275948031,6,33,single organism signaling,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
2738,GO:0060255,0.79191291074748,0.393279071240912,5,26,regulation of macromolecule metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2885,GO:0071216,0.793056693804842,0.60038147942975,1,5,cellular response to biotic stimulus,BP,TICAM1
2886,GO:0071219,0.793056693804842,0.60038147942975,1,5,cellular response to molecule of bacterial origin,BP,TICAM1
2887,GO:0071222,0.793056693804842,0.60038147942975,1,5,cellular response to lipopolysaccharide,BP,TICAM1
627,GO:0007154,0.79362294402397,0.377535427620845,6,33,cell communication,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
1682,GO:0033500,0.794280672288229,0.598581618260399,1,5,carbohydrate homeostasis,BP,PDK4
1941,GO:0042593,0.794280672288229,0.598581618260399,1,5,glucose homeostasis,BP,PDK4
364,GO:0005622,0.797987935246542,0.421802120140613,22,111,intracellular,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2127,GO:0044424,0.797987935246542,0.421802120140613,22,111,intracellular part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2463,GO:0048870,0.79929840327256,0.574049091198055,1,7,cell motility,BP,HEXB
2664,GO:0051674,0.79929840327256,0.574049091198055,1,7,localization of cell,BP,HEXB
2043,GO:0043412,0.800902842787981,0.419118084978857,3,21,macromolecule modification,BP,TICAM1;PDK4;RNASEL
912,GO:0010565,0.801661245909906,0.570412314080022,1,7,regulation of cellular ketone metabolic process,BP,PDK4
963,GO:0010876,0.802160337140947,0.569640171465942,1,7,lipid localization,BP,HEXB
132,GO:0002237,0.803056062257373,0.575272828128124,1,6,response to molecule of bacterial origin,BP,TICAM1
847,GO:0009617,0.803056062257373,0.575272828128124,1,6,response to bacterium,BP,TICAM1
1586,GO:0032496,0.803056062257373,0.575272828128124,1,6,response to lipopolysaccharide,BP,TICAM1
428,GO:0006082,0.803226205935378,0.350371021211909,8,41,organic acid metabolic process,BP,ACSF2;PNP;HEXB;MRI1;PDK4;PON2;BDH2;IDUA
2460,GO:0048856,0.80657660432372,0.370982864336843,5,29,anatomical structure development,BP,PNP;HEXB;HSD17B3;DHCR7;BDH2
220,GO:0003676,0.807563576164365,0.455290161917946,2,14,nucleic acid binding,MF,RBMS3;RNASEL
2006,GO:0043170,0.808009179904023,0.342582626462843,8,47,macromolecule metabolic process,BP,HEXB;TICAM1;CASP4;RBMS3;PDK4;IFI27;RNASEL;IDUA
2600,GO:0051239,0.808611390459272,0.407886883773167,3,21,regulation of multicellular organismal process,BP,PNP;TICAM1;PDK4
518,GO:0006644,0.808891223340158,0.549946019864747,1,9,phospholipid metabolic process,BP,HEXB
2561,GO:0051050,0.81184015847072,0.549172972020986,1,8,positive regulation of transport,BP,RNASEL
2017,GO:0043231,0.813784429480441,0.338981897452957,17,93,intracellular membrane-bounded organelle,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;IFI27;RNASEL;ASAH2;IDUA
2453,GO:0048731,0.815563303105668,0.373885126165224,4,25,system development,BP,PNP;HEXB;HSD17B3;DHCR7
1986,GO:0043066,0.81686731404187,0.553427034937517,1,6,negative regulation of apoptotic process,BP,PDK4
1989,GO:0043069,0.81686731404187,0.553427034937517,1,6,negative regulation of programmed cell death,BP,PDK4
2771,GO:0060548,0.81686731404187,0.553427034937517,1,6,negative regulation of cell death,BP,PDK4
376,GO:0005743,0.817223326436493,0.448221675287734,2,11,mitochondrial inner membrane,CC,HSD3B2;PDK4
1467,GO:0031224,0.817280682339276,0.343397434687826,6,37,intrinsic component of membrane,CC,HSD3B2;TMEM164;PRRT1;DHCR7;IFI27;ASAH2
2763,GO:0060429,0.817564959812876,0.55229306935944,1,6,epithelium development,BP,BDH2
2014,GO:0043228,0.818053412965767,0.394880618996683,3,20,non-membrane-bounded organelle,CC,PNP;MRI1;HSD17B11
2018,GO:0043232,0.818053412965767,0.394880618996683,3,20,intracellular non-membrane-bounded organelle,CC,PNP;MRI1;HSD17B11
568,GO:0006810,0.820415772264329,0.349826339849813,5,32,transport,BP,PNP;HEXB;SNX21;IFI27;RNASEL
2597,GO:0051234,0.820415772264329,0.349826339849813,5,32,establishment of localization,BP,PNP;HEXB;SNX21;IFI27;RNASEL
548,GO:0006733,0.820653271306953,0.547236720012106,1,6,oxidoreduction coenzyme metabolic process,BP,PNP
1253,GO:0019362,0.820653271306953,0.547236720012106,1,6,pyridine nucleotide metabolic process,BP,PNP
2315,GO:0046496,0.820653271306953,0.547236720012106,1,6,nicotinamide nucleotide metabolic process,BP,PNP
2512,GO:0050794,0.82610339846106,0.311380677864709,10,53,regulation of cellular process,BP,PNP;HEXB;TICAM1;CASP4;RBMS3;PDK4;DHCR7;IFI27;RNASEL;ASAH2
371,GO:0005730,0.827432545243776,0.523295192256918,1,8,nucleolus,CC,MRI1
881,GO:0009968,0.833212303599109,0.513309750000217,1,8,negative regulation of signal transduction,BP,TICAM1
927,GO:0010648,0.833212303599109,0.513309750000217,1,8,negative regulation of cell communication,BP,TICAM1
1341,GO:0023057,0.833212303599109,0.513309750000217,1,8,negative regulation of signaling,BP,TICAM1
2348,GO:0046872,0.833304748818415,0.347603514713818,4,25,metal ion binding,MF,CYP11A1;AOX1;PON2;RNASEL
2570,GO:0051094,0.834990359021776,0.522949365608803,1,6,positive regulation of developmental process,BP,PNP
1074,GO:0016042,0.835577434871064,0.369121628249569,3,19,lipid catabolic process,BP,HEXB;HSD17B11;BDH2
2005,GO:0043169,0.837199169418976,0.341000937132536,4,26,cation binding,MF,CYP11A1;AOX1;PON2;RNASEL
1305,GO:0022008,0.842782390033134,0.509153464618727,1,6,neurogenesis,BP,HEXB
2168,GO:0044765,0.843209346731504,0.354890510233112,3,21,single-organism transport,BP,PNP;HEXB;RNASEL
3241,GO:1902578,0.843209346731504,0.354890510233112,3,21,single-organism localization,BP,PNP;HEXB;RNASEL
1798,GO:0035556,0.843588076196027,0.395844741713092,2,15,intracellular signal transduction,BP,TICAM1;CASP4
1651,GO:0032879,0.84408998686572,0.393438097513767,2,16,regulation of localization,BP,IFI27;RNASEL
1374,GO:0030162,0.845655895088667,0.486885914014883,1,9,regulation of proteolysis,BP,IFI27
2169,GO:0044767,0.845660287176051,0.303066658390596,6,35,single-organism developmental process,BP,PNP;HEXB;HSD17B3;DHCR7;BDH2;RNASEL
851,GO:0009653,0.846262938069256,0.485768173047781,1,9,anatomical structure morphogenesis,BP,HEXB
2426,GO:0048584,0.852227144861122,0.382915694643091,2,14,positive regulation of response to stimulus,BP,TICAM1;RNASEL
603,GO:0006928,0.852973856181902,0.477402358063169,1,8,movement of cell or subcellular component,BP,HEXB
1854,GO:0040011,0.852973856181902,0.477402358063169,1,8,locomotion,BP,HEXB
1501,GO:0031399,0.854170187576332,0.470956161343187,1,9,regulation of protein modification process,BP,TICAM1
1920,GO:0042493,0.854476778305045,0.480048495674895,1,7,response to drug,BP,PNP
2013,GO:0043227,0.854915690196549,0.307429667749266,20,106,membrane-bounded organelle,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
1270,GO:0019637,0.856117406034606,0.371443009653139,2,17,organophosphate metabolic process,BP,PNP;HEXB
403,GO:0005856,0.858458008094763,0.472429804150316,1,7,cytoskeleton,CC,PNP
2414,GO:0048519,0.859151307574591,0.305025159058189,4,29,negative regulation of biological process,BP,TICAM1;PDK4;IFI27;RNASEL
2416,GO:0048523,0.859151307574591,0.305025159058189,4,29,negative regulation of cellular process,BP,TICAM1;PDK4;IFI27;RNASEL
3238,GO:1902533,0.861027335700679,0.461916826230113,1,8,positive regulation of intracellular signal transduction,BP,TICAM1
2427,GO:0048585,0.862058817130139,0.455691357540647,1,9,negative regulation of response to stimulus,BP,TICAM1
614,GO:0006979,0.865872548151636,0.457887243976394,1,7,response to oxidative stress,BP,PON2
2806,GO:0065009,0.866860513758458,0.349242224954796,2,20,regulation of molecular function,BP,TICAM1;IFI27
649,GO:0007275,0.867535191918355,0.292500710469455,4,27,multicellular organism development,BP,PNP;HEXB;HSD17B3;DHCR7
736,GO:0008289,0.870539750721216,0.442924399994365,1,8,lipid binding,MF,SNX21
1588,GO:0032502,0.871847200967512,0.262658376254998,6,36,developmental process,BP,PNP;HEXB;HSD17B3;DHCR7;BDH2;RNASEL
2020,GO:0043234,0.871869169524147,0.429993434693724,1,11,protein complex,CC,CASP4
1990,GO:0043085,0.872089564782827,0.427346760223405,1,12,positive regulation of catalytic activity,BP,IFI27
2012,GO:0043226,0.873622067844395,0.293730155916777,21,110,organelle,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
1079,GO:0016053,0.873866794495042,0.348752596101633,2,12,organic acid biosynthetic process,BP,MRI1;PDK4
2290,GO:0046394,0.873866794495042,0.348752596101633,2,12,carboxylic acid biosynthetic process,BP,MRI1;PDK4
407,GO:0005886,0.876296449158291,0.279941187200803,4,24,plasma membrane,CC,CASP4;PRRT1;PON2;ASAH2
2624,GO:0051336,0.876301662971861,0.420797491994853,1,11,regulation of hydrolase activity,BP,IFI27
2015,GO:0043229,0.876334626228668,0.263139535239457,19,102,intracellular organelle,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;IFI27;RNASEL;ASAH2;IDUA
509,GO:0006631,0.877620963094711,0.278505342311994,4,23,fatty acid metabolic process,BP,ACSF2;PDK4;PON2;BDH2
304,GO:0004871,0.880214337578789,0.428349569876276,1,7,signal transducer activity,MF,TICAM1
2405,GO:0048468,0.880590615197384,0.421962457121876,1,8,cell development,BP,HEXB
2975,GO:0072329,0.880689097450476,0.333409053017475,2,13,monocarboxylic acid catabolic process,BP,BDH2;IDUA
2048,GO:0043436,0.882981096580904,0.238631145467785,7,40,oxoacid metabolic process,BP,ACSF2;HEXB;MRI1;PDK4;PON2;BDH2;IDUA
3180,GO:1901605,0.883198465286579,0.421951923501412,1,7,alpha-amino acid metabolic process,BP,MRI1
2101,GO:0044255,0.885403639068119,0.240957809450719,6,36,cellular lipid metabolic process,BP,ACSF2;HEXB;PDK4;PON2;BDH2;ASAH2
341,GO:0005488,0.886676642946038,0.233148155889284,17,94,binding,MF,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;TICAM1;ACCS;RBMS3;PDK4;AOX1;PON2;DHCR7;BDH2;IFI27;RNASEL;IDUA
1640,GO:0032787,0.886735336818214,0.249812323224769,5,27,monocarboxylic acid metabolic process,BP,ACSF2;PDK4;PON2;BDH2;IDUA
865,GO:0009888,0.889206009265335,0.395631453457286,1,10,tissue development,BP,BDH2
2583,GO:0051174,0.891029312796995,0.388889155035357,1,11,regulation of phosphorus metabolic process,BP,PDK4
555,GO:0006753,0.891047302088858,0.394842831135968,1,9,nucleoside phosphate metabolic process,BP,PNP
799,GO:0009117,0.891047302088858,0.394842831135968,1,9,nucleotide metabolic process,BP,PNP
1260,GO:0019395,0.892625730569882,0.308131415469956,2,14,fatty acid oxidation,BP,PDK4;BDH2
1743,GO:0034440,0.892625730569882,0.308131415469956,2,14,lipid oxidation,BP,PDK4;BDH2
2425,GO:0048583,0.895199533197015,0.265524466551356,3,21,regulation of response to stimulus,BP,TICAM1;CASP4;RNASEL
1664,GO:0032991,0.896376153096671,0.292428748666295,2,21,macromolecular complex,CC,TICAM1;CASP4
1000,GO:0014070,0.89683906796928,0.391484817625091,1,7,response to organic cyclic compound,BP,TICAM1
659,GO:0007399,0.898264338997568,0.38259223273422,1,8,nervous system development,BP,HEXB
2358,GO:0046907,0.899898676172306,0.374544465360155,1,9,intracellular transport,BP,IFI27
2663,GO:0051649,0.899898676172306,0.374544465360155,1,9,establishment of localization in cell,BP,IFI27
1973,GO:0042995,0.900015622230747,0.378498321567362,1,8,cell projection,CC,MRI1
2584,GO:0051179,0.902625334921647,0.218975092501495,5,36,localization,BP,PNP;HEXB;SNX21;IFI27;RNASEL
2573,GO:0051128,0.902693685876696,0.364637977322014,1,10,regulation of cellular component organization,BP,HEXB
2662,GO:0051641,0.90507693752161,0.358938452584372,1,10,cellular localization,BP,IFI27
2511,GO:0050793,0.905457032649335,0.278862621006205,2,16,regulation of developmental process,BP,PNP;HEXB
2960,GO:0071944,0.905828268057292,0.227480563778078,4,25,cell periphery,CC,CASP4;PRRT1;PON2;ASAH2
2153,GO:0044699,0.909917636670418,0.206117062080001,19,100,single-organism process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
880,GO:0009967,0.912898094597274,0.337090389999672,1,11,positive regulation of signal transduction,BP,TICAM1
2508,GO:0050789,0.914364749144392,0.177894828409415,10,58,regulation of biological process,BP,PNP;HEXB;TICAM1;CASP4;RBMS3;PDK4;DHCR7;IFI27;RNASEL;ASAH2
869,GO:0009892,0.918221018152501,0.319627890729236,1,13,negative regulation of metabolic process,BP,IFI27
1480,GO:0031324,0.918221018152501,0.319627890729236,1,13,negative regulation of cellular metabolic process,BP,IFI27
510,GO:0006633,0.92165643093464,0.324542294524581,1,8,fatty acid biosynthetic process,BP,PDK4
1280,GO:0019752,0.922570381982893,0.176792277631922,6,38,carboxylic acid metabolic process,BP,ACSF2;MRI1;PDK4;PON2;BDH2;IDUA
3375,GO:2000026,0.925328051673021,0.302698179491108,1,12,regulation of multicellular organismal development,BP,PNP
1080,GO:0016054,0.925730358701311,0.234736838876313,2,16,organic acid catabolic process,BP,BDH2;IDUA
2291,GO:0046395,0.925730358701311,0.234736838876313,2,16,carboxylic acid catabolic process,BP,BDH2;IDUA
2219,GO:0045595,0.925762079102266,0.309410063976702,1,9,regulation of cell differentiation,BP,PNP
1293,GO:0019899,0.929722882127439,0.295353411757338,1,10,enzyme binding,MF,TICAM1
2097,GO:0044242,0.930828705164112,0.221833413116183,2,17,cellular lipid catabolic process,BP,HEXB;BDH2
491,GO:0006520,0.9319940849256,0.286475283038828,1,11,cellular amino acid metabolic process,BP,MRI1
365,GO:0005623,0.933956112085788,0.230612026652138,23,117,cell,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;PRRT1;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2149,GO:0044464,0.933956112085788,0.230612026652138,23,117,cell part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;RBMS3;HSD17B3;PDK4;PRRT1;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2113,GO:0044282,0.935166872485665,0.211606215475671,2,17,small molecule catabolic process,BP,BDH2;IDUA
3236,GO:1902531,0.936112846965863,0.274750163447118,1,11,regulation of intracellular signal transduction,BP,TICAM1
2158,GO:0044707,0.940957815455414,0.141921227964461,6,41,single-multicellular organism process,BP,PNP;HEXB;TICAM1;HSD17B3;PDK4;DHCR7
511,GO:0006635,0.944158942306576,0.253290192073657,1,10,fatty acid beta-oxidation,BP,BDH2
363,GO:0005615,0.9455649516701,0.242934037952647,1,13,extracellular space,CC,HEXB
1396,GO:0030258,0.945939393356929,0.184232879957626,2,18,lipid modification,BP,PDK4;BDH2
926,GO:0010647,0.946019735158537,0.241535066602899,1,13,positive regulation of cell communication,BP,TICAM1
1340,GO:0023056,0.946019735158537,0.241535066602899,1,13,positive regulation of signaling,BP,TICAM1
1587,GO:0032501,0.947421826853845,0.129139771835663,6,42,multicellular organismal process,BP,PNP;HEXB;TICAM1;HSD17B3;PDK4;DHCR7
2706,GO:0055085,0.947940097494471,0.237196445989448,1,12,transmembrane transport,BP,RNASEL
2509,GO:0050790,0.957898461668272,0.198992541017877,1,17,regulation of catalytic activity,BP,IFI27
219,GO:0003674,0.957940557763077,0.171080345086765,23,117,molecular_function,MF,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;ACCS;CASP4;RBMS3;HSD17B3;PDK4;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2976,GO:0072330,0.965504311210124,0.181638529404974,1,10,monocarboxylic acid biosynthetic process,BP,PDK4
2086,GO:0044085,0.967986811189038,0.165026682402007,1,15,cellular component biogenesis,BP,RNASEL
780,GO:0009062,0.970031188303373,0.160797589717375,1,12,fatty acid catabolic process,BP,BDH2
315,GO:0005102,0.973937926938322,0.139986407815275,1,18,receptor binding,MF,IDUA
879,GO:0009966,0.974052068799347,0.141627239993781,1,15,regulation of signal transduction,BP,TICAM1
358,GO:0005575,0.98123910739666,0.180120344732081,24,123,cellular_component,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;TMEM164;RBMS3;HSD17B3;PDK4;PRRT1;AOX1;PON2;HSD17B11;DHCR7;BDH2;IFI27;RNASEL;ASAH2;IDUA
2947,GO:0071840,0.987057147952905,0.0588897663245709,2,27,cellular component organization or biogenesis,BP,HEXB;RNASEL
348,GO:0005515,0.988536631186841,0.0340053318648635,9,72,protein binding,MF,ACSF2;HEXB;MRI1;TICAM1;ACCS;PON2;IFI27;RNASEL;IDUA
925,GO:0010646,0.993084017851367,0.0505643965888895,1,19,regulation of cell communication,BP,TICAM1
1338,GO:0023051,0.993307112573887,0.0490331484638883,1,20,regulation of signaling,BP,TICAM1
1075,GO:0016043,0.997861874276488,0.0191066222866955,1,26,cellular component organization,BP,HEXB
2,GO:0000030,1,0.982932946886051,0,1,mannosyltransferase activity,MF,
3,GO:0000038,1,0.689785429679781,0,1,very long-chain fatty acid metabolic process,BP,
4,GO:0000041,1,0.770314150802672,0,1,transition metal ion transport,BP,
5,GO:0000045,1,0.689785429679809,0,1,autophagosome assembly,BP,
6,GO:0000086,1,0.932920109189956,0,1,G2/M transition of mitotic cell cycle,BP,
10,GO:0000139,1,0.689785429679902,0,1,Golgi membrane,CC,
11,GO:0000165,1,0.50167522103421,0,4,MAPK cascade,BP,
13,GO:0000187,1,0.689785429679705,0,1,activation of MAPK activity,BP,
14,GO:0000209,1,0.781390431937291,0,2,protein polyubiquitination,BP,
15,GO:0000245,1,0.860646174064634,0,1,spliceosomal complex assembly,BP,
16,GO:0000247,1,0.90529521320746,0,1,C-8 sterol isomerase activity,MF,
17,GO:0000248,1,0.689785429679715,0,1,C-5 sterol desaturase activity,MF,
18,GO:0000255,1,0.689785429679705,0,1,allantoin metabolic process,BP,
19,GO:0000278,1,0.932920109189956,0,1,mitotic cell cycle,BP,
20,GO:0000285,1,0.859997101743051,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
21,GO:0000287,1,0.463961935659114,0,3,magnesium ion binding,MF,
22,GO:0000302,1,0.507856603709163,0,2,response to reactive oxygen species,BP,
23,GO:0000303,1,0.739171199267924,0,1,response to superoxide,BP,
24,GO:0000305,1,0.739171199267924,0,1,response to oxygen radical,BP,
25,GO:0000313,1,0.862856117640713,0,2,organellar ribosome,CC,
26,GO:0000315,1,0.862856117640713,0,2,organellar large ribosomal subunit,CC,
28,GO:0000375,1,0.860646174064634,0,1,RNA splicing, via transesterification reactions,BP,
29,GO:0000377,1,0.860646174064634,0,1,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
30,GO:0000398,1,0.860646174064634,0,1,mRNA splicing, via spliceosome,BP,
31,GO:0000502,1,0.932920109189956,0,1,proteasome complex,CC,
33,GO:0000904,1,0.317218305366826,0,4,cell morphogenesis involved in differentiation,BP,
34,GO:0000922,1,0.689785429679681,0,1,spindle pole,CC,
35,GO:0000932,1,0.689785429679705,0,1,P-body,CC,
36,GO:0000959,1,0.743963160689213,0,2,mitochondrial RNA metabolic process,BP,
37,GO:0000963,1,0.743963160689213,0,2,mitochondrial RNA processing,BP,
38,GO:0000975,1,0.689785429679797,0,1,regulatory region DNA binding,MF,
39,GO:0000976,1,0.689785429679797,0,1,transcription regulatory region sequence-specific DNA binding,MF,
40,GO:0000977,1,0.689785429679797,0,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
41,GO:0000981,1,0.689785429679797,0,1,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,
42,GO:0000982,1,0.689785429679797,0,1,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
43,GO:0000988,1,0.778601207185001,0,2,transcription factor activity, protein binding,MF,
44,GO:0000989,1,0.778601207185001,0,2,transcription factor activity, transcription factor binding,MF,
45,GO:0001012,1,0.689785429679797,0,1,RNA polymerase II regulatory region DNA binding,MF,
46,GO:0001067,1,0.689785429679797,0,1,regulatory region nucleic acid binding,MF,
47,GO:0001071,1,0.689785429679797,0,1,nucleic acid binding transcription factor activity,MF,
48,GO:0001077,1,0.689785429679797,0,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
52,GO:0001228,1,0.689785429679797,0,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
54,GO:0001503,1,0.83065676594881,0,1,ossification,BP,
55,GO:0001504,1,0.689785429679701,0,1,neurotransmitter uptake,BP,
56,GO:0001505,1,0.689785429679701,0,1,regulation of neurotransmitter levels,BP,
57,GO:0001510,1,0.937272715402406,0,1,RNA methylation,BP,
58,GO:0001522,1,0.794342025053001,0,1,pseudouridine synthesis,BP,
59,GO:0001523,1,0.94012643491917,0,1,retinoid metabolic process,BP,
60,GO:0001525,1,0.775028957425363,0,2,angiogenesis,BP,
61,GO:0001533,1,0.71008138889583,0,1,cornified envelope,CC,
62,GO:0001541,1,0.933624765294581,0,1,ovarian follicle development,BP,
63,GO:0001556,1,0.933624765294581,0,1,oocyte maturation,BP,
64,GO:0001561,1,0.572130722856343,0,2,fatty acid alpha-oxidation,BP,
67,GO:0001608,1,0.690383534494896,0,1,G-protein coupled nucleotide receptor activity,MF,
68,GO:0001614,1,0.690383534494896,0,1,purinergic nucleotide receptor activity,MF,
70,GO:0001654,1,0.94012643491917,0,1,eye development,BP,
71,GO:0001655,1,0.490803375639416,0,3,urogenital system development,BP,
72,GO:0001656,1,0.710373855442479,0,1,metanephros development,BP,
73,GO:0001659,1,0.700154732893895,0,1,temperature homeostasis,BP,
74,GO:0001664,1,0.927181811494571,0,2,G-protein coupled receptor binding,MF,
75,GO:0001666,1,0.679639001511281,0,4,response to hypoxia,BP,
76,GO:0001667,1,0.83065676594881,0,1,ameboidal-type cell migration,BP,
78,GO:0001676,1,0.473449921345707,0,2,long-chain fatty acid metabolic process,BP,
79,GO:0001678,1,0.689883197202292,0,1,cellular glucose homeostasis,BP,
80,GO:0001726,1,0.909149134363904,0,1,ruffle,CC,
81,GO:0001736,1,0.932920109189956,0,1,establishment of planar polarity,BP,
82,GO:0001738,1,0.932920109189956,0,1,morphogenesis of a polarized epithelium,BP,
83,GO:0001773,1,0.944573033403215,0,1,myeloid dendritic cell activation,BP,
85,GO:0001776,1,0.753843485045977,0,1,leukocyte homeostasis,BP,
88,GO:0001818,1,0.791213051698253,0,2,negative regulation of cytokine production,BP,
90,GO:0001822,1,0.523098508666123,0,2,kidney development,BP,
91,GO:0001836,1,0.812567533012029,0,2,release of cytochrome c from mitochondria,BP,
92,GO:0001848,1,0.689996137392405,0,1,complement binding,MF,
94,GO:0001883,1,0.693221867723898,0,1,purine nucleoside binding,MF,
95,GO:0001889,1,0.523098508666123,0,2,liver development,BP,
96,GO:0001890,1,0.933624765294581,0,1,placenta development,BP,
98,GO:0001906,1,0.753843485045977,0,1,cell killing,BP,
99,GO:0001909,1,0.753843485045977,0,1,leukocyte mediated cytotoxicity,BP,
100,GO:0001910,1,0.753843485045977,0,1,regulation of leukocyte mediated cytotoxicity,BP,
101,GO:0001912,1,0.753843485045977,0,1,positive regulation of leukocyte mediated cytotoxicity,BP,
102,GO:0001913,1,0.753843485045977,0,1,T cell mediated cytotoxicity,BP,
103,GO:0001914,1,0.753843485045977,0,1,regulation of T cell mediated cytotoxicity,BP,
104,GO:0001916,1,0.753843485045977,0,1,positive regulation of T cell mediated cytotoxicity,BP,
105,GO:0001932,1,0.280569134198666,0,6,regulation of protein phosphorylation,BP,
106,GO:0001933,1,0.535354857672809,0,3,negative regulation of protein phosphorylation,BP,
107,GO:0001934,1,0.502062463195851,0,4,positive regulation of protein phosphorylation,BP,
108,GO:0001935,1,0.933624765294581,0,1,endothelial cell proliferation,BP,
109,GO:0001936,1,0.933624765294581,0,1,regulation of endothelial cell proliferation,BP,
110,GO:0001938,1,0.933624765294581,0,1,positive regulation of endothelial cell proliferation,BP,
111,GO:0001942,1,0.838088519544645,0,1,hair follicle development,BP,
113,GO:0001957,1,0.83065676594881,0,1,intramembranous ossification,BP,
114,GO:0001958,1,0.83065676594881,0,1,endochondral ossification,BP,
115,GO:0001959,1,0.510179056364335,0,4,regulation of cytokine-mediated signaling pathway,BP,
116,GO:0001960,1,0.860646174064634,0,1,negative regulation of cytokine-mediated signaling pathway,BP,
117,GO:0001961,1,0.753843485045977,0,1,positive regulation of cytokine-mediated signaling pathway,BP,
118,GO:0001974,1,0.860646174064634,0,1,blood vessel remodeling,BP,
119,GO:0002009,1,0.932920109189956,0,1,morphogenesis of an epithelium,BP,
120,GO:0002020,1,0.610987918175662,0,3,protease binding,MF,
121,GO:0002028,1,0.97782001583703,0,1,regulation of sodium ion transport,BP,
124,GO:0002062,1,0.83065676594881,0,1,chondrocyte differentiation,BP,
125,GO:0002063,1,0.83065676594881,0,1,chondrocyte development,BP,
126,GO:0002084,1,0.745842816697877,0,1,protein depalmitoylation,BP,
128,GO:0002220,1,0.932920109189956,0,1,innate immune response activating cell surface receptor signaling pathway,BP,
130,GO:0002223,1,0.932920109189956,0,1,stimulatory C-type lectin receptor signaling pathway,BP,
133,GO:0002250,1,0.711475438092686,0,2,adaptive immune response,BP,
136,GO:0002260,1,0.753843485045977,0,1,lymphocyte homeostasis,BP,
140,GO:0002277,1,0.944573033403215,0,1,myeloid dendritic cell activation involved in immune response,BP,
145,GO:0002377,1,0.94012643491917,0,1,immunoglobulin production,BP,
146,GO:0002429,1,0.932920109189956,0,1,immune response-activating cell surface receptor signaling pathway,BP,
147,GO:0002440,1,0.94012643491917,0,1,production of molecular mediator of immune response,BP,
151,GO:0002449,1,0.753843485045977,0,1,lymphocyte mediated immunity,BP,
152,GO:0002456,1,0.753843485045977,0,1,T cell mediated immunity,BP,
153,GO:0002460,1,0.753843485045977,0,1,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
154,GO:0002474,1,0.862945372151557,0,2,antigen processing and presentation of peptide antigen via MHC class I,BP,
155,GO:0002478,1,0.862945372151557,0,2,antigen processing and presentation of exogenous peptide antigen,BP,
156,GO:0002479,1,0.932920109189956,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
157,GO:0002495,1,0.87376044201494,0,2,antigen processing and presentation of peptide antigen via MHC class II,BP,
158,GO:0002504,1,0.87376044201494,0,2,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
161,GO:0002526,1,0.689996137392405,0,1,acute inflammatory response,BP,
162,GO:0002573,1,0.753843485045977,0,1,myeloid leukocyte differentiation,BP,
163,GO:0002577,1,0.944573033403215,0,1,regulation of antigen processing and presentation,BP,
164,GO:0002579,1,0.944573033403215,0,1,positive regulation of antigen processing and presentation,BP,
165,GO:0002580,1,0.944573033403215,0,1,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
166,GO:0002582,1,0.944573033403215,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
167,GO:0002583,1,0.944573033403215,0,1,regulation of antigen processing and presentation of peptide antigen,BP,
168,GO:0002585,1,0.944573033403215,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
169,GO:0002586,1,0.944573033403215,0,1,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
170,GO:0002588,1,0.944573033403215,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
171,GO:0002637,1,0.94012643491917,0,1,regulation of immunoglobulin production,BP,
172,GO:0002639,1,0.94012643491917,0,1,positive regulation of immunoglobulin production,BP,
173,GO:0002673,1,0.689996137392405,0,1,regulation of acute inflammatory response,BP,
177,GO:0002685,1,0.711475438092686,0,2,regulation of leukocyte migration,BP,
178,GO:0002687,1,0.711475438092686,0,2,positive regulation of leukocyte migration,BP,
179,GO:0002691,1,0.753843485045977,0,1,regulation of cellular extravasation,BP,
180,GO:0002693,1,0.753843485045977,0,1,positive regulation of cellular extravasation,BP,
183,GO:0002697,1,0.486146583378858,0,3,regulation of immune effector process,BP,
184,GO:0002699,1,0.708094074044027,0,2,positive regulation of immune effector process,BP,
185,GO:0002700,1,0.94012643491917,0,1,regulation of production of molecular mediator of immune response,BP,
186,GO:0002702,1,0.94012643491917,0,1,positive regulation of production of molecular mediator of immune response,BP,
187,GO:0002703,1,0.753843485045977,0,1,regulation of leukocyte mediated immunity,BP,
188,GO:0002705,1,0.753843485045977,0,1,positive regulation of leukocyte mediated immunity,BP,
189,GO:0002706,1,0.753843485045977,0,1,regulation of lymphocyte mediated immunity,BP,
190,GO:0002708,1,0.753843485045977,0,1,positive regulation of lymphocyte mediated immunity,BP,
191,GO:0002709,1,0.753843485045977,0,1,regulation of T cell mediated immunity,BP,
192,GO:0002711,1,0.753843485045977,0,1,positive regulation of T cell mediated immunity,BP,
196,GO:0002761,1,0.753843485045977,0,1,regulation of myeloid leukocyte differentiation,BP,
197,GO:0002763,1,0.753843485045977,0,1,positive regulation of myeloid leukocyte differentiation,BP,
199,GO:0002768,1,0.932920109189956,0,1,immune response-regulating cell surface receptor signaling pathway,BP,
201,GO:0002791,1,0.569962745218887,0,4,regulation of peptide secretion,BP,
202,GO:0002793,1,0.569962745218887,0,4,positive regulation of peptide secretion,BP,
203,GO:0002819,1,0.711475438092686,0,2,regulation of adaptive immune response,BP,
204,GO:0002821,1,0.711475438092686,0,2,positive regulation of adaptive immune response,BP,
205,GO:0002822,1,0.753843485045977,0,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
206,GO:0002824,1,0.753843485045977,0,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
207,GO:0002920,1,0.689996137392405,0,1,regulation of humoral immune response,BP,
208,GO:0002931,1,0.860646174064634,0,1,response to ischemia,BP,
210,GO:0003007,1,0.94012643491917,0,1,heart morphogenesis,BP,
212,GO:0003012,1,0.733043580993669,0,3,muscle system process,BP,
213,GO:0003013,1,0.97782001583703,0,1,circulatory system process,BP,
214,GO:0003014,1,0.689785429679797,0,1,renal system process,BP,
215,GO:0003015,1,0.97782001583703,0,1,heart process,BP,
216,GO:0003205,1,0.94012643491917,0,1,cardiac chamber development,BP,
217,GO:0003206,1,0.94012643491917,0,1,cardiac chamber morphogenesis,BP,
218,GO:0003333,1,0.689785429679701,0,1,amino acid transmembrane transport,BP,
221,GO:0003677,1,0.440944347624558,0,3,DNA binding,MF,
222,GO:0003690,1,0.689785429679797,0,1,double-stranded DNA binding,MF,
223,GO:0003700,1,0.689785429679797,0,1,transcription factor activity, sequence-specific DNA binding,MF,
224,GO:0003712,1,0.778601207185001,0,2,transcription cofactor activity,MF,
225,GO:0003713,1,0.929610988847701,0,1,transcription coactivator activity,MF,
229,GO:0003735,1,0.862856117640713,0,2,structural constituent of ribosome,MF,
230,GO:0003746,1,0.728032091145752,0,1,translation elongation factor activity,MF,
231,GO:0003779,1,0.585802677333025,0,3,actin binding,MF,
234,GO:0003857,1,0.937272715402406,0,1,3-hydroxyacyl-CoA dehydrogenase activity,MF,
236,GO:0003874,1,0.939602622203017,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
238,GO:0003985,1,0.710373855442479,0,1,acetyl-CoA C-acetyltransferase activity,MF,
239,GO:0003986,1,0.928729318243992,0,1,acetyl-CoA hydrolase activity,MF,
240,GO:0003988,1,0.710373855442479,0,1,acetyl-CoA C-acyltransferase activity,MF,
241,GO:0003993,1,0.814550451684994,0,1,acid phosphatase activity,MF,
242,GO:0003995,1,0.700154732893895,0,1,acyl-CoA dehydrogenase activity,MF,
245,GO:0004033,1,0.953244849717105,0,1,aldo-keto reductase (NADP) activity,MF,
247,GO:0004095,1,0.473449921345967,0,2,carnitine O-palmitoyltransferase activity,MF,
248,GO:0004129,1,0.953244849717105,0,1,cytochrome-c oxidase activity,MF,
249,GO:0004139,1,0.780410045217068,0,1,deoxyribose-phosphate aldolase activity,MF,
250,GO:0004165,1,0.770314150802672,0,1,dodecenoyl-CoA delta-isomerase activity,MF,
251,GO:0004174,1,0.695746712093305,0,1,electron-transferring-flavoprotein dehydrogenase activity,MF,
253,GO:0004177,1,0.745090050957516,0,1,aminopeptidase activity,MF,
254,GO:0004180,1,0.745090050957516,0,1,carboxypeptidase activity,MF,
255,GO:0004181,1,0.745090050957516,0,1,metallocarboxypeptidase activity,MF,
257,GO:0004252,1,0.689996137392405,0,1,serine-type endopeptidase activity,MF,
258,GO:0004298,1,0.932920109189956,0,1,threonine-type endopeptidase activity,MF,
259,GO:0004300,1,0.693218538690539,0,2,enoyl-CoA hydratase activity,MF,
261,GO:0004312,1,0.689785429679781,0,1,fatty acid synthase activity,MF,
262,GO:0004321,1,0.693221867723898,0,1,fatty-acyl-CoA synthase activity,MF,
263,GO:0004341,1,0.739171199267924,0,1,gluconolactonase activity,MF,
264,GO:0004364,1,0.955554231038555,0,1,glutathione transferase activity,MF,
265,GO:0004448,1,0.696680402390533,0,1,isocitrate dehydrogenase activity,MF,
266,GO:0004450,1,0.696680402390533,0,1,isocitrate dehydrogenase (NADP+) activity,MF,
267,GO:0004457,1,0.72207164834665,0,1,lactate dehydrogenase activity,MF,
268,GO:0004458,1,0.72207164834665,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
269,GO:0004464,1,0.955554231038555,0,1,leukotriene-C4 synthase activity,MF,
270,GO:0004466,1,0.700154732893895,0,1,long-chain-acyl-CoA dehydrogenase activity,MF,
271,GO:0004470,1,0.883274038622596,0,1,malic enzyme activity,MF,
273,GO:0004505,1,0.929610988847701,0,1,phenylalanine 4-monooxygenase activity,MF,
274,GO:0004508,1,0.749682324291769,0,1,steroid 17-alpha-monooxygenase activity,MF,
280,GO:0004557,1,0.852105267215681,0,1,alpha-galactosidase activity,MF,
282,GO:0004576,1,0.902523548288088,0,1,oligosaccharyl transferase activity,MF,
283,GO:0004581,1,0.902523548288088,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
284,GO:0004582,1,0.982932946886051,0,1,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
285,GO:0004601,1,0.955554231038555,0,1,peroxidase activity,MF,
286,GO:0004602,1,0.955554231038555,0,1,glutathione peroxidase activity,MF,
287,GO:0004620,1,0.662136155138939,0,2,phospholipase activity,MF,
288,GO:0004622,1,0.745842816697877,0,1,lysophospholipase activity,MF,
289,GO:0004623,1,0.889059397519768,0,1,phospholipase A2 activity,MF,
291,GO:0004713,1,0.83065676594881,0,1,protein tyrosine kinase activity,MF,
292,GO:0004721,1,0.966621339483423,0,1,phosphoprotein phosphatase activity,MF,
293,GO:0004725,1,0.966621339483423,0,1,protein tyrosine phosphatase activity,MF,
294,GO:0004730,1,0.794342025053001,0,1,pseudouridylate synthase activity,MF,
299,GO:0004857,1,0.582248821336173,0,3,enzyme inhibitor activity,MF,
300,GO:0004859,1,0.982136033016046,0,1,phospholipase inhibitor activity,MF,
301,GO:0004866,1,0.593335839232855,0,2,endopeptidase inhibitor activity,MF,
302,GO:0004867,1,0.690927624413754,0,1,serine-type endopeptidase inhibitor activity,MF,
303,GO:0004869,1,0.860646174064634,0,1,cysteine-type endopeptidase inhibitor activity,MF,
305,GO:0004872,1,0.291525629075156,0,4,receptor activity,MF,
306,GO:0004888,1,0.291525629075156,0,4,transmembrane signaling receptor activity,MF,
307,GO:0004896,1,0.689785429679705,0,1,cytokine receptor activity,MF,
308,GO:0004930,1,0.690383534494896,0,1,G-protein coupled receptor activity,MF,
309,GO:0004970,1,0.689785429679887,0,1,ionotropic glutamate receptor activity,MF,
310,GO:0004971,1,0.689785429679887,0,1,AMPA glutamate receptor activity,MF,
311,GO:0005057,1,0.746221125113029,0,1,signal transducer activity, downstream of receptor,MF,
312,GO:0005085,1,0.83065676594881,0,1,guanyl-nucleotide exchange factor activity,MF,
313,GO:0005088,1,0.83065676594881,0,1,Ras guanyl-nucleotide exchange factor activity,MF,
314,GO:0005096,1,0.689785429679809,0,1,GTPase activator activity,MF,
316,GO:0005104,1,0.83065676594881,0,1,fibroblast growth factor receptor binding,MF,
317,GO:0005105,1,0.83065676594881,0,1,type 1 fibroblast growth factor receptor binding,MF,
318,GO:0005111,1,0.83065676594881,0,1,type 2 fibroblast growth factor receptor binding,MF,
319,GO:0005123,1,0.647680022866411,0,2,death receptor binding,MF,
320,GO:0005126,1,0.495061702351698,0,5,cytokine receptor binding,MF,
321,GO:0005138,1,0.944573033403215,0,1,interleukin-6 receptor binding,MF,
322,GO:0005154,1,0.689785429679932,0,1,epidermal growth factor receptor binding,MF,
323,GO:0005158,1,0.746221125113029,0,1,insulin receptor binding,MF,
324,GO:0005164,1,0.630542903290721,0,2,tumor necrosis factor receptor binding,MF,
325,GO:0005198,1,0.611253950663845,0,3,structural molecule activity,MF,
326,GO:0005215,1,0.117282959059247,0,10,transporter activity,MF,
327,GO:0005216,1,0.674056819353636,0,2,ion channel activity,MF,
328,GO:0005230,1,0.689785429679887,0,1,extracellular ligand-gated ion channel activity,MF,
329,GO:0005231,1,0.689785429679887,0,1,excitatory extracellular ligand-gated ion channel activity,MF,
330,GO:0005234,1,0.689785429679887,0,1,extracellular-glutamate-gated ion channel activity,MF,
331,GO:0005253,1,0.97782001583703,0,1,anion channel activity,MF,
332,GO:0005254,1,0.97782001583703,0,1,chloride channel activity,MF,
333,GO:0005261,1,0.689785429679887,0,1,cation channel activity,MF,
334,GO:0005310,1,0.689785429679701,0,1,dicarboxylic acid transmembrane transporter activity,MF,
335,GO:0005313,1,0.689785429679701,0,1,L-glutamate transmembrane transporter activity,MF,
336,GO:0005314,1,0.689785429679701,0,1,high-affinity glutamate transmembrane transporter activity,MF,
337,GO:0005319,1,0.4052558024433,0,4,lipid transporter activity,MF,
338,GO:0005324,1,0.915413777710168,0,1,long-chain fatty acid transporter activity,MF,
339,GO:0005342,1,0.689785429679701,0,1,organic acid transmembrane transporter activity,MF,
340,GO:0005375,1,0.770314150802672,0,1,copper ion transmembrane transporter activity,MF,
342,GO:0005496,1,0.473517862731652,0,2,steroid binding,MF,
343,GO:0005501,1,0.94012643491917,0,1,retinoid binding,MF,
344,GO:0005504,1,0.898924003841621,0,2,fatty acid binding,MF,
346,GO:0005507,1,0.933624765294581,0,1,copper ion binding,MF,
347,GO:0005509,1,0.394608140569879,0,4,calcium ion binding,MF,
350,GO:0005523,1,0.823602209620197,0,2,tropomyosin binding,MF,
352,GO:0005525,1,0.693221867723898,0,1,GTP binding,MF,
353,GO:0005539,1,0.933624765294581,0,1,glycosaminoglycan binding,MF,
355,GO:0005544,1,0.690322142801083,0,1,calcium-dependent phospholipid binding,MF,
357,GO:0005548,1,0.689785429679902,0,1,phospholipid transporter activity,MF,
360,GO:0005578,1,0.643224194992536,0,2,proteinaceous extracellular matrix,CC,
361,GO:0005604,1,0.933624765294581,0,1,basement membrane,CC,
362,GO:0005605,1,0.933624765294581,0,1,basal lamina,CC,
379,GO:0005761,1,0.862856117640713,0,2,mitochondrial ribosome,CC,
380,GO:0005762,1,0.862856117640713,0,2,mitochondrial large ribosomal subunit,CC,
385,GO:0005770,1,0.770314150802672,0,1,late endosome,CC,
389,GO:0005777,1,0.150621493980518,0,8,peroxisome,CC,
390,GO:0005778,1,0.425710926094784,0,4,peroxisomal membrane,CC,
391,GO:0005782,1,0.366233511567831,0,4,peroxisomal matrix,CC,
395,GO:0005793,1,0.971719166134129,0,1,endoplasmic reticulum-Golgi intermediate compartment,CC,
396,GO:0005794,1,0.347416866022056,0,4,Golgi apparatus,CC,
398,GO:0005815,1,0.495661267332306,0,2,microtubule organizing center,CC,
399,GO:0005819,1,0.689785429679681,0,1,spindle,CC,
401,GO:0005839,1,0.932920109189956,0,1,proteasome core complex,CC,
402,GO:0005840,1,0.862856117640713,0,2,ribosome,CC,
404,GO:0005865,1,0.872301952309925,0,1,striated muscle thin filament,CC,
405,GO:0005874,1,0.689785429679681,0,1,microtubule,CC,
406,GO:0005882,1,0.71008138889583,0,1,intermediate filament,CC,
408,GO:0005887,1,0.0980240567658155,0,8,integral component of plasma membrane,CC,
409,GO:0005890,1,0.97782001583703,0,1,sodium:potassium-exchanging ATPase complex,CC,
410,GO:0005912,1,0.859997101743051,0,1,adherens junction,CC,
411,GO:0005924,1,0.859997101743051,0,1,cell-substrate adherens junction,CC,
412,GO:0005925,1,0.859997101743051,0,1,focal adhesion,CC,
413,GO:0005938,1,0.689785429679681,0,1,cell cortex,CC,
418,GO:0006011,1,0.869799107756487,0,1,UDP-glucose metabolic process,BP,
419,GO:0006012,1,0.869799107756487,0,1,galactose metabolic process,BP,
421,GO:0006023,1,0.689785429679681,0,1,aminoglycan biosynthetic process,BP,
422,GO:0006024,1,0.689785429679681,0,1,glycosaminoglycan biosynthetic process,BP,
427,GO:0006081,1,0.370676254640944,0,3,cellular aldehyde metabolic process,BP,
433,GO:0006091,1,0.267080129069565,0,5,generation of precursor metabolites and energy,BP,
434,GO:0006094,1,0.830045349405611,0,2,gluconeogenesis,BP,
435,GO:0006097,1,0.696680402390533,0,1,glyoxylate cycle,BP,
436,GO:0006098,1,0.536475172301674,0,2,pentose-phosphate shunt,BP,
437,GO:0006099,1,0.614226365542606,0,2,tricarboxylic acid cycle,BP,
438,GO:0006101,1,0.420822871464881,0,3,citrate metabolic process,BP,
439,GO:0006102,1,0.696680402390533,0,1,isocitrate metabolic process,BP,
440,GO:0006103,1,0.377688775539753,0,3,2-oxoglutarate metabolic process,BP,
441,GO:0006105,1,0.689785429679705,0,1,succinate metabolic process,BP,
442,GO:0006107,1,0.608118480053522,0,2,oxaloacetate metabolic process,BP,
443,GO:0006108,1,0.883274038622596,0,1,malate metabolic process,BP,
446,GO:0006140,1,0.954275672359452,0,1,regulation of nucleotide metabolic process,BP,
452,GO:0006164,1,0.677305585898023,0,2,purine nucleotide biosynthetic process,BP,
453,GO:0006171,1,0.954275672359452,0,1,cAMP biosynthetic process,BP,
455,GO:0006258,1,0.869799107756487,0,1,UDP-glucose catabolic process,BP,
456,GO:0006259,1,0.669215170845932,0,2,DNA metabolic process,BP,
457,GO:0006260,1,0.906531724415968,0,1,DNA replication,BP,
458,GO:0006308,1,0.739171199267924,0,1,DNA catabolic process,BP,
460,GO:0006352,1,0.689785429679797,0,1,DNA-templated transcription, initiation,BP,
461,GO:0006354,1,0.728032091145752,0,1,DNA-templated transcription, elongation,BP,
466,GO:0006367,1,0.689785429679797,0,1,transcription initiation from RNA polymerase II promoter,BP,
467,GO:0006376,1,0.860646174064634,0,1,mRNA splice site selection,BP,
470,GO:0006399,1,0.564486489977807,0,3,tRNA metabolic process,BP,
471,GO:0006400,1,0.743963160689213,0,2,tRNA modification,BP,
473,GO:0006414,1,0.62680772179944,0,3,translational elongation,BP,
474,GO:0006415,1,0.862856117640713,0,2,translational termination,BP,
476,GO:0006461,1,0.11210318477857,0,11,protein complex assembly,BP,
479,GO:0006469,1,0.535354857672809,0,3,negative regulation of protein kinase activity,BP,
480,GO:0006470,1,0.714041787506714,0,2,protein dephosphorylation,BP,
481,GO:0006479,1,0.913412257399827,0,1,protein methylation,BP,
482,GO:0006486,1,0.610469436077768,0,3,protein glycosylation,BP,
483,GO:0006487,1,0.886968893436572,0,2,protein N-linked glycosylation,BP,
484,GO:0006493,1,0.982932946886051,0,1,protein O-linked glycosylation,BP,
485,GO:0006497,1,0.982932946886051,0,1,protein lipidation,BP,
486,GO:0006505,1,0.982932946886051,0,1,GPI anchor metabolic process,BP,
487,GO:0006506,1,0.982932946886051,0,1,GPI anchor biosynthetic process,BP,
489,GO:0006511,1,0.932920109189956,0,1,ubiquitin-dependent protein catabolic process,BP,
492,GO:0006521,1,0.932920109189956,0,1,regulation of cellular amino acid metabolic process,BP,
493,GO:0006536,1,0.689785429679701,0,1,glutamate metabolic process,BP,
494,GO:0006537,1,0.689785429679701,0,1,glutamate biosynthetic process,BP,
495,GO:0006549,1,0.487759927440917,0,2,isoleucine metabolic process,BP,
496,GO:0006550,1,0.710373855442479,0,1,isoleucine catabolic process,BP,
498,GO:0006558,1,0.929610988847701,0,1,L-phenylalanine metabolic process,BP,
499,GO:0006559,1,0.929610988847701,0,1,L-phenylalanine catabolic process,BP,
500,GO:0006573,1,0.689785429679705,0,1,valine metabolic process,BP,
501,GO:0006575,1,0.275077321618553,0,5,cellular modified amino acid metabolic process,BP,
502,GO:0006576,1,0.689785429679775,0,1,cellular biogenic amine metabolic process,BP,
503,GO:0006577,1,0.689785429680017,0,1,amino-acid betaine metabolic process,BP,
504,GO:0006600,1,0.689785429679705,0,1,creatine metabolic process,BP,
505,GO:0006605,1,0.860646174064634,0,1,protein targeting,BP,
506,GO:0006606,1,0.860646174064634,0,1,protein import into nucleus,BP,
512,GO:0006636,1,0.689785429679715,0,1,unsaturated fatty acid biosynthetic process,BP,
514,GO:0006638,1,0.548317780028525,0,5,neutral lipid metabolic process,BP,
515,GO:0006639,1,0.548317780028525,0,5,acylglycerol metabolic process,BP,
516,GO:0006641,1,0.588433932761025,0,4,triglyceride metabolic process,BP,
519,GO:0006650,1,0.557444532462145,0,6,glycerophospholipid metabolic process,BP,
520,GO:0006651,1,0.933624765294581,0,1,diacylglycerol biosynthetic process,BP,
521,GO:0006656,1,0.915413777710168,0,1,phosphatidylcholine biosynthetic process,BP,
522,GO:0006658,1,0.889059397519768,0,1,phosphatidylserine metabolic process,BP,
523,GO:0006661,1,0.816239345427684,0,2,phosphatidylinositol biosynthetic process,BP,
524,GO:0006662,1,0.889059397519768,0,1,glycerol ether metabolic process,BP,
528,GO:0006677,1,0.852105267215681,0,1,glycosylceramide metabolic process,BP,
532,GO:0006691,1,0.955554231038555,0,1,leukotriene metabolic process,BP,
535,GO:0006699,1,0.689883197202292,0,1,bile acid biosynthetic process,BP,
543,GO:0006720,1,0.381051740371716,0,4,isoprenoid metabolic process,BP,
544,GO:0006721,1,0.482579361498511,0,3,terpenoid metabolic process,BP,
546,GO:0006729,1,0.873228977733856,0,2,tetrahydrobiopterin biosynthetic process,BP,
549,GO:0006734,1,0.883274038622596,0,1,NADH metabolic process,BP,
551,GO:0006739,1,0.370676254640944,0,3,NADP metabolic process,BP,
552,GO:0006740,1,0.696680402390533,0,1,NADPH regeneration,BP,
553,GO:0006749,1,0.665119149062594,0,2,glutathione metabolic process,BP,
554,GO:0006750,1,0.955554231038555,0,1,glutathione biosynthetic process,BP,
558,GO:0006771,1,0.814550451684994,0,1,riboflavin metabolic process,BP,
564,GO:0006801,1,0.739171199267924,0,1,superoxide metabolic process,BP,
569,GO:0006811,1,0.0838449188076571,0,11,ion transport,BP,
570,GO:0006812,1,0.452345891917474,0,5,cation transport,BP,
571,GO:0006814,1,0.97782001583703,0,1,sodium ion transport,BP,
572,GO:0006816,1,0.635004410324262,0,2,calcium ion transport,BP,
573,GO:0006818,1,0.953244849717105,0,1,hydrogen transport,BP,
574,GO:0006820,1,0.281769055205065,0,6,anion transport,BP,
575,GO:0006821,1,0.97782001583703,0,1,chloride transport,BP,
576,GO:0006825,1,0.770314150802672,0,1,copper ion transport,BP,
577,GO:0006835,1,0.689785429679701,0,1,dicarboxylic acid transport,BP,
578,GO:0006836,1,0.689785429679701,0,1,neurotransmitter transport,BP,
579,GO:0006839,1,0.592349499123615,0,2,mitochondrial transport,BP,
580,GO:0006853,1,0.689785429679855,0,1,carnitine shuttle,BP,
581,GO:0006855,1,0.90529521320746,0,1,drug transmembrane transport,BP,
582,GO:0006865,1,0.689785429679701,0,1,amino acid transport,BP,
583,GO:0006869,1,0.270484181155953,0,6,lipid transport,BP,
587,GO:0006878,1,0.770314150802672,0,1,cellular copper ion homeostasis,BP,
591,GO:0006888,1,0.971719166134129,0,1,ER to Golgi vesicle-mediated transport,BP,
592,GO:0006890,1,0.948778839941827,0,1,retrograde vesicle-mediated transport, Golgi to ER,BP,
593,GO:0006897,1,0.638789230513851,0,3,endocytosis,BP,
594,GO:0006898,1,0.982136033016046,0,1,receptor-mediated endocytosis,BP,
595,GO:0006906,1,0.689785429679809,0,1,vesicle fusion,BP,
596,GO:0006907,1,0.944573033403215,0,1,pinocytosis,BP,
597,GO:0006909,1,0.944573033403215,0,1,phagocytosis,BP,
602,GO:0006924,1,0.753843485045977,0,1,activation-induced cell death of T cells,BP,
604,GO:0006935,1,0.618537431092925,0,2,chemotaxis,BP,
605,GO:0006936,1,0.852742609589982,0,2,muscle contraction,BP,
610,GO:0006956,1,0.689996137392405,0,1,complement activation,BP,
611,GO:0006957,1,0.689996137392405,0,1,complement activation, alternative pathway,BP,
612,GO:0006959,1,0.642929676688613,0,2,humoral immune response,BP,
613,GO:0006974,1,0.944573033403215,0,1,cellular response to DNA damage stimulus,BP,
615,GO:0006986,1,0.700154732893895,0,1,response to unfolded protein,BP,
617,GO:0007005,1,0.602782488368058,0,4,mitochondrion organization,BP,
618,GO:0007006,1,0.860646174064634,0,1,mitochondrial membrane organization,BP,
619,GO:0007010,1,0.768372008400137,0,3,cytoskeleton organization,BP,
620,GO:0007015,1,0.768372008400137,0,3,actin filament organization,BP,
621,GO:0007031,1,0.889059397519768,0,1,peroxisome organization,BP,
623,GO:0007034,1,0.948778839941827,0,1,vacuolar transport,BP,
625,GO:0007041,1,0.948778839941827,0,1,lysosomal transport,BP,
626,GO:0007049,1,0.82906426527132,0,2,cell cycle,BP,
630,GO:0007164,1,0.932920109189956,0,1,establishment of tissue polarity,BP,
635,GO:0007173,1,0.746221125113029,0,1,epidermal growth factor receptor signaling pathway,BP,
636,GO:0007186,1,0.474238858774298,0,2,G-protein coupled receptor signaling pathway,BP,
637,GO:0007202,1,0.933624765294581,0,1,activation of phospholipase C activity,BP,
638,GO:0007204,1,0.860646174064634,0,1,positive regulation of cytosolic calcium ion concentration,BP,
639,GO:0007215,1,0.689785429679887,0,1,glutamate receptor signaling pathway,BP,
641,GO:0007254,1,0.944573033403215,0,1,JNK cascade,BP,
642,GO:0007259,1,0.576634378193675,0,2,JAK-STAT cascade,BP,
643,GO:0007260,1,0.689785429679705,0,1,tyrosine phosphorylation of STAT protein,BP,
644,GO:0007264,1,0.746221125113029,0,1,small GTPase mediated signal transduction,BP,
645,GO:0007265,1,0.746221125113029,0,1,Ras protein signal transduction,BP,
646,GO:0007267,1,0.0993398484286491,0,9,cell-cell signaling,BP,
647,GO:0007268,1,0.208030927622597,0,5,chemical synaptic transmission,BP,
652,GO:0007283,1,0.739171199267924,0,1,spermatogenesis,BP,
656,GO:0007346,1,0.932920109189956,0,1,regulation of mitotic cell cycle,BP,
657,GO:0007368,1,0.902523548288088,0,1,determination of left/right symmetry,BP,
658,GO:0007389,1,0.902523548288088,0,1,pattern specification process,BP,
660,GO:0007409,1,0.464807221264095,0,3,axonogenesis,BP,
661,GO:0007411,1,0.746221125113029,0,1,axon guidance,BP,
662,GO:0007417,1,0.414414869451559,0,4,central nervous system development,BP,
663,GO:0007420,1,0.487829858939189,0,2,brain development,BP,
664,GO:0007423,1,0.94012643491917,0,1,sensory organ development,BP,
665,GO:0007507,1,0.94012643491917,0,1,heart development,BP,
666,GO:0007517,1,0.854431527474896,0,2,muscle organ development,BP,
667,GO:0007519,1,0.909149134363904,0,1,skeletal muscle tissue development,BP,
669,GO:0007568,1,0.739171199267924,0,1,aging,BP,
670,GO:0007584,1,0.689883197202292,0,1,response to nutrient,BP,
671,GO:0007586,1,0.94012643491917,0,1,digestion,BP,
672,GO:0007596,1,0.474243671643786,0,2,blood coagulation,BP,
673,GO:0007598,1,0.690927624413754,0,1,blood coagulation, extrinsic pathway,BP,
674,GO:0007599,1,0.474243671643786,0,2,hemostasis,BP,
676,GO:0007601,1,0.94012643491917,0,1,visual perception,BP,
679,GO:0007611,1,0.909149134363904,0,1,learning or memory,BP,
680,GO:0007613,1,0.909149134363904,0,1,memory,BP,
684,GO:0007622,1,0.689883197202292,0,1,rhythmic behavior,BP,
685,GO:0007623,1,0.689883197202292,0,1,circadian rhythm,BP,
687,GO:0007638,1,0.689785429679701,0,1,mechanosensory behavior,BP,
688,GO:0008015,1,0.97782001583703,0,1,blood circulation,BP,
689,GO:0008016,1,0.97782001583703,0,1,regulation of heart contraction,BP,
690,GO:0008033,1,0.564486489977807,0,3,tRNA processing,BP,
691,GO:0008047,1,0.609661269403253,0,4,enzyme activator activity,MF,
693,GO:0008064,1,0.823602209620197,0,2,regulation of actin polymerization or depolymerization,BP,
694,GO:0008066,1,0.689785429679887,0,1,glutamate receptor activity,MF,
695,GO:0008083,1,0.757858830785565,0,2,growth factor activity,MF,
696,GO:0008092,1,0.211375699128835,0,8,cytoskeletal protein binding,MF,
698,GO:0008108,1,0.869799107756487,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
699,GO:0008112,1,0.815981061082205,0,1,nicotinamide N-methyltransferase activity,MF,
700,GO:0008113,1,0.837858240375495,0,1,peptide-methionine (S)-S-oxide reductase activity,MF,
701,GO:0008124,1,0.929610988847701,0,1,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
703,GO:0008135,1,0.728032091145752,0,1,translation factor activity, RNA binding,MF,
707,GO:0008154,1,0.768372008400137,0,3,actin polymerization or depolymerization,BP,
708,GO:0008168,1,0.815981061082205,0,1,methyltransferase activity,MF,
709,GO:0008170,1,0.815981061082205,0,1,N-methyltransferase activity,MF,
711,GO:0008198,1,0.646211089439751,0,2,ferrous iron binding,MF,
712,GO:0008199,1,0.814550451684994,0,1,ferric iron binding,MF,
713,GO:0008201,1,0.933624765294581,0,1,heparin binding,MF,
716,GO:0008206,1,0.689883197202292,0,1,bile acid metabolic process,BP,
722,GO:0008213,1,0.913412257399827,0,1,protein alkylation,BP,
726,GO:0008235,1,0.745090050957516,0,1,metalloexopeptidase activity,MF,
727,GO:0008236,1,0.689996137392405,0,1,serine-type peptidase activity,MF,
728,GO:0008237,1,0.745090050957516,0,1,metallopeptidase activity,MF,
729,GO:0008238,1,0.745090050957516,0,1,exopeptidase activity,MF,
730,GO:0008270,1,0.582399585347958,0,3,zinc ion binding,MF,
731,GO:0008277,1,0.690322142801083,0,1,regulation of G-protein coupled receptor protein signaling pathway,BP,
734,GO:0008285,1,0.546163593623407,0,5,negative regulation of cell proliferation,BP,
737,GO:0008324,1,0.34422206874086,0,4,cation transmembrane transporter activity,MF,
738,GO:0008328,1,0.473449921345991,0,2,ionotropic glutamate receptor complex,CC,
741,GO:0008361,1,0.770314150802672,0,1,regulation of cell size,BP,
743,GO:0008374,1,0.473449921345967,0,2,O-acyltransferase activity,MF,
745,GO:0008380,1,0.742960534906432,0,2,RNA splicing,BP,
746,GO:0008385,1,0.944573033403215,0,1,IkappaB kinase complex,CC,
749,GO:0008406,1,0.445485188652002,0,3,gonad development,BP,
750,GO:0008474,1,0.745842816697877,0,1,palmitoyl-(protein) hydrolase activity,MF,
751,GO:0008480,1,0.689785429679775,0,1,sarcosine dehydrogenase activity,MF,
752,GO:0008509,1,0.674056819353456,0,2,anion transmembrane transporter activity,MF,
753,GO:0008514,1,0.689785429679701,0,1,organic anion transmembrane transporter activity,MF,
754,GO:0008543,1,0.83065676594881,0,1,fibroblast growth factor receptor signaling pathway,BP,
755,GO:0008544,1,0.593711349227464,0,2,epidermis development,BP,
756,GO:0008565,1,0.689785429679902,0,1,protein transporter activity,MF,
757,GO:0008584,1,0.689883197202292,0,1,male gonad development,BP,
758,GO:0008585,1,0.6496736281172,0,2,female gonad development,BP,
760,GO:0008625,1,0.630542903290721,0,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,
761,GO:0008630,1,0.944573033403215,0,1,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
762,GO:0008631,1,0.860646174064634,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
763,GO:0008637,1,0.812567533012029,0,2,apoptotic mitochondrial changes,BP,
768,GO:0008656,1,0.944573033403215,0,1,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
769,GO:0008670,1,0.886430651618205,0,1,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
770,GO:0008709,1,0.937272715402406,0,1,cholate 7-alpha-dehydrogenase activity,MF,
771,GO:0008757,1,0.815981061082205,0,1,S-adenosylmethionine-dependent methyltransferase activity,MF,
772,GO:0008970,1,0.889059397519768,0,1,phosphatidylcholine 1-acylhydrolase activity,MF,
773,GO:0009052,1,0.689785429679685,0,1,pentose-phosphate shunt, non-oxidative branch,BP,
779,GO:0009060,1,0.614226365542606,0,2,aerobic respiration,BP,
781,GO:0009063,1,0.422856081599643,0,4,cellular amino acid catabolic process,BP,
782,GO:0009064,1,0.689785429679701,0,1,glutamine family amino acid metabolic process,BP,
785,GO:0009072,1,0.929610988847701,0,1,aromatic amino acid family metabolic process,BP,
786,GO:0009074,1,0.929610988847701,0,1,aromatic amino acid family catabolic process,BP,
787,GO:0009081,1,0.456131830862965,0,3,branched-chain amino acid metabolic process,BP,
788,GO:0009083,1,0.665100968031531,0,2,branched-chain amino acid catabolic process,BP,
789,GO:0009084,1,0.689785429679701,0,1,glutamine family amino acid biosynthetic process,BP,
792,GO:0009101,1,0.610469436077768,0,3,glycoprotein biosynthetic process,BP,
794,GO:0009109,1,0.65896949055495,0,2,coenzyme catabolic process,BP,
795,GO:0009110,1,0.739171199267924,0,1,vitamin biosynthetic process,BP,
801,GO:0009120,1,0.780410045217068,0,1,deoxyribonucleoside metabolic process,BP,
802,GO:0009132,1,0.928729318243992,0,1,nucleoside diphosphate metabolic process,BP,
803,GO:0009150,1,0.62814739260899,0,3,purine ribonucleotide metabolic process,BP,
804,GO:0009152,1,0.677305585898023,0,2,purine ribonucleotide biosynthetic process,BP,
805,GO:0009154,1,0.928729318243992,0,1,purine ribonucleotide catabolic process,BP,
809,GO:0009187,1,0.954275672359452,0,1,cyclic nucleotide metabolic process,BP,
810,GO:0009190,1,0.954275672359452,0,1,cyclic nucleotide biosynthetic process,BP,
811,GO:0009225,1,0.869799107756487,0,1,nucleotide-sugar metabolic process,BP,
812,GO:0009227,1,0.869799107756487,0,1,nucleotide-sugar catabolic process,BP,
814,GO:0009247,1,0.982932946886051,0,1,glycolipid biosynthetic process,BP,
815,GO:0009259,1,0.62814739260899,0,3,ribonucleotide metabolic process,BP,
816,GO:0009260,1,0.677305585898023,0,2,ribonucleotide biosynthetic process,BP,
817,GO:0009261,1,0.928729318243992,0,1,ribonucleotide catabolic process,BP,
818,GO:0009262,1,0.780410045217068,0,1,deoxyribonucleotide metabolic process,BP,
819,GO:0009264,1,0.780410045217068,0,1,deoxyribonucleotide catabolic process,BP,
820,GO:0009266,1,0.700154732893895,0,1,response to temperature stimulus,BP,
822,GO:0009295,1,0.700154732893895,0,1,nucleoid,CC,
823,GO:0009303,1,0.933624765294581,0,1,rRNA transcription,BP,
825,GO:0009308,1,0.642732733398094,0,2,amine metabolic process,BP,
826,GO:0009310,1,0.689785429679775,0,1,amine catabolic process,BP,
829,GO:0009314,1,0.473517862731513,0,2,response to radiation,BP,
830,GO:0009395,1,0.683846949876915,0,2,phospholipid catabolic process,BP,
831,GO:0009404,1,0.689883197202292,0,1,toxin metabolic process,BP,
832,GO:0009409,1,0.700154732893895,0,1,response to cold,BP,
834,GO:0009416,1,0.689785429679701,0,1,response to light stimulus,BP,
836,GO:0009437,1,0.689785429680017,0,1,carnitine metabolic process,BP,
837,GO:0009448,1,0.689785429679701,0,1,gamma-aminobutyric acid metabolic process,BP,
838,GO:0009449,1,0.689785429679701,0,1,gamma-aminobutyric acid biosynthetic process,BP,
839,GO:0009451,1,0.743963160689213,0,2,RNA modification,BP,
841,GO:0009593,1,0.689785429679902,0,1,detection of chemical stimulus,BP,
844,GO:0009611,1,0.276840158723579,0,4,response to wounding,BP,
845,GO:0009612,1,0.517989755675493,0,2,response to mechanical stimulus,BP,
848,GO:0009628,1,0.162260665323272,0,8,response to abiotic stimulus,BP,
849,GO:0009635,1,0.689883197202292,0,1,response to herbicide,BP,
853,GO:0009720,1,0.689785429679902,0,1,detection of hormone stimulus,BP,
855,GO:0009726,1,0.689785429679902,0,1,detection of endogenous stimulus,BP,
856,GO:0009743,1,0.689883197202292,0,1,response to carbohydrate,BP,
857,GO:0009746,1,0.689883197202292,0,1,response to hexose,BP,
858,GO:0009749,1,0.689883197202292,0,1,response to glucose,BP,
859,GO:0009790,1,0.94012643491917,0,1,embryo development,BP,
861,GO:0009792,1,0.94012643491917,0,1,embryo development ending in birth or egg hatching,BP,
862,GO:0009799,1,0.902523548288088,0,1,specification of symmetry,BP,
863,GO:0009855,1,0.902523548288088,0,1,determination of bilateral symmetry,BP,
864,GO:0009887,1,0.727449313591866,0,3,animal organ morphogenesis,BP,
872,GO:0009895,1,0.498176838459616,0,3,negative regulation of catabolic process,BP,
874,GO:0009897,1,0.689785429679902,0,1,external side of plasma membrane,CC,
875,GO:0009913,1,0.71008138889583,0,1,epidermal cell differentiation,BP,
876,GO:0009914,1,0.94012643491917,0,1,hormone transport,BP,
878,GO:0009922,1,0.689785429679781,0,1,fatty acid elongase activity,MF,
882,GO:0009982,1,0.794342025053001,0,1,pseudouridine synthase activity,MF,
883,GO:0009986,1,0.220014127898448,0,4,cell surface,CC,
886,GO:0009994,1,0.933624765294581,0,1,oocyte differentiation,BP,
887,GO:0010001,1,0.909149134363904,0,1,glial cell differentiation,BP,
890,GO:0010035,1,0.48326283820092,0,3,response to inorganic substance,BP,
891,GO:0010038,1,0.65700329833437,0,2,response to metal ion,BP,
892,GO:0010212,1,0.689883197202292,0,1,response to ionizing radiation,BP,
894,GO:0010288,1,0.689883197202292,0,1,response to lead ion,BP,
895,GO:0010389,1,0.932920109189956,0,1,regulation of G2/M transition of mitotic cell cycle,BP,
896,GO:0010466,1,0.593335839232855,0,2,negative regulation of peptidase activity,BP,
899,GO:0010498,1,0.932920109189956,0,1,proteasomal protein catabolic process,BP,
901,GO:0010507,1,0.689785429679809,0,1,negative regulation of autophagy,BP,
904,GO:0010517,1,0.933624765294581,0,1,regulation of phospholipase activity,BP,
905,GO:0010518,1,0.933624765294581,0,1,positive regulation of phospholipase activity,BP,
909,GO:0010562,1,0.319194311948315,0,7,positive regulation of phosphorus metabolic process,BP,
910,GO:0010563,1,0.525253391582431,0,4,negative regulation of phosphorus metabolic process,BP,
911,GO:0010564,1,0.932920109189956,0,1,regulation of cell cycle process,BP,
913,GO:0010594,1,0.83065676594881,0,1,regulation of endothelial cell migration,BP,
914,GO:0010595,1,0.83065676594881,0,1,positive regulation of endothelial cell migration,BP,
920,GO:0010631,1,0.83065676594881,0,1,epithelial cell migration,BP,
921,GO:0010632,1,0.83065676594881,0,1,regulation of epithelial cell migration,BP,
922,GO:0010634,1,0.83065676594881,0,1,positive regulation of epithelial cell migration,BP,
923,GO:0010638,1,0.944573033403215,0,1,positive regulation of organelle organization,BP,
924,GO:0010639,1,0.750065063096119,0,2,negative regulation of organelle organization,BP,
928,GO:0010656,1,0.860646174064634,0,1,negative regulation of muscle cell apoptotic process,BP,
929,GO:0010657,1,0.860646174064634,0,1,muscle cell apoptotic process,BP,
930,GO:0010658,1,0.860646174064634,0,1,striated muscle cell apoptotic process,BP,
931,GO:0010659,1,0.860646174064634,0,1,cardiac muscle cell apoptotic process,BP,
932,GO:0010660,1,0.860646174064634,0,1,regulation of muscle cell apoptotic process,BP,
933,GO:0010662,1,0.860646174064634,0,1,regulation of striated muscle cell apoptotic process,BP,
934,GO:0010664,1,0.860646174064634,0,1,negative regulation of striated muscle cell apoptotic process,BP,
935,GO:0010665,1,0.860646174064634,0,1,regulation of cardiac muscle cell apoptotic process,BP,
936,GO:0010667,1,0.860646174064634,0,1,negative regulation of cardiac muscle cell apoptotic process,BP,
937,GO:0010669,1,0.94012643491917,0,1,epithelial structure maintenance,BP,
939,GO:0010676,1,0.739171199267924,0,1,positive regulation of cellular carbohydrate metabolic process,BP,
940,GO:0010720,1,0.689883197202292,0,1,positive regulation of cell development,BP,
941,GO:0010721,1,0.689785429679932,0,1,negative regulation of cell development,BP,
942,GO:0010742,1,0.689785429679902,0,1,macrophage derived foam cell differentiation,BP,
943,GO:0010743,1,0.689785429679902,0,1,regulation of macrophage derived foam cell differentiation,BP,
944,GO:0010745,1,0.689785429679902,0,1,negative regulation of macrophage derived foam cell differentiation,BP,
945,GO:0010765,1,0.97782001583703,0,1,positive regulation of sodium ion transport,BP,
946,GO:0010769,1,0.689785429679932,0,1,regulation of cell morphogenesis involved in differentiation,BP,
947,GO:0010771,1,0.689785429679932,0,1,negative regulation of cell morphogenesis involved in differentiation,BP,
948,GO:0010803,1,0.679866982578268,0,3,regulation of tumor necrosis factor-mediated signaling pathway,BP,
949,GO:0010804,1,0.860646174064634,0,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
951,GO:0010821,1,0.812567533012029,0,2,regulation of mitochondrion organization,BP,
952,GO:0010822,1,0.944573033403215,0,1,positive regulation of mitochondrion organization,BP,
953,GO:0010823,1,0.860646174064634,0,1,negative regulation of mitochondrion organization,BP,
956,GO:0010863,1,0.933624765294581,0,1,positive regulation of phospholipase C activity,BP,
957,GO:0010866,1,0.739171199267924,0,1,regulation of triglyceride biosynthetic process,BP,
958,GO:0010867,1,0.739171199267924,0,1,positive regulation of triglyceride biosynthetic process,BP,
959,GO:0010872,1,0.677068771719113,0,2,regulation of cholesterol esterification,BP,
960,GO:0010873,1,0.982136033016046,0,1,positive regulation of cholesterol esterification,BP,
961,GO:0010874,1,0.689785429679902,0,1,regulation of cholesterol efflux,BP,
962,GO:0010875,1,0.689785429679902,0,1,positive regulation of cholesterol efflux,BP,
964,GO:0010878,1,0.689785429679902,0,1,cholesterol storage,BP,
965,GO:0010883,1,0.689785429679902,0,1,regulation of lipid storage,BP,
966,GO:0010885,1,0.689785429679902,0,1,regulation of cholesterol storage,BP,
967,GO:0010887,1,0.689785429679902,0,1,negative regulation of cholesterol storage,BP,
968,GO:0010888,1,0.689785429679902,0,1,negative regulation of lipid storage,BP,
969,GO:0010893,1,0.473517862731652,0,2,positive regulation of steroid biosynthetic process,BP,
970,GO:0010899,1,0.982136033016046,0,1,regulation of phosphatidylcholine catabolic process,BP,
971,GO:0010900,1,0.982136033016046,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
973,GO:0010907,1,0.739171199267924,0,1,positive regulation of glucose metabolic process,BP,
974,GO:0010915,1,0.982136033016046,0,1,regulation of very-low-density lipoprotein particle clearance,BP,
975,GO:0010916,1,0.982136033016046,0,1,negative regulation of very-low-density lipoprotein particle clearance,BP,
976,GO:0010921,1,0.739171199267924,0,1,regulation of phosphatase activity,BP,
977,GO:0010922,1,0.739171199267924,0,1,positive regulation of phosphatase activity,BP,
978,GO:0010923,1,0.739171199267924,0,1,negative regulation of phosphatase activity,BP,
979,GO:0010939,1,0.54111979308309,0,3,regulation of necrotic cell death,BP,
982,GO:0010948,1,0.932920109189956,0,1,negative regulation of cell cycle process,BP,
984,GO:0010951,1,0.593335839232855,0,2,negative regulation of endopeptidase activity,BP,
986,GO:0010955,1,0.860646174064634,0,1,negative regulation of protein processing,BP,
987,GO:0010959,1,0.554568607218397,0,3,regulation of metal ion transport,BP,
988,GO:0010972,1,0.932920109189956,0,1,negative regulation of G2/M transition of mitotic cell cycle,BP,
989,GO:0010975,1,0.689785429679932,0,1,regulation of neuron projection development,BP,
990,GO:0010977,1,0.689785429679932,0,1,negative regulation of neuron projection development,BP,
991,GO:0010984,1,0.982136033016046,0,1,regulation of lipoprotein particle clearance,BP,
992,GO:0010985,1,0.982136033016046,0,1,negative regulation of lipoprotein particle clearance,BP,
993,GO:0010996,1,0.689785429679701,0,1,response to auditory stimulus,BP,
997,GO:0014047,1,0.689785429679701,0,1,glutamate secretion,BP,
998,GO:0014065,1,0.83065676594881,0,1,phosphatidylinositol 3-kinase signaling,BP,
999,GO:0014066,1,0.83065676594881,0,1,regulation of phosphatidylinositol 3-kinase signaling,BP,
1001,GO:0014072,1,0.753843485045977,0,1,response to isoquinoline alkaloid,BP,
1002,GO:0014074,1,0.689883197202292,0,1,response to purine-containing compound,BP,
1003,GO:0014706,1,0.854431527474896,0,2,striated muscle tissue development,BP,
1004,GO:0014735,1,0.860646174064634,0,1,regulation of muscle atrophy,BP,
1005,GO:0014736,1,0.860646174064634,0,1,negative regulation of muscle atrophy,BP,
1006,GO:0014745,1,0.860646174064634,0,1,negative regulation of muscle adaptation,BP,
1007,GO:0014808,1,0.860646174064634,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1008,GO:0014823,1,0.689883197202292,0,1,response to activity,BP,
1009,GO:0014855,1,0.94012643491917,0,1,striated muscle cell proliferation,BP,
1010,GO:0014874,1,0.860646174064634,0,1,response to stimulus involved in regulation of muscle adaptation,BP,
1011,GO:0014876,1,0.860646174064634,0,1,response to injury involved in regulation of muscle adaptation,BP,
1012,GO:0014889,1,0.860646174064634,0,1,muscle atrophy,BP,
1013,GO:0015002,1,0.953244849717105,0,1,heme-copper terminal oxidase activity,MF,
1014,GO:0015012,1,0.689785429679681,0,1,heparan sulfate proteoglycan biosynthetic process,BP,
1016,GO:0015065,1,0.690383534494896,0,1,uridine nucleotide receptor activity,MF,
1017,GO:0015075,1,0.335946892343541,0,5,ion transmembrane transporter activity,MF,
1018,GO:0015077,1,0.656909963638031,0,2,monovalent inorganic cation transmembrane transporter activity,MF,
1019,GO:0015078,1,0.953244849717105,0,1,hydrogen ion transmembrane transporter activity,MF,
1020,GO:0015081,1,0.689785429679701,0,1,sodium ion transmembrane transporter activity,MF,
1021,GO:0015103,1,0.97782001583703,0,1,inorganic anion transmembrane transporter activity,MF,
1022,GO:0015108,1,0.97782001583703,0,1,chloride transmembrane transporter activity,MF,
1023,GO:0015171,1,0.689785429679701,0,1,amino acid transmembrane transporter activity,MF,
1024,GO:0015172,1,0.689785429679701,0,1,acidic amino acid transmembrane transporter activity,MF,
1025,GO:0015179,1,0.689785429679701,0,1,L-amino acid transmembrane transporter activity,MF,
1026,GO:0015197,1,0.689785429679902,0,1,peptide transporter activity,MF,
1027,GO:0015238,1,0.90529521320746,0,1,drug transmembrane transporter activity,MF,
1028,GO:0015245,1,0.915413777710168,0,1,fatty acid transporter activity,MF,
1029,GO:0015248,1,0.473517862731652,0,2,sterol transporter activity,MF,
1030,GO:0015267,1,0.674056819353636,0,2,channel activity,MF,
1031,GO:0015276,1,0.689785429679887,0,1,ligand-gated ion channel activity,MF,
1032,GO:0015291,1,0.689785429679701,0,1,secondary active transmembrane transporter activity,MF,
1033,GO:0015293,1,0.689785429679701,0,1,symporter activity,MF,
1034,GO:0015294,1,0.689785429679701,0,1,solute:cation symporter activity,MF,
1035,GO:0015370,1,0.689785429679701,0,1,solute:sodium symporter activity,MF,
1036,GO:0015399,1,0.689785429679902,0,1,primary active transmembrane transporter activity,MF,
1037,GO:0015405,1,0.689785429679902,0,1,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
1038,GO:0015485,1,0.473517862731652,0,2,cholesterol binding,MF,
1039,GO:0015629,1,0.730104225784034,0,2,actin cytoskeleton,CC,
1040,GO:0015630,1,0.495661267332306,0,2,microtubule cytoskeleton,CC,
1041,GO:0015631,1,0.689785429679681,0,1,tubulin binding,MF,
1042,GO:0015645,1,0.693221867723898,0,1,fatty acid ligase activity,MF,
1043,GO:0015672,1,0.932007505597157,0,2,monovalent inorganic cation transport,BP,
1044,GO:0015698,1,0.97782001583703,0,1,inorganic anion transport,BP,
1045,GO:0015711,1,0.288808642455763,0,5,organic anion transport,BP,
1046,GO:0015718,1,0.630524391743369,0,2,monocarboxylic acid transport,BP,
1047,GO:0015740,1,0.689785429679701,0,1,C4-dicarboxylate transport,BP,
1048,GO:0015748,1,0.677068771719113,0,2,organophosphate ester transport,BP,
1051,GO:0015800,1,0.689785429679701,0,1,acidic amino acid transport,BP,
1052,GO:0015807,1,0.689785429679701,0,1,L-amino acid transport,BP,
1053,GO:0015810,1,0.689785429679701,0,1,aspartate transport,BP,
1054,GO:0015813,1,0.689785429679701,0,1,L-glutamate transport,BP,
1056,GO:0015849,1,0.432130626877822,0,3,organic acid transport,BP,
1057,GO:0015850,1,0.435649632816697,0,4,organic hydroxy compound transport,BP,
1058,GO:0015893,1,0.90529521320746,0,1,drug transport,BP,
1059,GO:0015908,1,0.630524391743369,0,2,fatty acid transport,BP,
1060,GO:0015909,1,0.630524391743369,0,2,long-chain fatty acid transport,BP,
1061,GO:0015914,1,0.677068771719113,0,2,phospholipid transport,BP,
1062,GO:0015918,1,0.464509537089103,0,3,sterol transport,BP,
1063,GO:0015925,1,0.852105267215681,0,1,galactosidase activity,MF,
1065,GO:0015934,1,0.862856117640713,0,2,large ribosomal subunit,CC,
1066,GO:0015936,1,0.65896949055495,0,2,coenzyme A metabolic process,BP,
1067,GO:0015937,1,0.710373855442479,0,1,coenzyme A biosynthetic process,BP,
1068,GO:0015938,1,0.928729318243992,0,1,coenzyme A catabolic process,BP,
1069,GO:0015980,1,0.267080129069565,0,5,energy derivation by oxidation of organic compounds,BP,
1070,GO:0015992,1,0.953244849717105,0,1,proton transport,BP,
1076,GO:0016050,1,0.689785429679809,0,1,vesicle organization,BP,
1077,GO:0016051,1,0.612015645681683,0,3,carbohydrate biosynthetic process,BP,
1081,GO:0016055,1,0.932920109189956,0,1,Wnt signaling pathway,BP,
1085,GO:0016101,1,0.482579361498511,0,3,diterpenoid metabolic process,BP,
1092,GO:0016137,1,0.852105267215681,0,1,glycoside metabolic process,BP,
1093,GO:0016139,1,0.852105267215681,0,1,glycoside catabolic process,BP,
1095,GO:0016197,1,0.591897243930164,0,2,endosomal transport,BP,
1096,GO:0016202,1,0.854431527474896,0,2,regulation of striated muscle tissue development,BP,
1097,GO:0016209,1,0.955554231038555,0,1,antioxidant activity,MF,
1099,GO:0016236,1,0.689785429679809,0,1,macroautophagy,BP,
1100,GO:0016241,1,0.689785429679809,0,1,regulation of macroautophagy,BP,
1101,GO:0016247,1,0.97782001583703,0,1,channel regulator activity,MF,
1102,GO:0016289,1,0.928729318243992,0,1,CoA hydrolase activity,MF,
1103,GO:0016298,1,0.662136155138939,0,2,lipase activity,MF,
1105,GO:0016303,1,0.83065676594881,0,1,1-phosphatidylinositol-3-kinase activity,MF,
1106,GO:0016307,1,0.859997101743051,0,1,phosphatidylinositol phosphate kinase activity,MF,
1108,GO:0016311,1,0.579968878945392,0,3,dephosphorylation,BP,
1112,GO:0016406,1,0.473449921345967,0,2,carnitine O-acyltransferase activity,MF,
1113,GO:0016407,1,0.710373855442479,0,1,acetyltransferase activity,MF,
1114,GO:0016408,1,0.490218021240553,0,2,C-acyltransferase activity,MF,
1115,GO:0016409,1,0.473449921345967,0,2,palmitoyltransferase activity,MF,
1116,GO:0016416,1,0.473449921345967,0,2,O-palmitoyltransferase activity,MF,
1117,GO:0016453,1,0.710373855442479,0,1,C-acetyltransferase activity,MF,
1118,GO:0016462,1,0.689785429679902,0,1,pyrophosphatase activity,MF,
1120,GO:0016482,1,0.591897243930164,0,2,cytosolic transport,BP,
1121,GO:0016485,1,0.444174940205243,0,3,protein processing,BP,
1123,GO:0016502,1,0.690383534494896,0,1,nucleotide receptor activity,MF,
1124,GO:0016504,1,0.944573033403215,0,1,peptidase activator activity,MF,
1125,GO:0016505,1,0.944573033403215,0,1,peptidase activator activity involved in apoptotic process,MF,
1126,GO:0016528,1,0.787346397409486,0,2,sarcoplasm,CC,
1127,GO:0016529,1,0.860646174064634,0,1,sarcoplasmic reticulum,CC,
1128,GO:0016556,1,0.794342025053001,0,1,mRNA modification,BP,
1130,GO:0016579,1,0.932920109189956,0,1,protein deubiquitination,BP,
1131,GO:0016595,1,0.689785429679701,0,1,glutamate binding,MF,
1132,GO:0016597,1,0.689785429679701,0,1,amino acid binding,MF,
1134,GO:0016607,1,0.864085044215159,0,1,nuclear speck,CC,
1136,GO:0016615,1,0.883274038622596,0,1,malate dehydrogenase activity,MF,
1141,GO:0016645,1,0.477592794614311,0,2,oxidoreductase activity, acting on the CH-NH group of donors,MF,
1142,GO:0016649,1,0.695746712093305,0,1,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
1143,GO:0016651,1,0.886430651618205,0,1,oxidoreductase activity, acting on NAD(P)H,MF,
1144,GO:0016667,1,0.774735616109406,0,2,oxidoreductase activity, acting on a sulfur group of donors,MF,
1145,GO:0016671,1,0.837858240375495,0,1,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
1146,GO:0016675,1,0.953244849717105,0,1,oxidoreductase activity, acting on a heme group of donors,MF,
1147,GO:0016676,1,0.953244849717105,0,1,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
1148,GO:0016684,1,0.955554231038555,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1150,GO:0016706,1,0.79481320556046,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
1152,GO:0016714,1,0.929610988847701,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
1153,GO:0016717,1,0.689785429679715,0,1,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
1154,GO:0016722,1,0.695746712093305,0,1,oxidoreductase activity, oxidizing metal ions,MF,
1158,GO:0016741,1,0.815981061082205,0,1,transferase activity, transferring one-carbon groups,MF,
1159,GO:0016746,1,0.135522479264409,0,6,transferase activity, transferring acyl groups,MF,
1160,GO:0016747,1,0.153871413206215,0,5,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
1164,GO:0016765,1,0.955554231038555,0,1,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
1167,GO:0016779,1,0.869799107756487,0,1,nucleotidyltransferase activity,MF,
1170,GO:0016790,1,0.691980922227548,0,2,thiolester hydrolase activity,MF,
1171,GO:0016791,1,0.787011738409305,0,2,phosphatase activity,MF,
1173,GO:0016805,1,0.745090050957516,0,1,dipeptidase activity,MF,
1176,GO:0016817,1,0.689785429679902,0,1,hydrolase activity, acting on acid anhydrides,MF,
1177,GO:0016818,1,0.689785429679902,0,1,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,
1178,GO:0016820,1,0.689785429679902,0,1,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,
1179,GO:0016829,1,0.128380395347157,0,10,lyase activity,MF,
1180,GO:0016830,1,0.293964664855202,0,4,carbon-carbon lyase activity,MF,
1181,GO:0016832,1,0.583477690407395,0,2,aldehyde-lyase activity,MF,
1182,GO:0016835,1,0.477248142321916,0,5,carbon-oxygen lyase activity,MF,
1183,GO:0016836,1,0.509056916133957,0,4,hydro-lyase activity,MF,
1184,GO:0016838,1,0.939602622203017,0,1,carbon-oxygen lyase activity, acting on phosphates,MF,
1185,GO:0016846,1,0.955554231038555,0,1,carbon-sulfur lyase activity,MF,
1190,GO:0016866,1,0.794342025053001,0,1,intramolecular transferase activity,MF,
1194,GO:0016885,1,0.710373855442479,0,1,ligase activity, forming carbon-carbon bonds,MF,
1195,GO:0016887,1,0.689785429679902,0,1,ATPase activity,MF,
1196,GO:0016898,1,0.72207164834665,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
1198,GO:0016918,1,0.94012643491917,0,1,retinal binding,MF,
1199,GO:0016936,1,0.852105267215681,0,1,galactoside binding,MF,
1200,GO:0017016,1,0.473822899733455,0,2,Ras GTPase binding,MF,
1201,GO:0017022,1,0.944573033403215,0,1,myosin binding,MF,
1202,GO:0017024,1,0.944573033403215,0,1,myosin I binding,MF,
1203,GO:0017038,1,0.860646174064634,0,1,protein import,BP,
1205,GO:0017046,1,0.689785429679705,0,1,peptide hormone binding,MF,
1207,GO:0017080,1,0.97782001583703,0,1,sodium channel regulator activity,MF,
1208,GO:0017085,1,0.689883197202292,0,1,response to insecticide,BP,
1209,GO:0017111,1,0.689785429679902,0,1,nucleoside-triphosphatase activity,MF,
1210,GO:0017127,1,0.473517862731652,0,2,cholesterol transporter activity,MF,
1211,GO:0017133,1,0.695746712093305,0,1,mitochondrial electron transfer flavoprotein complex,CC,
1212,GO:0017137,1,0.473822899733455,0,2,Rab GTPase binding,MF,
1213,GO:0017143,1,0.689883197202292,0,1,insecticide metabolic process,BP,
1214,GO:0017148,1,0.933624765294581,0,1,negative regulation of translation,BP,
1215,GO:0017156,1,0.690322142801083,0,1,calcium ion regulated exocytosis,BP,
1216,GO:0017157,1,0.690322142801083,0,1,regulation of exocytosis,BP,
1217,GO:0017158,1,0.690322142801083,0,1,regulation of calcium ion-dependent exocytosis,BP,
1218,GO:0017171,1,0.689996137392405,0,1,serine hydrolase activity,MF,
1219,GO:0018103,1,0.982932946886051,0,1,protein C-linked glycosylation,BP,
1220,GO:0018108,1,0.571458039272209,0,2,peptidyl-tyrosine phosphorylation,BP,
1222,GO:0018149,1,0.71008138889583,0,1,peptide cross-linking,BP,
1223,GO:0018193,1,0.505141598551971,0,4,peptidyl-amino acid modification,BP,
1224,GO:0018196,1,0.886968893436572,0,2,peptidyl-asparagine modification,BP,
1225,GO:0018211,1,0.982932946886051,0,1,peptidyl-tryptophan modification,BP,
1226,GO:0018212,1,0.571458039272209,0,2,peptidyl-tyrosine modification,BP,
1227,GO:0018279,1,0.886968893436572,0,2,protein N-linked glycosylation via asparagine,BP,
1228,GO:0018317,1,0.982932946886051,0,1,protein C-linked glycosylation via tryptophan,BP,
1229,GO:0018406,1,0.982932946886051,0,1,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
1230,GO:0018879,1,0.689883197202292,0,1,biphenyl metabolic process,BP,
1231,GO:0018894,1,0.689883197202292,0,1,dibenzo-p-dioxin metabolic process,BP,
1232,GO:0018904,1,0.889059397519768,0,1,ether metabolic process,BP,
1233,GO:0018958,1,0.689883197202292,0,1,phenol-containing compound metabolic process,BP,
1234,GO:0018963,1,0.689883197202292,0,1,phthalate metabolic process,BP,
1235,GO:0019001,1,0.693221867723898,0,1,guanyl nucleotide binding,MF,
1239,GO:0019166,1,0.748517463788975,0,1,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
1245,GO:0019220,1,0.162311086570083,0,10,regulation of phosphate metabolic process,BP,
1250,GO:0019319,1,0.830045349405611,0,2,hexose biosynthetic process,BP,
1251,GO:0019320,1,0.869799107756487,0,1,hexose catabolic process,BP,
1255,GO:0019367,1,0.689785429679781,0,1,fatty acid elongation, saturated fatty acid,BP,
1256,GO:0019370,1,0.955554231038555,0,1,leukotriene biosynthetic process,BP,
1259,GO:0019388,1,0.869799107756487,0,1,galactose catabolic process,BP,
1261,GO:0019430,1,0.739171199267924,0,1,removal of superoxide radicals,BP,
1262,GO:0019432,1,0.739171199267924,0,1,triglyceride biosynthetic process,BP,
1263,GO:0019433,1,0.915413777710168,0,1,triglyceride catabolic process,BP,
1267,GO:0019530,1,0.689785429679705,0,1,taurine metabolic process,BP,
1268,GO:0019534,1,0.689785429679902,0,1,toxin transporter activity,MF,
1272,GO:0019682,1,0.536475172301674,0,2,glyceraldehyde-3-phosphate metabolic process,BP,
1273,GO:0019692,1,0.780410045217068,0,1,deoxyribose phosphate metabolic process,BP,
1274,GO:0019693,1,0.333052329588143,0,5,ribose phosphate metabolic process,BP,
1275,GO:0019694,1,0.689785429679705,0,1,alkanesulfonate metabolic process,BP,
1276,GO:0019695,1,0.689785429679775,0,1,choline metabolic process,BP,
1277,GO:0019722,1,0.739171199267924,0,1,calcium-mediated signaling,BP,
1281,GO:0019825,1,0.749682324291769,0,1,oxygen binding,MF,
1282,GO:0019840,1,0.94012643491917,0,1,isoprenoid binding,MF,
1283,GO:0019841,1,0.94012643491917,0,1,retinol binding,MF,
1286,GO:0019852,1,0.704060535514113,0,2,L-ascorbic acid metabolic process,BP,
1287,GO:0019853,1,0.739171199267924,0,1,L-ascorbic acid biosynthetic process,BP,
1290,GO:0019882,1,0.814696110019901,0,3,antigen processing and presentation,BP,
1291,GO:0019884,1,0.862945372151557,0,2,antigen processing and presentation of exogenous antigen,BP,
1292,GO:0019886,1,0.925278227405574,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
1296,GO:0019904,1,0.212714920579427,0,7,protein domain specific binding,MF,
1298,GO:0019932,1,0.739171199267924,0,1,second-messenger-mediated signaling,BP,
1299,GO:0019941,1,0.932920109189956,0,1,modification-dependent protein catabolic process,BP,
1302,GO:0021545,1,0.689785429679701,0,1,cranial nerve development,BP,
1303,GO:0021675,1,0.689785429679701,0,1,nerve development,BP,
1304,GO:0021700,1,0.933624765294581,0,1,developmental maturation,BP,
1306,GO:0022402,1,0.932920109189956,0,1,cell cycle process,BP,
1307,GO:0022404,1,0.838088519544645,0,1,molting cycle process,BP,
1308,GO:0022405,1,0.838088519544645,0,1,hair cycle process,BP,
1311,GO:0022410,1,0.689883197202292,0,1,circadian sleep/wake cycle process,BP,
1312,GO:0022411,1,0.751897570173457,0,3,cellular component disassembly,BP,
1315,GO:0022600,1,0.94012643491917,0,1,digestive system process,BP,
1316,GO:0022602,1,0.933624765294581,0,1,ovulation cycle process,BP,
1319,GO:0022607,1,0.0485495511938251,0,14,cellular component assembly,BP,
1322,GO:0022618,1,0.860646174064634,0,1,ribonucleoprotein complex assembly,BP,
1323,GO:0022803,1,0.674056819353636,0,2,passive transmembrane transporter activity,MF,
1324,GO:0022804,1,0.473449921345783,0,2,active transmembrane transporter activity,MF,
1325,GO:0022824,1,0.689785429679887,0,1,transmitter-gated ion channel activity,MF,
1326,GO:0022834,1,0.689785429679887,0,1,ligand-gated channel activity,MF,
1327,GO:0022835,1,0.689785429679887,0,1,transmitter-gated channel activity,MF,
1328,GO:0022836,1,0.689785429679887,0,1,gated channel activity,MF,
1329,GO:0022838,1,0.674056819353636,0,2,substrate-specific channel activity,MF,
1330,GO:0022857,1,0.205165136796912,0,7,transmembrane transporter activity,MF,
1331,GO:0022890,1,0.34422206874086,0,4,inorganic cation transmembrane transporter activity,MF,
1332,GO:0022891,1,0.335946892343541,0,5,substrate-specific transmembrane transporter activity,MF,
1334,GO:0022898,1,0.722399050317903,0,2,regulation of transmembrane transporter activity,BP,
1335,GO:0022900,1,0.63458633040096,0,2,electron transport chain,BP,
1336,GO:0022904,1,0.63458633040096,0,2,respiratory electron transport chain,BP,
1337,GO:0023014,1,0.50167522103421,0,4,signal transduction by protein phosphorylation,BP,
1342,GO:0023061,1,0.94012643491917,0,1,signal release,BP,
1343,GO:0030001,1,0.475501165410305,0,4,metal ion transport,BP,
1345,GO:0030016,1,0.872301952309925,0,1,myofibril,CC,
1346,GO:0030017,1,0.872301952309925,0,1,sarcomere,CC,
1347,GO:0030029,1,0.768372008400137,0,3,actin filament-based process,BP,
1348,GO:0030030,1,0.317218305366816,0,4,cell projection organization,BP,
1349,GO:0030031,1,0.689785429679681,0,1,cell projection assembly,BP,
1350,GO:0030036,1,0.768372008400137,0,3,actin cytoskeleton organization,BP,
1351,GO:0030041,1,0.768372008400137,0,3,actin filament polymerization,BP,
1352,GO:0030042,1,0.872301952309925,0,1,actin filament depolymerization,BP,
1354,GO:0030055,1,0.859997101743051,0,1,cell-substrate junction,CC,
1355,GO:0030060,1,0.883274038622596,0,1,L-malate dehydrogenase activity,MF,
1356,GO:0030061,1,0.689883197202292,0,1,mitochondrial crista,CC,
1357,GO:0030072,1,0.94012643491917,0,1,peptide hormone secretion,BP,
1358,GO:0030073,1,0.94012643491917,0,1,insulin secretion,BP,
1359,GO:0030091,1,0.837858240375495,0,1,protein repair,BP,
1362,GO:0030099,1,0.753843485045977,0,1,myeloid cell differentiation,BP,
1363,GO:0030100,1,0.927602284504246,0,2,regulation of endocytosis,BP,
1365,GO:0030111,1,0.932920109189956,0,1,regulation of Wnt signaling pathway,BP,
1366,GO:0030133,1,0.690322142801083,0,1,transport vesicle,CC,
1368,GO:0030139,1,0.689785429679887,0,1,endocytic vesicle,CC,
1370,GO:0030145,1,0.691280260402906,0,2,manganese ion binding,MF,
1375,GO:0030163,1,0.484478505007864,0,4,protein catabolic process,BP,
1376,GO:0030166,1,0.689785429679681,0,1,proteoglycan biosynthetic process,BP,
1379,GO:0030177,1,0.932920109189956,0,1,positive regulation of Wnt signaling pathway,BP,
1380,GO:0030178,1,0.932920109189956,0,1,negative regulation of Wnt signaling pathway,BP,
1381,GO:0030182,1,0.317218305366826,0,4,neuron differentiation,BP,
1382,GO:0030193,1,0.689785429680012,0,1,regulation of blood coagulation,BP,
1383,GO:0030201,1,0.689785429679681,0,1,heparan sulfate proteoglycan metabolic process,BP,
1391,GO:0030216,1,0.71008138889583,0,1,keratinocyte differentiation,BP,
1393,GO:0030225,1,0.753843485045977,0,1,macrophage differentiation,BP,
1394,GO:0030234,1,0.261146756947929,0,7,enzyme regulator activity,MF,
1395,GO:0030246,1,0.79481320556046,0,1,carbohydrate binding,MF,
1397,GO:0030274,1,0.690322142801083,0,1,LIM domain binding,MF,
1398,GO:0030277,1,0.94012643491917,0,1,maintenance of gastrointestinal epithelium,BP,
1399,GO:0030280,1,0.71008138889583,0,1,structural constituent of epidermis,MF,
1400,GO:0030283,1,0.937272715402406,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
1401,GO:0030301,1,0.464509537089103,0,3,cholesterol transport,BP,
1402,GO:0030317,1,0.739171199267924,0,1,flagellated sperm motility,BP,
1405,GO:0030334,1,0.40348040318604,0,4,regulation of cell migration,BP,
1406,GO:0030335,1,0.40348040318604,0,4,positive regulation of cell migration,BP,
1407,GO:0030414,1,0.593335839232855,0,2,peptidase inhibitor activity,MF,
1408,GO:0030424,1,0.515095057994551,0,2,axon,CC,
1409,GO:0030425,1,0.689785429680017,0,1,dendrite,CC,
1410,GO:0030426,1,0.933624765294581,0,1,growth cone,CC,
1411,GO:0030427,1,0.933624765294581,0,1,site of polarized growth,CC,
1412,GO:0030431,1,0.689883197202292,0,1,sleep,BP,
1413,GO:0030449,1,0.689996137392405,0,1,regulation of complement activation,BP,
1414,GO:0030488,1,0.937272715402406,0,1,tRNA methylation,BP,
1415,GO:0030497,1,0.689785429679781,0,1,fatty acid elongation,BP,
1416,GO:0030515,1,0.928729318243992,0,1,snoRNA binding,MF,
1417,GO:0030529,1,0.555459746725411,0,4,intracellular ribonucleoprotein complex,CC,
1418,GO:0030534,1,0.753843485045977,0,1,adult behavior,BP,
1420,GO:0030540,1,0.94012643491917,0,1,female genitalia development,BP,
1422,GO:0030574,1,0.745090050957516,0,1,collagen catabolic process,BP,
1423,GO:0030594,1,0.689785429679887,0,1,neurotransmitter receptor activity,MF,
1424,GO:0030658,1,0.690322142801083,0,1,transport vesicle membrane,CC,
1426,GO:0030666,1,0.689785429679887,0,1,endocytic vesicle membrane,CC,
1427,GO:0030667,1,0.690322142801083,0,1,secretory granule membrane,CC,
1428,GO:0030677,1,0.937272715402406,0,1,ribonuclease P complex,CC,
1429,GO:0030678,1,0.937272715402406,0,1,mitochondrial ribonuclease P complex,CC,
1430,GO:0030695,1,0.689785429679809,0,1,GTPase regulator activity,MF,
1431,GO:0030760,1,0.815981061082205,0,1,pyridine N-methyltransferase activity,MF,
1432,GO:0030799,1,0.954275672359452,0,1,regulation of cyclic nucleotide metabolic process,BP,
1433,GO:0030801,1,0.954275672359452,0,1,positive regulation of cyclic nucleotide metabolic process,BP,
1434,GO:0030802,1,0.954275672359452,0,1,regulation of cyclic nucleotide biosynthetic process,BP,
1435,GO:0030804,1,0.954275672359452,0,1,positive regulation of cyclic nucleotide biosynthetic process,BP,
1436,GO:0030808,1,0.954275672359452,0,1,regulation of nucleotide biosynthetic process,BP,
1437,GO:0030810,1,0.954275672359452,0,1,positive regulation of nucleotide biosynthetic process,BP,
1438,GO:0030814,1,0.954275672359452,0,1,regulation of cAMP metabolic process,BP,
1439,GO:0030816,1,0.954275672359452,0,1,positive regulation of cAMP metabolic process,BP,
1440,GO:0030817,1,0.954275672359452,0,1,regulation of cAMP biosynthetic process,BP,
1441,GO:0030819,1,0.954275672359452,0,1,positive regulation of cAMP biosynthetic process,BP,
1442,GO:0030832,1,0.823602209620197,0,2,regulation of actin filament length,BP,
1443,GO:0030833,1,0.823602209620197,0,2,regulation of actin filament polymerization,BP,
1444,GO:0030834,1,0.872301952309925,0,1,regulation of actin filament depolymerization,BP,
1445,GO:0030835,1,0.872301952309925,0,1,negative regulation of actin filament depolymerization,BP,
1446,GO:0030837,1,0.872301952309925,0,1,negative regulation of actin filament polymerization,BP,
1447,GO:0030838,1,0.944573033403215,0,1,positive regulation of actin filament polymerization,BP,
1452,GO:0030947,1,0.83065676594881,0,1,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
1453,GO:0030949,1,0.83065676594881,0,1,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
1454,GO:0030968,1,0.700154732893895,0,1,endoplasmic reticulum unfolded protein response,BP,
1455,GO:0030976,1,0.721871631227007,0,1,thiamine pyrophosphate binding,MF,
1456,GO:0031012,1,0.643224194992536,0,2,extracellular matrix,CC,
1458,GO:0031098,1,0.944573033403215,0,1,stress-activated protein kinase signaling cascade,BP,
1459,GO:0031099,1,0.601720910585843,0,2,regeneration,BP,
1460,GO:0031100,1,0.601720910585843,0,2,animal organ regeneration,BP,
1461,GO:0031119,1,0.794342025053001,0,1,tRNA pseudouridine synthesis,BP,
1462,GO:0031145,1,0.932920109189956,0,1,anaphase-promoting complex-dependent catabolic process,BP,
1463,GO:0031146,1,0.932920109189956,0,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
1464,GO:0031175,1,0.464807221264095,0,3,neuron projection development,BP,
1465,GO:0031210,1,0.982136033016046,0,1,phosphatidylcholine binding,MF,
1466,GO:0031223,1,0.689785429679701,0,1,auditory behavior,BP,
1468,GO:0031225,1,0.690927624413754,0,1,anchored component of membrane,CC,
1469,GO:0031226,1,0.0980240567658155,0,8,intrinsic component of plasma membrane,CC,
1471,GO:0031252,1,0.909149134363904,0,1,cell leading edge,CC,
1472,GO:0031264,1,0.630542903290721,0,2,death-inducing signaling complex,CC,
1473,GO:0031265,1,0.753843485045977,0,1,CD95 death-inducing signaling complex,CC,
1474,GO:0031267,1,0.473822899733455,0,2,small GTPase binding,MF,
1475,GO:0031300,1,0.695746712093305,0,1,intrinsic component of organelle membrane,CC,
1476,GO:0031301,1,0.695746712093305,0,1,integral component of organelle membrane,CC,
1477,GO:0031304,1,0.695746712093305,0,1,intrinsic component of mitochondrial inner membrane,CC,
1478,GO:0031305,1,0.695746712093305,0,1,integral component of mitochondrial inner membrane,CC,
1486,GO:0031330,1,0.498176838459616,0,3,negative regulation of cellular catabolic process,BP,
1488,GO:0031333,1,0.872301952309925,0,1,negative regulation of protein complex assembly,BP,
1489,GO:0031334,1,0.650860617933289,0,2,positive regulation of protein complex assembly,BP,
1490,GO:0031338,1,0.689785429679809,0,1,regulation of vesicle fusion,BP,
1491,GO:0031341,1,0.753843485045977,0,1,regulation of cell killing,BP,
1492,GO:0031343,1,0.753843485045977,0,1,positive regulation of cell killing,BP,
1493,GO:0031344,1,0.473449921345789,0,2,regulation of cell projection organization,BP,
1494,GO:0031345,1,0.689785429679932,0,1,negative regulation of cell projection organization,BP,
1496,GO:0031348,1,0.838088519544645,0,1,negative regulation of defense response,BP,
1499,GO:0031397,1,0.932920109189956,0,1,negative regulation of protein ubiquitination,BP,
1502,GO:0031400,1,0.498365199788878,0,4,negative regulation of protein modification process,BP,
1504,GO:0031406,1,0.489601963145851,0,4,carboxylic acid binding,MF,
1506,GO:0031418,1,0.79481320556046,0,1,L-ascorbic acid binding,MF,
1507,GO:0031424,1,0.71008138889583,0,1,keratinization,BP,
1508,GO:0031501,1,0.982932946886051,0,1,mannosyltransferase complex,CC,
1509,GO:0031503,1,0.860646174064634,0,1,protein complex localization,BP,
1510,GO:0031638,1,0.753843485045977,0,1,zymogen activation,BP,
1511,GO:0031647,1,0.858643194101069,0,3,regulation of protein stability,BP,
1516,GO:0031730,1,0.971719166134129,0,1,CCR5 chemokine receptor binding,MF,
1517,GO:0031779,1,0.954275672359452,0,1,melanocortin receptor binding,MF,
1518,GO:0031780,1,0.954275672359452,0,1,corticotropin hormone receptor binding,MF,
1519,GO:0031781,1,0.954275672359452,0,1,type 3 melanocortin receptor binding,MF,
1520,GO:0031782,1,0.954275672359452,0,1,type 4 melanocortin receptor binding,MF,
1521,GO:0031783,1,0.954275672359452,0,1,type 5 melanocortin receptor binding,MF,
1523,GO:0031903,1,0.425710926094784,0,4,microbody membrane,CC,
1524,GO:0031907,1,0.366233511567831,0,4,microbody lumen,CC,
1525,GO:0031929,1,0.770314150802672,0,1,TOR signaling,BP,
1526,GO:0031960,1,0.626245403248184,0,2,response to corticosteroid,BP,
1537,GO:0032006,1,0.770314150802672,0,1,regulation of TOR signaling,BP,
1538,GO:0032007,1,0.770314150802672,0,1,negative regulation of TOR signaling,BP,
1539,GO:0032024,1,0.94012643491917,0,1,positive regulation of insulin secretion,BP,
1540,GO:0032088,1,0.944573033403215,0,1,negative regulation of NF-kappaB transcription factor activity,BP,
1541,GO:0032090,1,0.944573033403215,0,1,Pyrin domain binding,MF,
1544,GO:0032103,1,0.83065676594881,0,1,positive regulation of response to external stimulus,BP,
1545,GO:0032147,1,0.643224194992326,0,2,activation of protein kinase activity,BP,
1546,GO:0032148,1,0.933624765294581,0,1,activation of protein kinase B activity,BP,
1547,GO:0032259,1,0.697284712111265,0,3,methylation,BP,
1550,GO:0032269,1,0.270850124607129,0,7,negative regulation of cellular protein metabolic process,BP,
1552,GO:0032271,1,0.823602209620197,0,2,regulation of protein polymerization,BP,
1553,GO:0032272,1,0.872301952309925,0,1,negative regulation of protein polymerization,BP,
1554,GO:0032273,1,0.944573033403215,0,1,positive regulation of protein polymerization,BP,
1555,GO:0032281,1,0.473449921345991,0,2,AMPA glutamate receptor complex,CC,
1556,GO:0032311,1,0.933624765294581,0,1,angiogenin-PRI complex,CC,
1557,GO:0032330,1,0.83065676594881,0,1,regulation of chondrocyte differentiation,BP,
1558,GO:0032332,1,0.83065676594881,0,1,positive regulation of chondrocyte differentiation,BP,
1559,GO:0032354,1,0.689883197202292,0,1,response to follicle-stimulating hormone,BP,
1560,GO:0032355,1,0.690927624413754,0,1,response to estradiol,BP,
1561,GO:0032365,1,0.323360397648465,0,3,intracellular lipid transport,BP,
1562,GO:0032366,1,0.473517862731652,0,2,intracellular sterol transport,BP,
1563,GO:0032367,1,0.473517862731652,0,2,intracellular cholesterol transport,BP,
1564,GO:0032368,1,0.677068771719113,0,2,regulation of lipid transport,BP,
1565,GO:0032369,1,0.982136033016046,0,1,negative regulation of lipid transport,BP,
1566,GO:0032370,1,0.689785429679902,0,1,positive regulation of lipid transport,BP,
1567,GO:0032371,1,0.677068771719113,0,2,regulation of sterol transport,BP,
1568,GO:0032372,1,0.982136033016046,0,1,negative regulation of sterol transport,BP,
1569,GO:0032373,1,0.689785429679902,0,1,positive regulation of sterol transport,BP,
1570,GO:0032374,1,0.677068771719113,0,2,regulation of cholesterol transport,BP,
1571,GO:0032375,1,0.982136033016046,0,1,negative regulation of cholesterol transport,BP,
1572,GO:0032376,1,0.689785429679902,0,1,positive regulation of cholesterol transport,BP,
1574,GO:0032403,1,0.406547655462058,0,4,protein complex binding,MF,
1575,GO:0032409,1,0.722399050317903,0,2,regulation of transporter activity,BP,
1576,GO:0032411,1,0.739171199267924,0,1,positive regulation of transporter activity,BP,
1577,GO:0032412,1,0.722399050317903,0,2,regulation of ion transmembrane transporter activity,BP,
1578,GO:0032414,1,0.739171199267924,0,1,positive regulation of ion transmembrane transporter activity,BP,
1579,GO:0032429,1,0.933624765294581,0,1,regulation of phospholipase A2 activity,BP,
1580,GO:0032430,1,0.933624765294581,0,1,positive regulation of phospholipase A2 activity,BP,
1581,GO:0032431,1,0.933624765294581,0,1,activation of phospholipase A2 activity,BP,
1584,GO:0032480,1,0.791213051698253,0,2,negative regulation of type I interferon production,BP,
1590,GO:0032515,1,0.739171199267924,0,1,negative regulation of phosphoprotein phosphatase activity,BP,
1591,GO:0032526,1,0.94012643491917,0,1,response to retinoic acid,BP,
1592,GO:0032535,1,0.633006412739069,0,3,regulation of cellular component size,BP,
1593,GO:0032543,1,0.62680772179944,0,3,mitochondrial translation,BP,
1594,GO:0032549,1,0.693221867723898,0,1,ribonucleoside binding,MF,
1595,GO:0032550,1,0.693221867723898,0,1,purine ribonucleoside binding,MF,
1599,GO:0032561,1,0.693221867723898,0,1,guanyl ribonucleotide binding,MF,
1600,GO:0032592,1,0.695746712093305,0,1,integral component of mitochondrial membrane,CC,
1603,GO:0032607,1,0.838088519544645,0,1,interferon-alpha production,BP,
1605,GO:0032609,1,0.711475438092686,0,2,interferon-gamma production,BP,
1606,GO:0032611,1,0.944573033403215,0,1,interleukin-1 beta production,BP,
1607,GO:0032612,1,0.944573033403215,0,1,interleukin-1 production,BP,
1608,GO:0032613,1,0.944573033403215,0,1,interleukin-10 production,BP,
1611,GO:0032637,1,0.711475438092686,0,2,interleukin-8 production,BP,
1614,GO:0032647,1,0.838088519544645,0,1,regulation of interferon-alpha production,BP,
1616,GO:0032649,1,0.711475438092686,0,2,regulation of interferon-gamma production,BP,
1617,GO:0032651,1,0.944573033403215,0,1,regulation of interleukin-1 beta production,BP,
1618,GO:0032652,1,0.944573033403215,0,1,regulation of interleukin-1 production,BP,
1619,GO:0032653,1,0.944573033403215,0,1,regulation of interleukin-10 production,BP,
1621,GO:0032677,1,0.711475438092686,0,2,regulation of interleukin-8 production,BP,
1623,GO:0032687,1,0.838088519544645,0,1,negative regulation of interferon-alpha production,BP,
1624,GO:0032688,1,0.791213051698253,0,2,negative regulation of interferon-beta production,BP,
1627,GO:0032729,1,0.711475438092686,0,2,positive regulation of interferon-gamma production,BP,
1628,GO:0032731,1,0.944573033403215,0,1,positive regulation of interleukin-1 beta production,BP,
1629,GO:0032732,1,0.944573033403215,0,1,positive regulation of interleukin-1 production,BP,
1630,GO:0032733,1,0.944573033403215,0,1,positive regulation of interleukin-10 production,BP,
1632,GO:0032757,1,0.711475438092686,0,2,positive regulation of interleukin-8 production,BP,
1634,GO:0032768,1,0.800224065184713,0,2,regulation of monooxygenase activity,BP,
1635,GO:0032769,1,0.852105267215681,0,1,negative regulation of monooxygenase activity,BP,
1637,GO:0032780,1,0.739171199267924,0,1,negative regulation of ATPase activity,BP,
1638,GO:0032781,1,0.739171199267924,0,1,positive regulation of ATPase activity,BP,
1639,GO:0032784,1,0.728032091145752,0,1,regulation of DNA-templated transcription, elongation,BP,
1641,GO:0032813,1,0.54111979308309,0,3,tumor necrosis factor receptor superfamily binding,MF,
1645,GO:0032845,1,0.647680022866411,0,2,negative regulation of homeostatic process,BP,
1649,GO:0032872,1,0.944573033403215,0,1,regulation of stress-activated MAPK cascade,BP,
1650,GO:0032874,1,0.944573033403215,0,1,positive regulation of stress-activated MAPK cascade,BP,
1653,GO:0032934,1,0.473517862731652,0,2,sterol binding,MF,
1658,GO:0032956,1,0.823602209620197,0,2,regulation of actin cytoskeleton organization,BP,
1659,GO:0032963,1,0.745090050957516,0,1,collagen metabolic process,BP,
1660,GO:0032970,1,0.823602209620197,0,2,regulation of actin filament-based process,BP,
1661,GO:0032984,1,0.751897570173457,0,3,macromolecular complex disassembly,BP,
1663,GO:0032990,1,0.464807221264095,0,3,cell part morphogenesis,BP,
1665,GO:0032994,1,0.982136033016046,0,1,protein-lipid complex,CC,
1666,GO:0033002,1,0.8775005707112,0,2,muscle cell proliferation,BP,
1669,GO:0033043,1,0.485648942605149,0,4,regulation of organelle organization,BP,
1670,GO:0033077,1,0.753843485045977,0,1,T cell differentiation in thymus,BP,
1672,GO:0033185,1,0.982932946886051,0,1,dolichol-phosphate-mannose synthase complex,CC,
1673,GO:0033209,1,0.633366787959991,0,4,tumor necrosis factor-mediated signaling pathway,BP,
1674,GO:0033218,1,0.643224194992326,0,2,amide binding,MF,
1675,GO:0033238,1,0.932920109189956,0,1,regulation of cellular amine metabolic process,BP,
1676,GO:0033293,1,0.898924003841621,0,2,monocarboxylic acid binding,MF,
1677,GO:0033306,1,0.748517463788975,0,1,phytol metabolic process,BP,
1678,GO:0033344,1,0.677068771719113,0,2,cholesterol efflux,BP,
1679,GO:0033365,1,0.860646174064634,0,1,protein localization to organelle,BP,
1683,GO:0033539,1,0.441593444435077,0,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
1685,GO:0033559,1,0.689785429679715,0,1,unsaturated fatty acid metabolic process,BP,
1686,GO:0033612,1,0.711475438092686,0,2,receptor serine/threonine kinase binding,MF,
1688,GO:0033673,1,0.535354857672809,0,3,negative regulation of kinase activity,BP,
1689,GO:0033674,1,0.532534418822557,0,3,positive regulation of kinase activity,BP,
1690,GO:0033700,1,0.677068771719113,0,2,phospholipid efflux,BP,
1692,GO:0033865,1,0.65896949055495,0,2,nucleoside bisphosphate metabolic process,BP,
1693,GO:0033866,1,0.710373855442479,0,1,nucleoside bisphosphate biosynthetic process,BP,
1694,GO:0033869,1,0.928729318243992,0,1,nucleoside bisphosphate catabolic process,BP,
1695,GO:0033875,1,0.65896949055495,0,2,ribonucleoside bisphosphate metabolic process,BP,
1697,GO:0034030,1,0.710373855442479,0,1,ribonucleoside bisphosphate biosynthetic process,BP,
1698,GO:0034031,1,0.928729318243992,0,1,ribonucleoside bisphosphate catabolic process,BP,
1699,GO:0034032,1,0.65896949055495,0,2,purine nucleoside bisphosphate metabolic process,BP,
1700,GO:0034033,1,0.710373855442479,0,1,purine nucleoside bisphosphate biosynthetic process,BP,
1701,GO:0034034,1,0.928729318243992,0,1,purine nucleoside bisphosphate catabolic process,BP,
1702,GO:0034040,1,0.689785429679902,0,1,lipid-transporting ATPase activity,MF,
1703,GO:0034041,1,0.689785429679902,0,1,sterol-transporting ATPase activity,MF,
1710,GO:0034220,1,0.141036140546696,0,8,ion transmembrane transport,BP,
1712,GO:0034249,1,0.933624765294581,0,1,negative regulation of cellular amide metabolic process,BP,
1714,GO:0034260,1,0.739171199267924,0,1,negative regulation of GTPase activity,BP,
1715,GO:0034284,1,0.689883197202292,0,1,response to monosaccharide,BP,
1716,GO:0034308,1,0.703077024122844,0,2,primary alcohol metabolic process,BP,
1717,GO:0034330,1,0.933624765294581,0,1,cell junction organization,BP,
1718,GO:0034332,1,0.933624765294581,0,1,adherens junction organization,BP,
1720,GO:0034341,1,0.532555188379633,0,3,response to interferon-gamma,BP,
1722,GO:0034358,1,0.982136033016046,0,1,plasma lipoprotein particle,CC,
1723,GO:0034361,1,0.982136033016046,0,1,very-low-density lipoprotein particle,CC,
1724,GO:0034364,1,0.982136033016046,0,1,high-density lipoprotein particle,CC,
1725,GO:0034367,1,0.677068771719113,0,2,macromolecular complex remodeling,BP,
1726,GO:0034368,1,0.677068771719113,0,2,protein-lipid complex remodeling,BP,
1727,GO:0034369,1,0.677068771719113,0,2,plasma lipoprotein particle remodeling,BP,
1728,GO:0034374,1,0.689785429679902,0,1,low-density lipoprotein particle remodeling,BP,
1729,GO:0034375,1,0.677068771719113,0,2,high-density lipoprotein particle remodeling,BP,
1730,GO:0034377,1,0.982136033016046,0,1,plasma lipoprotein particle assembly,BP,
1731,GO:0034379,1,0.982136033016046,0,1,very-low-density lipoprotein particle assembly,BP,
1732,GO:0034381,1,0.982136033016046,0,1,plasma lipoprotein particle clearance,BP,
1733,GO:0034382,1,0.982136033016046,0,1,chylomicron remnant clearance,BP,
1734,GO:0034385,1,0.982136033016046,0,1,triglyceride-rich plasma lipoprotein particle,CC,
1735,GO:0034394,1,0.954275672359452,0,1,protein localization to cell surface,BP,
1738,GO:0034433,1,0.677068771719113,0,2,steroid esterification,BP,
1739,GO:0034434,1,0.677068771719113,0,2,sterol esterification,BP,
1740,GO:0034435,1,0.677068771719113,0,2,cholesterol esterification,BP,
1741,GO:0034436,1,0.689785429679902,0,1,glycoprotein transport,BP,
1742,GO:0034437,1,0.689785429679902,0,1,glycoprotein transporter activity,MF,
1744,GO:0034447,1,0.982136033016046,0,1,very-low-density lipoprotein particle clearance,BP,
1746,GO:0034504,1,0.860646174064634,0,1,protein localization to nucleus,BP,
1747,GO:0034599,1,0.635004410324262,0,2,cellular response to oxidative stress,BP,
1748,GO:0034612,1,0.633366787959991,0,4,response to tumor necrosis factor,BP,
1750,GO:0034614,1,0.739171199267924,0,1,cellular response to reactive oxygen species,BP,
1751,GO:0034620,1,0.700154732893895,0,1,cellular response to unfolded protein,BP,
1752,GO:0034622,1,0.660030026347867,0,4,cellular macromolecular complex assembly,BP,
1753,GO:0034632,1,0.94012643491917,0,1,retinol transporter activity,MF,
1754,GO:0034633,1,0.94012643491917,0,1,retinol transport,BP,
1755,GO:0034638,1,0.982136033016046,0,1,phosphatidylcholine catabolic process,BP,
1761,GO:0034698,1,0.689883197202292,0,1,response to gonadotropin,BP,
1762,GO:0034699,1,0.689883197202292,0,1,response to luteinizing hormone,BP,
1763,GO:0034702,1,0.462350989713185,0,3,ion channel complex,CC,
1764,GO:0034703,1,0.473449921345991,0,2,cation channel complex,CC,
1765,GO:0034707,1,0.97782001583703,0,1,chloride channel complex,CC,
1767,GO:0034762,1,0.554568607218397,0,3,regulation of transmembrane transport,BP,
1768,GO:0034764,1,0.722399050317903,0,2,positive regulation of transmembrane transport,BP,
1769,GO:0034765,1,0.554568607218397,0,3,regulation of ion transmembrane transport,BP,
1770,GO:0034767,1,0.722399050317903,0,2,positive regulation of ion transmembrane transport,BP,
1773,GO:0035004,1,0.83065676594881,0,1,phosphatidylinositol 3-kinase activity,MF,
1775,GO:0035094,1,0.689883197202292,0,1,response to nicotine,BP,
1776,GO:0035112,1,0.94012643491917,0,1,genitalia morphogenesis,BP,
1777,GO:0035235,1,0.689785429679887,0,1,ionotropic glutamate receptor signaling pathway,BP,
1778,GO:0035251,1,0.902523548288088,0,1,UDP-glucosyltransferase activity,MF,
1780,GO:0035265,1,0.94012643491917,0,1,organ growth,BP,
1781,GO:0035268,1,0.982932946886051,0,1,protein mannosylation,BP,
1782,GO:0035269,1,0.982932946886051,0,1,protein O-linked mannosylation,BP,
1784,GO:0035303,1,0.739171199267924,0,1,regulation of dephosphorylation,BP,
1785,GO:0035304,1,0.739171199267924,0,1,regulation of protein dephosphorylation,BP,
1786,GO:0035305,1,0.739171199267924,0,1,negative regulation of dephosphorylation,BP,
1787,GO:0035306,1,0.739171199267924,0,1,positive regulation of dephosphorylation,BP,
1788,GO:0035308,1,0.739171199267924,0,1,negative regulation of protein dephosphorylation,BP,
1789,GO:0035335,1,0.966621339483423,0,1,peptidyl-tyrosine dephosphorylation,BP,
1795,GO:0035434,1,0.770314150802672,0,1,copper ion transmembrane transport,BP,
1796,GO:0035455,1,0.689883197202292,0,1,response to interferon-alpha,BP,
1797,GO:0035457,1,0.689883197202292,0,1,cellular response to interferon-alpha,BP,
1799,GO:0035567,1,0.932920109189956,0,1,non-canonical Wnt signaling pathway,BP,
1801,GO:0035586,1,0.690383534494896,0,1,purinergic receptor activity,MF,
1802,GO:0035587,1,0.690383534494896,0,1,purinergic receptor signaling pathway,BP,
1803,GO:0035588,1,0.690383534494896,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
1804,GO:0035589,1,0.690383534494896,0,1,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
1805,GO:0035590,1,0.690383534494896,0,1,purinergic nucleotide receptor signaling pathway,BP,
1806,GO:0035601,1,0.745842816697877,0,1,protein deacylation,BP,
1807,GO:0035623,1,0.689785429679797,0,1,renal glucose absorption,BP,
1808,GO:0035637,1,0.97782001583703,0,1,multicellular organismal signaling,BP,
1811,GO:0035697,1,0.753843485045977,0,1,CD8-positive, alpha-beta T cell extravasation,BP,
1812,GO:0035698,1,0.753843485045977,0,1,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
1813,GO:0035725,1,0.97782001583703,0,1,sodium ion transmembrane transport,BP,
1814,GO:0035766,1,0.83065676594881,0,1,cell chemotaxis to fibroblast growth factor,BP,
1815,GO:0035767,1,0.83065676594881,0,1,endothelial cell chemotaxis,BP,
1816,GO:0035768,1,0.83065676594881,0,1,endothelial cell chemotaxis to fibroblast growth factor,BP,
1817,GO:0035770,1,0.689785429679705,0,1,ribonucleoprotein granule,CC,
1818,GO:0035795,1,0.860646174064634,0,1,negative regulation of mitochondrial membrane permeability,BP,
1819,GO:0035877,1,0.647680022866411,0,2,death effector domain binding,MF,
1820,GO:0035914,1,0.909149134363904,0,1,skeletal muscle cell differentiation,BP,
1821,GO:0035962,1,0.689785429679685,0,1,response to interleukin-13,BP,
1822,GO:0035963,1,0.689785429679685,0,1,cellular response to interleukin-13,BP,
1823,GO:0035966,1,0.700154732893895,0,1,response to topologically incorrect protein,BP,
1824,GO:0035967,1,0.700154732893895,0,1,cellular response to topologically incorrect protein,BP,
1825,GO:0036041,1,0.915413777710168,0,1,long-chain fatty acid binding,MF,
1826,GO:0036072,1,0.83065676594881,0,1,direct ossification,BP,
1827,GO:0036075,1,0.83065676594881,0,1,replacement ossification,BP,
1828,GO:0036092,1,0.83065676594881,0,1,phosphatidylinositol-3-phosphate biosynthetic process,BP,
1830,GO:0036109,1,0.689785429679715,0,1,alpha-linolenic acid metabolic process,BP,
1831,GO:0036149,1,0.889059397519768,0,1,phosphatidylinositol acyl-chain remodeling,BP,
1832,GO:0036150,1,0.889059397519768,0,1,phosphatidylserine acyl-chain remodeling,BP,
1833,GO:0036151,1,0.889059397519768,0,1,phosphatidylcholine acyl-chain remodeling,BP,
1834,GO:0036152,1,0.889059397519768,0,1,phosphatidylethanolamine acyl-chain remodeling,BP,
1837,GO:0036293,1,0.679639001511281,0,4,response to decreased oxygen levels,BP,
1838,GO:0036294,1,0.847856813831993,0,2,cellular response to decreased oxygen levels,BP,
1839,GO:0036376,1,0.97782001583703,0,1,sodium ion export from cell,BP,
1840,GO:0036379,1,0.872301952309925,0,1,myofilament,CC,
1841,GO:0036462,1,0.753843485045977,0,1,TRAIL-activated apoptotic signaling pathway,BP,
1842,GO:0036464,1,0.689785429679705,0,1,cytoplasmic ribonucleoprotein granule,CC,
1843,GO:0036473,1,0.860646174064634,0,1,cell death in response to oxidative stress,BP,
1844,GO:0036477,1,0.201024884472395,0,6,somatodendritic compartment,CC,
1845,GO:0036498,1,0.700154732893895,0,1,IRE1-mediated unfolded protein response,BP,
1846,GO:0038023,1,0.291525629075156,0,4,signaling receptor activity,MF,
1847,GO:0038034,1,0.753843485045977,0,1,signal transduction in absence of ligand,BP,
1848,GO:0038061,1,0.932920109189956,0,1,NIK/NF-kappaB signaling,BP,
1849,GO:0038093,1,0.932920109189956,0,1,Fc receptor signaling pathway,BP,
1850,GO:0038095,1,0.932920109189956,0,1,Fc-epsilon receptor signaling pathway,BP,
1851,GO:0038127,1,0.746221125113029,0,1,ERBB signaling pathway,BP,
1853,GO:0040008,1,0.647758985185692,0,2,regulation of growth,BP,
1855,GO:0040012,1,0.295094985858091,0,5,regulation of locomotion,BP,
1856,GO:0040013,1,0.739171199267924,0,1,negative regulation of locomotion,BP,
1857,GO:0040014,1,0.689785429679705,0,1,regulation of multicellular organism growth,BP,
1858,GO:0040017,1,0.40348040318604,0,4,positive regulation of locomotion,BP,
1859,GO:0040018,1,0.689785429679705,0,1,positive regulation of multicellular organism growth,BP,
1862,GO:0042036,1,0.838088519544645,0,1,negative regulation of cytokine biosynthetic process,BP,
1863,GO:0042058,1,0.746221125113029,0,1,regulation of epidermal growth factor receptor signaling pathway,BP,
1864,GO:0042060,1,0.474243671643786,0,2,wound healing,BP,
1870,GO:0042104,1,0.711475438092686,0,2,positive regulation of activated T cell proliferation,BP,
1879,GO:0042147,1,0.591897243930164,0,2,retrograde transport, endosome to Golgi,BP,
1880,GO:0042157,1,0.493612340749074,0,4,lipoprotein metabolic process,BP,
1881,GO:0042158,1,0.982932946886051,0,1,lipoprotein biosynthetic process,BP,
1882,GO:0042159,1,0.745842816697877,0,1,lipoprotein catabolic process,BP,
1885,GO:0042176,1,0.688897299215273,0,2,regulation of protein catabolic process,BP,
1888,GO:0042219,1,0.689785429679775,0,1,cellular modified amino acid catabolic process,BP,
1889,GO:0042220,1,0.753843485045977,0,1,response to cocaine,BP,
1892,GO:0042277,1,0.643224194992326,0,2,peptide binding,MF,
1895,GO:0042303,1,0.838088519544645,0,1,molting cycle,BP,
1897,GO:0042306,1,0.860646174064634,0,1,regulation of protein import into nucleus,BP,
1898,GO:0042325,1,0.280569134198666,0,6,regulation of phosphorylation,BP,
1899,GO:0042326,1,0.535354857672809,0,3,negative regulation of phosphorylation,BP,
1900,GO:0042327,1,0.502062463195851,0,4,positive regulation of phosphorylation,BP,
1901,GO:0042330,1,0.618537431092925,0,2,taxis,BP,
1904,GO:0042345,1,0.860646174064634,0,1,regulation of NF-kappaB import into nucleus,BP,
1905,GO:0042348,1,0.860646174064634,0,1,NF-kappaB import into nucleus,BP,
1907,GO:0042364,1,0.739171199267924,0,1,water-soluble vitamin biosynthetic process,BP,
1908,GO:0042379,1,0.971719166134129,0,1,chemokine receptor binding,MF,
1909,GO:0042383,1,0.97782001583703,0,1,sarcolemma,CC,
1910,GO:0042391,1,0.674056819353636,0,2,regulation of membrane potential,BP,
1911,GO:0042398,1,0.955554231038555,0,1,cellular modified amino acid biosynthetic process,BP,
1912,GO:0042402,1,0.689785429679775,0,1,cellular biogenic amine catabolic process,BP,
1913,GO:0042426,1,0.689785429679775,0,1,choline catabolic process,BP,
1918,GO:0042448,1,0.749682324291769,0,1,progesterone metabolic process,BP,
1921,GO:0042503,1,0.689785429679705,0,1,tyrosine phosphorylation of Stat3 protein,BP,
1922,GO:0042506,1,0.689785429679705,0,1,tyrosine phosphorylation of Stat5 protein,BP,
1923,GO:0042509,1,0.689785429679705,0,1,regulation of tyrosine phosphorylation of STAT protein,BP,
1924,GO:0042516,1,0.689785429679705,0,1,regulation of tyrosine phosphorylation of Stat3 protein,BP,
1925,GO:0042517,1,0.689785429679705,0,1,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
1926,GO:0042522,1,0.689785429679705,0,1,regulation of tyrosine phosphorylation of Stat5 protein,BP,
1927,GO:0042523,1,0.689785429679705,0,1,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
1928,GO:0042531,1,0.689785429679705,0,1,positive regulation of tyrosine phosphorylation of STAT protein,BP,
1929,GO:0042537,1,0.689883197202292,0,1,benzene-containing compound metabolic process,BP,
1930,GO:0042542,1,0.689883197202292,0,1,response to hydrogen peroxide,BP,
1932,GO:0042558,1,0.873228977733856,0,2,pteridine-containing compound metabolic process,BP,
1933,GO:0042559,1,0.873228977733856,0,2,pteridine-containing compound biosynthetic process,BP,
1934,GO:0042562,1,0.689785429679705,0,1,hormone binding,MF,
1935,GO:0042572,1,0.94012643491917,0,1,retinol metabolic process,BP,
1936,GO:0042578,1,0.787011738409305,0,2,phosphoric ester hydrolase activity,MF,
1937,GO:0042579,1,0.150621493980518,0,8,microbody,CC,
1939,GO:0042590,1,0.862945372151557,0,2,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
1943,GO:0042623,1,0.689785429679902,0,1,ATPase activity, coupled,MF,
1944,GO:0042626,1,0.689785429679902,0,1,ATPase activity, coupled to transmembrane movement of substances,MF,
1945,GO:0042627,1,0.982136033016046,0,1,chylomicron,CC,
1946,GO:0042632,1,0.630524391743412,0,2,cholesterol homeostasis,BP,
1947,GO:0042633,1,0.838088519544645,0,1,hair cycle,BP,
1948,GO:0042634,1,0.838088519544645,0,1,regulation of hair cycle,BP,
1949,GO:0042635,1,0.838088519544645,0,1,positive regulation of hair cycle,BP,
1950,GO:0042645,1,0.700154732893895,0,1,mitochondrial nucleoid,CC,
1951,GO:0042698,1,0.933624765294581,0,1,ovulation cycle,BP,
1952,GO:0042726,1,0.814550451684994,0,1,flavin-containing compound metabolic process,BP,
1953,GO:0042742,1,0.944573033403215,0,1,defense response to bacterium,BP,
1954,GO:0042745,1,0.689883197202292,0,1,circadian sleep/wake cycle,BP,
1955,GO:0042747,1,0.689883197202292,0,1,circadian sleep/wake cycle, REM sleep,BP,
1956,GO:0042759,1,0.689785429679781,0,1,long-chain fatty acid biosynthetic process,BP,
1957,GO:0042761,1,0.689785429679781,0,1,very long-chain fatty acid biosynthetic process,BP,
1959,GO:0042771,1,0.944573033403215,0,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
1960,GO:0042787,1,0.932920109189956,0,1,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
1965,GO:0042940,1,0.689785429679701,0,1,D-amino acid transport,BP,
1966,GO:0042976,1,0.689785429679705,0,1,activation of Janus kinase activity,BP,
1967,GO:0042977,1,0.689785429679705,0,1,activation of JAK2 kinase activity,BP,
1969,GO:0042982,1,0.689785429679902,0,1,amyloid precursor protein metabolic process,BP,
1970,GO:0042987,1,0.689785429679902,0,1,amyloid precursor protein catabolic process,BP,
1971,GO:0042990,1,0.860646174064634,0,1,regulation of transcription factor import into nucleus,BP,
1972,GO:0042991,1,0.860646174064634,0,1,transcription factor import into nucleus,BP,
1974,GO:0043005,1,0.165067399075941,0,6,neuron projection,CC,
1975,GO:0043009,1,0.94012643491917,0,1,chordate embryonic development,BP,
1976,GO:0043010,1,0.94012643491917,0,1,camera-type eye development,BP,
1977,GO:0043014,1,0.689785429679681,0,1,alpha-tubulin binding,MF,
1979,GO:0043025,1,0.29647510157424,0,5,neuronal cell body,CC,
1980,GO:0043027,1,0.860646174064634,0,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
1981,GO:0043028,1,0.812567533012029,0,2,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
1982,GO:0043029,1,0.753843485045977,0,1,T cell homeostasis,BP,
1983,GO:0043030,1,0.689785429679685,0,1,regulation of macrophage activation,BP,
1991,GO:0043086,1,0.241224827366386,0,8,negative regulation of catalytic activity,BP,
1992,GO:0043087,1,0.41973282433638,0,3,regulation of GTPase activity,BP,
1993,GO:0043090,1,0.689785429679701,0,1,amino acid import,BP,
1994,GO:0043092,1,0.689785429679701,0,1,L-amino acid import,BP,
2000,GO:0043124,1,0.944573033403215,0,1,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
2001,GO:0043154,1,0.860646174064634,0,1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
2002,GO:0043161,1,0.932920109189956,0,1,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
2007,GO:0043177,1,0.489601963145851,0,4,organic acid binding,MF,
2008,GO:0043178,1,0.444155936507722,0,3,alcohol binding,MF,
2011,GO:0043209,1,0.883274038622596,0,1,myelin sheath,CC,
2021,GO:0043235,1,0.268852524281311,0,4,receptor complex,CC,
2022,GO:0043241,1,0.751897570173457,0,3,protein complex disassembly,BP,
2023,GO:0043242,1,0.872301952309925,0,1,negative regulation of protein complex disassembly,BP,
2024,GO:0043244,1,0.872301952309925,0,1,regulation of protein complex disassembly,BP,
2025,GO:0043254,1,0.566336681292782,0,3,regulation of protein complex assembly,BP,
2026,GO:0043269,1,0.554568607218397,0,3,regulation of ion transport,BP,
2027,GO:0043270,1,0.722399050317903,0,2,positive regulation of ion transport,BP,
2029,GO:0043278,1,0.753843485045977,0,1,response to morphine,BP,
2030,GO:0043279,1,0.518063885559813,0,2,response to alkaloid,BP,
2033,GO:0043292,1,0.872301952309925,0,1,contractile fiber,CC,
2039,GO:0043405,1,0.571458039272209,0,2,regulation of MAP kinase activity,BP,
2040,GO:0043406,1,0.571458039272209,0,2,positive regulation of MAP kinase activity,BP,
2041,GO:0043408,1,0.538899387139997,0,3,regulation of MAPK cascade,BP,
2042,GO:0043410,1,0.538899387139997,0,3,positive regulation of MAPK cascade,BP,
2044,GO:0043413,1,0.610469436077768,0,3,macromolecule glycosylation,BP,
2045,GO:0043414,1,0.855834033326111,0,2,macromolecule methylation,BP,
2046,GO:0043433,1,0.944573033403215,0,1,negative regulation of sequence-specific DNA binding transcription factor activity,BP,
2049,GO:0043462,1,0.739171199267924,0,1,regulation of ATPase activity,BP,
2052,GO:0043491,1,0.689785429679681,0,1,protein kinase B signaling,BP,
2053,GO:0043492,1,0.689785429679902,0,1,ATPase activity, coupled to movement of substances,MF,
2055,GO:0043500,1,0.860646174064634,0,1,muscle adaptation,BP,
2056,GO:0043502,1,0.860646174064634,0,1,regulation of muscle adaptation,BP,
2057,GO:0043523,1,0.689883197202292,0,1,regulation of neuron apoptotic process,BP,
2058,GO:0043524,1,0.689883197202292,0,1,negative regulation of neuron apoptotic process,BP,
2059,GO:0043531,1,0.689785429679902,0,1,ADP binding,MF,
2060,GO:0043542,1,0.83065676594881,0,1,endothelial cell migration,BP,
2062,GO:0043547,1,0.41973282433638,0,3,positive regulation of GTPase activity,BP,
2063,GO:0043549,1,0.280569134198666,0,6,regulation of kinase activity,BP,
2064,GO:0043565,1,0.689785429679797,0,1,sequence-specific DNA binding,MF,
2065,GO:0043588,1,0.593711349227464,0,2,skin development,BP,
2069,GO:0043618,1,0.932920109189956,0,1,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
2070,GO:0043620,1,0.932920109189956,0,1,regulation of DNA-templated transcription in response to stress,BP,
2071,GO:0043623,1,0.768372008400137,0,3,cellular protein complex assembly,BP,
2072,GO:0043624,1,0.751897570173457,0,3,cellular protein complex disassembly,BP,
2073,GO:0043627,1,0.689883197202292,0,1,response to estrogen,BP,
2074,GO:0043632,1,0.932920109189956,0,1,modification-dependent macromolecule catabolic process,BP,
2075,GO:0043648,1,0.152363586513482,0,6,dicarboxylic acid metabolic process,BP,
2076,GO:0043650,1,0.689785429679701,0,1,dicarboxylic acid biosynthetic process,BP,
2077,GO:0043651,1,0.689785429679715,0,1,linoleic acid metabolic process,BP,
2078,GO:0043666,1,0.739171199267924,0,1,regulation of phosphoprotein phosphatase activity,BP,
2079,GO:0043691,1,0.689785429679902,0,1,reverse cholesterol transport,BP,
2080,GO:0043783,1,0.695746712093305,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
2084,GO:0043933,1,0.0618720460411132,0,15,macromolecular complex subunit organization,BP,
2085,GO:0044057,1,0.841329449172186,0,2,regulation of system process,BP,
2087,GO:0044087,1,0.263728838001147,0,5,regulation of cellular component biogenesis,BP,
2088,GO:0044088,1,0.689785429679809,0,1,regulation of vacuole organization,BP,
2089,GO:0044089,1,0.650860617933289,0,2,positive regulation of cellular component biogenesis,BP,
2090,GO:0044092,1,0.241224827366386,0,8,negative regulation of molecular function,BP,
2092,GO:0044106,1,0.642732733398094,0,2,cellular amine metabolic process,BP,
2093,GO:0044212,1,0.689785429679797,0,1,transcription regulatory region DNA binding,MF,
2094,GO:0044236,1,0.511900682263835,0,2,multicellular organism metabolic process,BP,
2098,GO:0044243,1,0.745090050957516,0,1,multicellular organismal catabolic process,BP,
2102,GO:0044257,1,0.688897299215273,0,2,cellular protein catabolic process,BP,
2103,GO:0044259,1,0.745090050957516,0,1,multicellular organismal macromolecule metabolic process,BP,
2106,GO:0044265,1,0.688897299215273,0,2,cellular macromolecule catabolic process,BP,
2115,GO:0044297,1,0.220534769116006,0,6,cell body,CC,
2116,GO:0044321,1,0.689883197202292,0,1,response to leptin,BP,
2117,GO:0044325,1,0.97782001583703,0,1,ion channel binding,MF,
2118,GO:0044344,1,0.571539577158986,0,2,cellular response to fibroblast growth factor stimulus,BP,
2119,GO:0044351,1,0.944573033403215,0,1,macropinocytosis,BP,
2121,GO:0044391,1,0.862856117640713,0,2,ribosomal subunit,CC,
2124,GO:0044420,1,0.933624765294581,0,1,extracellular matrix component,CC,
2131,GO:0044430,1,0.302540482062914,0,4,cytoskeletal part,CC,
2132,GO:0044431,1,0.689785429679902,0,1,Golgi apparatus part,CC,
2136,GO:0044438,1,0.150621493980518,0,8,microbody part,CC,
2137,GO:0044439,1,0.150621493980518,0,8,peroxisomal part,CC,
2142,GO:0044449,1,0.872301952309925,0,1,contractile fiber part,CC,
2145,GO:0044455,1,0.477661312339313,0,2,mitochondrial membrane part,CC,
2146,GO:0044456,1,0.689785429679887,0,1,synapse part,CC,
2147,GO:0044459,1,0.0592179148604227,0,10,plasma membrane part,CC,
2148,GO:0044463,1,0.933624765294581,0,1,cell projection part,CC,
2150,GO:0044539,1,0.915413777710168,0,1,long-chain fatty acid import,BP,
2151,GO:0044548,1,0.909149134363904,0,1,S100 protein binding,MF,
2159,GO:0044708,1,0.320600480335207,0,4,single-organism behavior,BP,
2165,GO:0044744,1,0.860646174064634,0,1,protein targeting to nucleus,BP,
2170,GO:0044770,1,0.932920109189956,0,1,cell cycle phase transition,BP,
2171,GO:0044772,1,0.932920109189956,0,1,mitotic cell cycle phase transition,BP,
2172,GO:0044801,1,0.689785429679809,0,1,single-organism membrane fusion,BP,
2173,GO:0044802,1,0.592349499123574,0,2,single-organism membrane organization,BP,
2174,GO:0044839,1,0.932920109189956,0,1,cell cycle G2/M phase transition,BP,
2176,GO:0045017,1,0.51207234812086,0,5,glycerolipid biosynthetic process,BP,
2177,GO:0045019,1,0.62863855509776,0,2,negative regulation of nitric oxide biosynthetic process,BP,
2178,GO:0045028,1,0.690383534494896,0,1,G-protein coupled purinergic nucleotide receptor activity,MF,
2179,GO:0045029,1,0.690383534494896,0,1,UDP-activated nucleotide receptor activity,MF,
2188,GO:0045111,1,0.71008138889583,0,1,intermediate filament cytoskeleton,CC,
2189,GO:0045121,1,0.630542903290721,0,2,membrane raft,CC,
2190,GO:0045123,1,0.753843485045977,0,1,cellular extravasation,BP,
2192,GO:0045137,1,0.445485188652002,0,3,development of primary sexual characteristics,BP,
2195,GO:0045211,1,0.689785429679887,0,1,postsynaptic membrane,CC,
2196,GO:0045216,1,0.933624765294581,0,1,cell-cell junction organization,BP,
2197,GO:0045251,1,0.695746712093305,0,1,electron transfer flavoprotein complex,CC,
2198,GO:0045296,1,0.696680402390533,0,1,cadherin binding,MF,
2200,GO:0045333,1,0.386404265411457,0,4,cellular respiration,BP,
2201,GO:0045349,1,0.838088519544645,0,1,interferon-alpha biosynthetic process,BP,
2204,GO:0045354,1,0.838088519544645,0,1,regulation of interferon-alpha biosynthetic process,BP,
2205,GO:0045355,1,0.838088519544645,0,1,negative regulation of interferon-alpha biosynthetic process,BP,
2207,GO:0045358,1,0.838088519544645,0,1,negative regulation of interferon-beta biosynthetic process,BP,
2213,GO:0045471,1,0.6478510588882,0,2,response to ethanol,BP,
2214,GO:0045485,1,0.689785429679715,0,1,omega-6 fatty acid desaturase activity,MF,
2216,GO:0045542,1,0.689785429679902,0,1,positive regulation of cholesterol biosynthetic process,BP,
2220,GO:0045596,1,0.395404773114727,0,4,negative regulation of cell differentiation,BP,
2224,GO:0045637,1,0.753843485045977,0,1,regulation of myeloid cell differentiation,BP,
2225,GO:0045639,1,0.753843485045977,0,1,positive regulation of myeloid cell differentiation,BP,
2226,GO:0045649,1,0.753843485045977,0,1,regulation of macrophage differentiation,BP,
2227,GO:0045651,1,0.753843485045977,0,1,positive regulation of macrophage differentiation,BP,
2228,GO:0045664,1,0.689785429679932,0,1,regulation of neuron differentiation,BP,
2229,GO:0045665,1,0.689785429679932,0,1,negative regulation of neuron differentiation,BP,
2230,GO:0045682,1,0.838088519544645,0,1,regulation of epidermis development,BP,
2231,GO:0045684,1,0.838088519544645,0,1,positive regulation of epidermis development,BP,
2232,GO:0045717,1,0.687262467473769,0,2,negative regulation of fatty acid biosynthetic process,BP,
2233,GO:0045723,1,0.739171199267924,0,1,positive regulation of fatty acid biosynthetic process,BP,
2235,GO:0045732,1,0.688897299215273,0,2,positive regulation of protein catabolic process,BP,
2236,GO:0045742,1,0.746221125113029,0,1,positive regulation of epidermal growth factor receptor signaling pathway,BP,
2237,GO:0045744,1,0.690322142801083,0,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
2239,GO:0045786,1,0.82906426527132,0,2,negative regulation of cell cycle,BP,
2240,GO:0045792,1,0.770314150802672,0,1,negative regulation of cell size,BP,
2241,GO:0045806,1,0.982136033016046,0,1,negative regulation of endocytosis,BP,
2242,GO:0045807,1,0.944573033403215,0,1,positive regulation of endocytosis,BP,
2243,GO:0045824,1,0.838088519544645,0,1,negative regulation of innate immune response,BP,
2244,GO:0045833,1,0.687262467473769,0,2,negative regulation of lipid metabolic process,BP,
2245,GO:0045834,1,0.310188459943778,0,5,positive regulation of lipid metabolic process,BP,
2246,GO:0045843,1,0.854431527474896,0,2,negative regulation of striated muscle tissue development,BP,
2247,GO:0045859,1,0.280569134198666,0,6,regulation of protein kinase activity,BP,
2248,GO:0045860,1,0.532534418822557,0,3,positive regulation of protein kinase activity,BP,
2249,GO:0045861,1,0.593335839232855,0,2,negative regulation of proteolysis,BP,
2253,GO:0045913,1,0.739171199267924,0,1,positive regulation of carbohydrate metabolic process,BP,
2254,GO:0045922,1,0.687262467473769,0,2,negative regulation of fatty acid metabolic process,BP,
2255,GO:0045923,1,0.739171199267924,0,1,positive regulation of fatty acid metabolic process,BP,
2256,GO:0045926,1,0.94012643491917,0,1,negative regulation of growth,BP,
2257,GO:0045927,1,0.689785429679705,0,1,positive regulation of growth,BP,
2258,GO:0045930,1,0.932920109189956,0,1,negative regulation of mitotic cell cycle,BP,
2261,GO:0045936,1,0.525253391582431,0,4,negative regulation of phosphate metabolic process,BP,
2262,GO:0045937,1,0.319194311948315,0,7,positive regulation of phosphate metabolic process,BP,
2263,GO:0045940,1,0.464509537089103,0,3,positive regulation of steroid metabolic process,BP,
2265,GO:0045981,1,0.954275672359452,0,1,positive regulation of nucleotide metabolic process,BP,
2266,GO:0046006,1,0.711475438092686,0,2,regulation of activated T cell proliferation,BP,
2267,GO:0046058,1,0.954275672359452,0,1,cAMP metabolic process,BP,
2271,GO:0046121,1,0.780410045217068,0,1,deoxyribonucleoside catabolic process,BP,
2274,GO:0046146,1,0.873228977733856,0,2,tetrahydrobiopterin metabolic process,BP,
2278,GO:0046322,1,0.700154732893895,0,1,negative regulation of fatty acid oxidation,BP,
2282,GO:0046328,1,0.944573033403215,0,1,regulation of JNK cascade,BP,
2283,GO:0046330,1,0.944573033403215,0,1,positive regulation of JNK cascade,BP,
2284,GO:0046339,1,0.933624765294581,0,1,diacylglycerol metabolic process,BP,
2285,GO:0046356,1,0.65896949055495,0,2,acetyl-CoA catabolic process,BP,
2286,GO:0046364,1,0.612015645681683,0,3,monosaccharide biosynthetic process,BP,
2287,GO:0046365,1,0.869799107756487,0,1,monosaccharide catabolic process,BP,
2288,GO:0046386,1,0.780410045217068,0,1,deoxyribose phosphate catabolic process,BP,
2289,GO:0046390,1,0.677305585898023,0,2,ribose phosphate biosynthetic process,BP,
2293,GO:0046425,1,0.689785429679705,0,1,regulation of JAK-STAT cascade,BP,
2294,GO:0046427,1,0.689785429679705,0,1,positive regulation of JAK-STAT cascade,BP,
2296,GO:0046449,1,0.689785429679705,0,1,creatinine metabolic process,BP,
2297,GO:0046456,1,0.658521068639755,0,2,icosanoid biosynthetic process,BP,
2298,GO:0046460,1,0.689422952463184,0,2,neutral lipid biosynthetic process,BP,
2299,GO:0046461,1,0.915413777710168,0,1,neutral lipid catabolic process,BP,
2300,GO:0046463,1,0.689422952463184,0,2,acylglycerol biosynthetic process,BP,
2301,GO:0046464,1,0.915413777710168,0,1,acylglycerol catabolic process,BP,
2303,GO:0046467,1,0.982932946886051,0,1,membrane lipid biosynthetic process,BP,
2304,GO:0046470,1,0.798623187528096,0,3,phosphatidylcholine metabolic process,BP,
2305,GO:0046474,1,0.746508699683985,0,3,glycerophospholipid biosynthetic process,BP,
2306,GO:0046475,1,0.982136033016046,0,1,glycerophospholipid catabolic process,BP,
2307,GO:0046477,1,0.852105267215681,0,1,glycosylceramide catabolic process,BP,
2310,GO:0046485,1,0.889059397519768,0,1,ether lipid metabolic process,BP,
2311,GO:0046486,1,0.380408819472467,0,8,glycerolipid metabolic process,BP,
2312,GO:0046487,1,0.696680402390533,0,1,glyoxylate metabolic process,BP,
2313,GO:0046488,1,0.621961062889965,0,4,phosphatidylinositol metabolic process,BP,
2316,GO:0046503,1,0.898924003841621,0,2,glycerolipid catabolic process,BP,
2319,GO:0046527,1,0.902523548288088,0,1,glucosyltransferase activity,MF,
2320,GO:0046545,1,0.6496736281172,0,2,development of primary female sexual characteristics,BP,
2321,GO:0046546,1,0.689883197202292,0,1,development of primary male sexual characteristics,BP,
2323,GO:0046620,1,0.94012643491917,0,1,regulation of organ growth,BP,
2324,GO:0046621,1,0.94012643491917,0,1,negative regulation of organ growth,BP,
2333,GO:0046660,1,0.609944995460112,0,3,female sex differentiation,BP,
2335,GO:0046677,1,0.473517862731513,0,2,response to antibiotic,BP,
2336,GO:0046683,1,0.689883197202292,0,1,response to organophosphorus,BP,
2337,GO:0046686,1,0.65700329833437,0,2,response to cadmium ion,BP,
2339,GO:0046717,1,0.689785429679701,0,1,acid secretion,BP,
2342,GO:0046834,1,0.713519383031278,0,2,lipid phosphorylation,BP,
2345,GO:0046854,1,0.713519383031278,0,2,phosphatidylinositol phosphorylation,BP,
2346,GO:0046864,1,0.94012643491917,0,1,isoprenoid transport,BP,
2347,GO:0046865,1,0.94012643491917,0,1,terpenoid transport,BP,
2349,GO:0046873,1,0.529449391795353,0,2,metal ion transmembrane transporter activity,MF,
2350,GO:0046879,1,0.94012643491917,0,1,hormone secretion,BP,
2351,GO:0046883,1,0.94012643491917,0,1,regulation of hormone secretion,BP,
2352,GO:0046887,1,0.94012643491917,0,1,positive regulation of hormone secretion,BP,
2353,GO:0046889,1,0.316422413889177,0,4,positive regulation of lipid biosynthetic process,BP,
2355,GO:0046902,1,0.860646174064634,0,1,regulation of mitochondrial membrane permeability,BP,
2360,GO:0046915,1,0.770314150802672,0,1,transition metal ion transmembrane transporter activity,MF,
2361,GO:0046916,1,0.770314150802672,0,1,cellular transition metal ion homeostasis,BP,
2362,GO:0046934,1,0.83065676594881,0,1,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
2363,GO:0046942,1,0.432130626877822,0,3,carboxylic acid transport,BP,
2364,GO:0046943,1,0.689785429679701,0,1,carboxylic acid transmembrane transporter activity,MF,
2368,GO:0046952,1,0.710373855442479,0,1,ketone body catabolic process,BP,
2371,GO:0046997,1,0.689785429679775,0,1,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
2372,GO:0047015,1,0.937272715402406,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
2375,GO:0047442,1,0.749682324291769,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
2377,GO:0047750,1,0.90529521320746,0,1,cholestenol delta-isomerase activity,MF,
2378,GO:0047760,1,0.693221867723898,0,1,butyrate-CoA ligase activity,MF,
2379,GO:0047860,1,0.883274038622596,0,1,diiodophenylpyruvate reductase activity,MF,
2380,GO:0048002,1,0.814696110019901,0,3,antigen processing and presentation of peptide antigen,BP,
2381,GO:0048009,1,0.689785429679705,0,1,insulin-like growth factor receptor signaling pathway,BP,
2382,GO:0048010,1,0.83065676594881,0,1,vascular endothelial growth factor receptor signaling pathway,BP,
2383,GO:0048015,1,0.83065676594881,0,1,phosphatidylinositol-mediated signaling,BP,
2384,GO:0048017,1,0.83065676594881,0,1,inositol lipid-mediated signaling,BP,
2385,GO:0048020,1,0.971719166134129,0,1,CCR chemokine receptor binding,MF,
2386,GO:0048029,1,0.79481320556046,0,1,monosaccharide binding,MF,
2388,GO:0048038,1,0.695746712093305,0,1,quinone binding,MF,
2389,GO:0048039,1,0.695746712093305,0,1,ubiquinone binding,MF,
2390,GO:0048144,1,0.925278227405574,0,1,fibroblast proliferation,BP,
2391,GO:0048145,1,0.925278227405574,0,1,regulation of fibroblast proliferation,BP,
2392,GO:0048147,1,0.925278227405574,0,1,negative regulation of fibroblast proliferation,BP,
2393,GO:0048148,1,0.753843485045977,0,1,behavioral response to cocaine,BP,
2394,GO:0048156,1,0.909149134363904,0,1,tau protein binding,MF,
2395,GO:0048167,1,0.626245403248184,0,2,regulation of synaptic plasticity,BP,
2396,GO:0048168,1,0.626245403248184,0,2,regulation of neuronal synaptic plasticity,BP,
2397,GO:0048193,1,0.634766113480441,0,3,Golgi vesicle transport,BP,
2398,GO:0048232,1,0.739171199267924,0,1,male gamete generation,BP,
2399,GO:0048244,1,0.79481320556046,0,1,phytanoyl-CoA dioxygenase activity,MF,
2400,GO:0048259,1,0.982136033016046,0,1,regulation of receptor-mediated endocytosis,BP,
2401,GO:0048261,1,0.982136033016046,0,1,negative regulation of receptor-mediated endocytosis,BP,
2402,GO:0048284,1,0.689785429679809,0,1,organelle fusion,BP,
2403,GO:0048305,1,0.94012643491917,0,1,immunoglobulin secretion,BP,
2404,GO:0048306,1,0.909149134363904,0,1,calcium-dependent protein binding,MF,
2406,GO:0048469,1,0.933624765294581,0,1,cell maturation,BP,
2407,GO:0048471,1,0.601208815314005,0,3,perinuclear region of cytoplasm,CC,
2409,GO:0048511,1,0.643315643608327,0,2,rhythmic process,BP,
2410,GO:0048512,1,0.689883197202292,0,1,circadian behavior,BP,
2412,GO:0048514,1,0.775028957425363,0,2,blood vessel morphogenesis,BP,
2419,GO:0048535,1,0.753843485045977,0,1,lymph node development,BP,
2420,GO:0048536,1,0.753843485045977,0,1,spleen development,BP,
2421,GO:0048538,1,0.753843485045977,0,1,thymus development,BP,
2422,GO:0048545,1,0.433522192239594,0,3,response to steroid hormone,BP,
2423,GO:0048562,1,0.94012643491917,0,1,embryonic organ morphogenesis,BP,
2424,GO:0048568,1,0.94012643491917,0,1,embryonic organ development,BP,
2429,GO:0048592,1,0.94012643491917,0,1,eye morphogenesis,BP,
2430,GO:0048593,1,0.94012643491917,0,1,camera-type eye morphogenesis,BP,
2431,GO:0048598,1,0.94012643491917,0,1,embryonic morphogenesis,BP,
2432,GO:0048599,1,0.933624765294581,0,1,oocyte development,BP,
2435,GO:0048634,1,0.854431527474896,0,2,regulation of muscle organ development,BP,
2436,GO:0048635,1,0.854431527474896,0,2,negative regulation of muscle organ development,BP,
2437,GO:0048638,1,0.647758985185692,0,2,regulation of developmental growth,BP,
2438,GO:0048639,1,0.689785429679705,0,1,positive regulation of developmental growth,BP,
2439,GO:0048640,1,0.94012643491917,0,1,negative regulation of developmental growth,BP,
2440,GO:0048641,1,0.909149134363904,0,1,regulation of skeletal muscle tissue development,BP,
2441,GO:0048642,1,0.909149134363904,0,1,negative regulation of skeletal muscle tissue development,BP,
2442,GO:0048646,1,0.728004006713616,0,3,anatomical structure formation involved in morphogenesis,BP,
2443,GO:0048659,1,0.933624765294581,0,1,smooth muscle cell proliferation,BP,
2444,GO:0048660,1,0.933624765294581,0,1,regulation of smooth muscle cell proliferation,BP,
2445,GO:0048662,1,0.933624765294581,0,1,negative regulation of smooth muscle cell proliferation,BP,
2446,GO:0048666,1,0.317218305366826,0,4,neuron development,BP,
2447,GO:0048667,1,0.317218305366826,0,4,cell morphogenesis involved in neuron differentiation,BP,
2448,GO:0048699,1,0.215392447277368,0,5,generation of neurons,BP,
2449,GO:0048705,1,0.83065676594881,0,1,skeletal system morphogenesis,BP,
2450,GO:0048706,1,0.94012643491917,0,1,embryonic skeletal system development,BP,
2451,GO:0048708,1,0.909149134363904,0,1,astrocyte differentiation,BP,
2452,GO:0048729,1,0.932920109189956,0,1,tissue morphogenesis,BP,
2454,GO:0048732,1,0.391649222471463,0,3,gland development,BP,
2455,GO:0048738,1,0.94012643491917,0,1,cardiac muscle tissue development,BP,
2458,GO:0048807,1,0.94012643491917,0,1,female genitalia morphogenesis,BP,
2459,GO:0048812,1,0.464807221264095,0,3,neuron projection morphogenesis,BP,
2461,GO:0048858,1,0.464807221264095,0,3,cell projection morphogenesis,BP,
2465,GO:0048872,1,0.753843485045977,0,1,homeostasis of number of cells,BP,
2467,GO:0050277,1,0.689785429679685,0,1,sedoheptulokinase activity,MF,
2468,GO:0050508,1,0.689785429679681,0,1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
2469,GO:0050543,1,0.915413777710168,0,1,icosatetraenoic acid binding,MF,
2478,GO:0050673,1,0.689422952463184,0,2,epithelial cell proliferation,BP,
2479,GO:0050678,1,0.689422952463184,0,2,regulation of epithelial cell proliferation,BP,
2480,GO:0050679,1,0.933624765294581,0,1,positive regulation of epithelial cell proliferation,BP,
2481,GO:0050680,1,0.739171199267924,0,1,negative regulation of epithelial cell proliferation,BP,
2482,GO:0050699,1,0.90369147852398,0,1,WW domain binding,MF,
2483,GO:0050701,1,0.944573033403215,0,1,interleukin-1 secretion,BP,
2484,GO:0050702,1,0.944573033403215,0,1,interleukin-1 beta secretion,BP,
2485,GO:0050704,1,0.944573033403215,0,1,regulation of interleukin-1 secretion,BP,
2486,GO:0050706,1,0.944573033403215,0,1,regulation of interleukin-1 beta secretion,BP,
2487,GO:0050707,1,0.944573033403215,0,1,regulation of cytokine secretion,BP,
2488,GO:0050708,1,0.569962745218887,0,4,regulation of protein secretion,BP,
2489,GO:0050714,1,0.569962745218887,0,4,positive regulation of protein secretion,BP,
2490,GO:0050715,1,0.944573033403215,0,1,positive regulation of cytokine secretion,BP,
2491,GO:0050716,1,0.944573033403215,0,1,positive regulation of interleukin-1 secretion,BP,
2492,GO:0050718,1,0.944573033403215,0,1,positive regulation of interleukin-1 beta secretion,BP,
2494,GO:0050730,1,0.689785429679705,0,1,regulation of peptidyl-tyrosine phosphorylation,BP,
2495,GO:0050731,1,0.689785429679705,0,1,positive regulation of peptidyl-tyrosine phosphorylation,BP,
2497,GO:0050764,1,0.944573033403215,0,1,regulation of phagocytosis,BP,
2498,GO:0050766,1,0.944573033403215,0,1,positive regulation of phagocytosis,BP,
2499,GO:0050767,1,0.473517862731672,0,2,regulation of neurogenesis,BP,
2500,GO:0050768,1,0.689785429679932,0,1,negative regulation of neurogenesis,BP,
2501,GO:0050769,1,0.689883197202292,0,1,positive regulation of neurogenesis,BP,
2502,GO:0050770,1,0.689785429679932,0,1,regulation of axonogenesis,BP,
2503,GO:0050771,1,0.689785429679932,0,1,negative regulation of axonogenesis,BP,
2505,GO:0050777,1,0.838088519544645,0,1,negative regulation of immune response,BP,
2507,GO:0050786,1,0.909149134363904,0,1,RAGE receptor binding,MF,
2513,GO:0050796,1,0.94012643491917,0,1,regulation of insulin secretion,BP,
2514,GO:0050798,1,0.711475438092686,0,2,activated T cell proliferation,BP,
2516,GO:0050802,1,0.689883197202292,0,1,circadian sleep/wake cycle, sleep,BP,
2517,GO:0050804,1,0.306556077351388,0,4,modulation of synaptic transmission,BP,
2518,GO:0050806,1,0.626156308506379,0,2,positive regulation of synaptic transmission,BP,
2521,GO:0050817,1,0.474243671643786,0,2,coagulation,BP,
2522,GO:0050818,1,0.689785429680012,0,1,regulation of coagulation,BP,
2523,GO:0050821,1,0.925278227405574,0,1,protein stabilization,BP,
2524,GO:0050829,1,0.944573033403215,0,1,defense response to Gram-negative bacterium,BP,
2525,GO:0050839,1,0.696680402390533,0,1,cell adhesion molecule binding,MF,
2526,GO:0050848,1,0.739171199267924,0,1,regulation of calcium-mediated signaling,BP,
2527,GO:0050851,1,0.932920109189956,0,1,antigen receptor-mediated signaling pathway,BP,
2528,GO:0050852,1,0.932920109189956,0,1,T cell receptor signaling pathway,BP,
2535,GO:0050873,1,0.886066225194754,0,2,brown fat cell differentiation,BP,
2537,GO:0050878,1,0.474243671643786,0,2,regulation of body fluid levels,BP,
2539,GO:0050890,1,0.909149134363904,0,1,cognition,BP,
2541,GO:0050900,1,0.711475438092686,0,2,leukocyte migration,BP,
2543,GO:0050920,1,0.83065676594881,0,1,regulation of chemotaxis,BP,
2544,GO:0050921,1,0.83065676594881,0,1,positive regulation of chemotaxis,BP,
2545,GO:0050953,1,0.94012643491917,0,1,sensory perception of light stimulus,BP,
2547,GO:0050994,1,0.683846949876915,0,2,regulation of lipid catabolic process,BP,
2548,GO:0050995,1,0.982136033016046,0,1,negative regulation of lipid catabolic process,BP,
2549,GO:0050997,1,0.982136033016046,0,1,quaternary ammonium group binding,MF,
2550,GO:0050999,1,0.800224065184713,0,2,regulation of nitric-oxide synthase activity,BP,
2551,GO:0051001,1,0.852105267215681,0,1,negative regulation of nitric-oxide synthase activity,BP,
2552,GO:0051004,1,0.982136033016046,0,1,regulation of lipoprotein lipase activity,BP,
2553,GO:0051005,1,0.982136033016046,0,1,negative regulation of lipoprotein lipase activity,BP,
2554,GO:0051015,1,0.872301952309925,0,1,actin filament binding,MF,
2555,GO:0051020,1,0.473822899733455,0,2,GTPase binding,MF,
2556,GO:0051023,1,0.94012643491917,0,1,regulation of immunoglobulin secretion,BP,
2557,GO:0051024,1,0.94012643491917,0,1,positive regulation of immunoglobulin secretion,BP,
2558,GO:0051046,1,0.569962745218887,0,4,regulation of secretion,BP,
2559,GO:0051047,1,0.569962745218887,0,4,positive regulation of secretion,BP,
2562,GO:0051051,1,0.982136033016046,0,1,negative regulation of transport,BP,
2563,GO:0051052,1,0.739171199267924,0,1,regulation of DNA metabolic process,BP,
2564,GO:0051053,1,0.739171199267924,0,1,negative regulation of DNA metabolic process,BP,
2565,GO:0051055,1,0.687262467473769,0,2,negative regulation of lipid biosynthetic process,BP,
2569,GO:0051093,1,0.270743776662479,0,6,negative regulation of developmental process,BP,
2574,GO:0051129,1,0.505421105574453,0,4,negative regulation of cellular component organization,BP,
2575,GO:0051130,1,0.650860617933289,0,2,positive regulation of cellular component organization,BP,
2576,GO:0051156,1,0.536475172301674,0,2,glucose 6-phosphate metabolic process,BP,
2579,GO:0051170,1,0.860646174064634,0,1,nuclear import,BP,
2585,GO:0051183,1,0.94012643491917,0,1,vitamin transporter activity,MF,
2587,GO:0051187,1,0.65896949055495,0,2,cofactor catabolic process,BP,
2591,GO:0051208,1,0.860646174064634,0,1,sequestering of calcium ion,BP,
2592,GO:0051209,1,0.860646174064634,0,1,release of sequestered calcium ion into cytosol,BP,
2593,GO:0051213,1,0.79481320556046,0,1,dioxygenase activity,MF,
2594,GO:0051216,1,0.83065676594881,0,1,cartilage development,BP,
2595,GO:0051222,1,0.569962745218887,0,4,positive regulation of protein transport,BP,
2599,GO:0051238,1,0.860646174064634,0,1,sequestering of metal ion,BP,
2602,GO:0051241,1,0.260827093412511,0,9,negative regulation of multicellular organismal process,BP,
2605,GO:0051248,1,0.224782286309797,0,8,negative regulation of protein metabolic process,BP,
2611,GO:0051258,1,0.768372008400137,0,3,protein polymerization,BP,
2612,GO:0051259,1,0.297771282627142,0,6,protein oligomerization,BP,
2613,GO:0051260,1,0.583417579540917,0,3,protein homooligomerization,BP,
2614,GO:0051261,1,0.872301952309925,0,1,protein depolymerization,BP,
2615,GO:0051262,1,0.823659742844826,0,2,protein tetramerization,BP,
2616,GO:0051270,1,0.295094985858091,0,5,regulation of cellular component movement,BP,
2617,GO:0051271,1,0.739171199267924,0,1,negative regulation of cellular component movement,BP,
2618,GO:0051272,1,0.40348040318604,0,4,positive regulation of cellular component movement,BP,
2619,GO:0051282,1,0.860646174064634,0,1,regulation of sequestering of calcium ion,BP,
2620,GO:0051283,1,0.860646174064634,0,1,negative regulation of sequestering of calcium ion,BP,
2622,GO:0051289,1,0.823659742844826,0,2,protein homotetramerization,BP,
2623,GO:0051291,1,0.778601207185001,0,2,protein heterooligomerization,BP,
2625,GO:0051338,1,0.260578889068121,0,7,regulation of transferase activity,BP,
2626,GO:0051340,1,0.739171199267924,0,1,regulation of ligase activity,BP,
2627,GO:0051341,1,0.589806179082116,0,3,regulation of oxidoreductase activity,BP,
2628,GO:0051342,1,0.739171199267924,0,1,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2629,GO:0051344,1,0.739171199267924,0,1,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2631,GO:0051346,1,0.42760995788285,0,4,negative regulation of hydrolase activity,BP,
2632,GO:0051347,1,0.495731411326129,0,4,positive regulation of transferase activity,BP,
2633,GO:0051348,1,0.498365199788878,0,4,negative regulation of transferase activity,BP,
2634,GO:0051352,1,0.739171199267924,0,1,negative regulation of ligase activity,BP,
2635,GO:0051353,1,0.739171199267924,0,1,positive regulation of oxidoreductase activity,BP,
2636,GO:0051354,1,0.852105267215681,0,1,negative regulation of oxidoreductase activity,BP,
2637,GO:0051384,1,0.626245403248184,0,2,response to glucocorticoid,BP,
2638,GO:0051385,1,0.689883197202292,0,1,response to mineralocorticoid,BP,
2639,GO:0051402,1,0.518063885559813,0,2,neuron apoptotic process,BP,
2640,GO:0051403,1,0.944573033403215,0,1,stress-activated MAPK cascade,BP,
2641,GO:0051412,1,0.689883197202292,0,1,response to corticosterone,BP,
2642,GO:0051436,1,0.932920109189956,0,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
2643,GO:0051437,1,0.932920109189956,0,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,
2644,GO:0051438,1,0.932920109189956,0,1,regulation of ubiquitin-protein transferase activity,BP,
2645,GO:0051439,1,0.932920109189956,0,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
2646,GO:0051443,1,0.932920109189956,0,1,positive regulation of ubiquitin-protein transferase activity,BP,
2647,GO:0051444,1,0.932920109189956,0,1,negative regulation of ubiquitin-protein transferase activity,BP,
2648,GO:0051480,1,0.860646174064634,0,1,regulation of cytosolic calcium ion concentration,BP,
2649,GO:0051493,1,0.823602209620197,0,2,regulation of cytoskeleton organization,BP,
2650,GO:0051494,1,0.872301952309925,0,1,negative regulation of cytoskeleton organization,BP,
2651,GO:0051495,1,0.944573033403215,0,1,positive regulation of cytoskeleton organization,BP,
2654,GO:0051539,1,0.695746712093305,0,1,4 iron, 4 sulfur cluster binding,MF,
2656,GO:0051591,1,0.689883197202292,0,1,response to cAMP,BP,
2657,GO:0051597,1,0.909149134363904,0,1,response to methylmercury,BP,
2658,GO:0051603,1,0.688897299215273,0,2,proteolysis involved in cellular protein catabolic process,BP,
2659,GO:0051604,1,0.444174940205243,0,3,protein maturation,BP,
2660,GO:0051606,1,0.689785429679902,0,1,detection of stimulus,BP,
2665,GO:0051693,1,0.872301952309925,0,1,actin filament capping,BP,
2666,GO:0051694,1,0.872301952309925,0,1,pointed-end actin filament capping,BP,
2670,GO:0051726,1,0.82906426527132,0,2,regulation of cell cycle,BP,
2671,GO:0051797,1,0.838088519544645,0,1,regulation of hair follicle development,BP,
2672,GO:0051798,1,0.838088519544645,0,1,positive regulation of hair follicle development,BP,
2673,GO:0051896,1,0.689785429679681,0,1,regulation of protein kinase B signaling,BP,
2674,GO:0051897,1,0.689785429679681,0,1,positive regulation of protein kinase B signaling,BP,
2675,GO:0051924,1,0.739171199267924,0,1,regulation of calcium ion transport,BP,
2676,GO:0051928,1,0.739171199267924,0,1,positive regulation of calcium ion transport,BP,
2677,GO:0051938,1,0.689785429679701,0,1,L-glutamate import,BP,
2678,GO:0051960,1,0.473517862731672,0,2,regulation of nervous system development,BP,
2679,GO:0051961,1,0.689785429679932,0,1,negative regulation of nervous system development,BP,
2680,GO:0051962,1,0.689883197202292,0,1,positive regulation of nervous system development,BP,
2681,GO:0051990,1,0.696680402390533,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
2684,GO:0052652,1,0.954275672359452,0,1,cyclic purine nucleotide metabolic process,BP,
2686,GO:0052692,1,0.852105267215681,0,1,raffinose alpha-galactosidase activity,MF,
2687,GO:0052739,1,0.889059397519768,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
2688,GO:0052740,1,0.889059397519768,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
2689,GO:0052742,1,0.83065676594881,0,1,phosphatidylinositol kinase activity,MF,
2690,GO:0052813,1,0.83065676594881,0,1,phosphatidylinositol bisphosphate kinase activity,MF,
2691,GO:0055017,1,0.94012643491917,0,1,cardiac muscle tissue growth,BP,
2692,GO:0055021,1,0.94012643491917,0,1,regulation of cardiac muscle tissue growth,BP,
2693,GO:0055022,1,0.94012643491917,0,1,negative regulation of cardiac muscle tissue growth,BP,
2694,GO:0055024,1,0.94012643491917,0,1,regulation of cardiac muscle tissue development,BP,
2695,GO:0055026,1,0.94012643491917,0,1,negative regulation of cardiac muscle tissue development,BP,
2696,GO:0055037,1,0.362064554551996,0,3,recycling endosome,CC,
2699,GO:0055070,1,0.770314150802672,0,1,copper ion homeostasis,BP,
2704,GO:0055081,1,0.630524391743412,0,2,anion homeostasis,BP,
2708,GO:0055088,1,0.630524391743412,0,2,lipid homeostasis,BP,
2709,GO:0055091,1,0.630524391743412,0,2,phospholipid homeostasis,BP,
2710,GO:0055092,1,0.630524391743412,0,2,sterol homeostasis,BP,
2711,GO:0055094,1,0.689785429679902,0,1,response to lipoprotein particle,BP,
2712,GO:0055099,1,0.689785429679902,0,1,response to high density lipoprotein particle,BP,
2713,GO:0055102,1,0.982136033016046,0,1,lipase inhibitor activity,MF,
2715,GO:0060038,1,0.94012643491917,0,1,cardiac muscle cell proliferation,BP,
2716,GO:0060041,1,0.94012643491917,0,1,retina development in camera-type eye,BP,
2717,GO:0060042,1,0.94012643491917,0,1,retina morphogenesis in camera-type eye,BP,
2718,GO:0060043,1,0.94012643491917,0,1,regulation of cardiac muscle cell proliferation,BP,
2719,GO:0060044,1,0.94012643491917,0,1,negative regulation of cardiac muscle cell proliferation,BP,
2720,GO:0060047,1,0.97782001583703,0,1,heart contraction,BP,
2721,GO:0060059,1,0.94012643491917,0,1,embryonic retina morphogenesis in camera-type eye,BP,
2722,GO:0060065,1,0.94012643491917,0,1,uterus development,BP,
2723,GO:0060068,1,0.94012643491917,0,1,vagina development,BP,
2724,GO:0060070,1,0.932920109189956,0,1,canonical Wnt signaling pathway,BP,
2725,GO:0060071,1,0.932920109189956,0,1,Wnt signaling pathway, planar cell polarity pathway,BP,
2726,GO:0060078,1,0.689785429679887,0,1,regulation of postsynaptic membrane potential,BP,
2727,GO:0060079,1,0.689785429679887,0,1,excitatory postsynaptic potential,BP,
2728,GO:0060089,1,0.291525629075156,0,4,molecular transducer activity,MF,
2729,GO:0060090,1,0.838088519544645,0,1,binding, bridging,MF,
2730,GO:0060157,1,0.94012643491917,0,1,urinary bladder development,BP,
2732,GO:0060191,1,0.916834443200247,0,2,regulation of lipase activity,BP,
2733,GO:0060192,1,0.982136033016046,0,1,negative regulation of lipase activity,BP,
2734,GO:0060193,1,0.933624765294581,0,1,positive regulation of lipase activity,BP,
2736,GO:0060228,1,0.982136033016046,0,1,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
2739,GO:0060260,1,0.689785429679797,0,1,regulation of transcription initiation from RNA polymerase II promoter,BP,
2740,GO:0060261,1,0.689785429679797,0,1,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
2741,GO:0060284,1,0.473517862731672,0,2,regulation of cell development,BP,
2742,GO:0060291,1,0.909149134363904,0,1,long-term synaptic potentiation,BP,
2743,GO:0060322,1,0.487829858939189,0,2,head development,BP,
2744,GO:0060326,1,0.83065676594881,0,1,cell chemotaxis,BP,
2745,GO:0060333,1,0.774949258320089,0,2,interferon-gamma-mediated signaling pathway,BP,
2747,GO:0060338,1,0.753843485045977,0,1,regulation of type I interferon-mediated signaling pathway,BP,
2748,GO:0060340,1,0.753843485045977,0,1,positive regulation of type I interferon-mediated signaling pathway,BP,
2750,GO:0060343,1,0.94012643491917,0,1,trabecula formation,BP,
2751,GO:0060347,1,0.94012643491917,0,1,heart trabecula formation,BP,
2752,GO:0060348,1,0.61265499123079,0,2,bone development,BP,
2753,GO:0060349,1,0.83065676594881,0,1,bone morphogenesis,BP,
2754,GO:0060350,1,0.83065676594881,0,1,endochondral bone morphogenesis,BP,
2755,GO:0060359,1,0.753843485045977,0,1,response to ammonium ion,BP,
2756,GO:0060396,1,0.689785429679705,0,1,growth hormone receptor signaling pathway,BP,
2757,GO:0060397,1,0.689785429679705,0,1,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
2758,GO:0060401,1,0.860646174064634,0,1,cytosolic calcium ion transport,BP,
2759,GO:0060402,1,0.860646174064634,0,1,calcium ion transport into cytosol,BP,
2760,GO:0060416,1,0.473517862731515,0,2,response to growth hormone,BP,
2761,GO:0060419,1,0.94012643491917,0,1,heart growth,BP,
2762,GO:0060420,1,0.94012643491917,0,1,regulation of heart growth,BP,
2764,GO:0060491,1,0.689785429679681,0,1,regulation of cell projection assembly,BP,
2765,GO:0060537,1,0.854431527474896,0,2,muscle tissue development,BP,
2766,GO:0060538,1,0.909149134363904,0,1,skeletal muscle organ development,BP,
2768,GO:0060544,1,0.630542903290721,0,2,regulation of necroptotic process,BP,
2769,GO:0060546,1,0.753843485045977,0,1,negative regulation of necroptotic process,BP,
2770,GO:0060547,1,0.647680022866411,0,2,negative regulation of necrotic cell death,BP,
2772,GO:0060589,1,0.689785429679809,0,1,nucleoside-triphosphatase regulator activity,MF,
2773,GO:0060612,1,0.630507201512011,0,2,adipose tissue development,BP,
2774,GO:0060627,1,0.438048224470191,0,4,regulation of vesicle-mediated transport,BP,
2775,GO:0060696,1,0.683846949876915,0,2,regulation of phospholipid catabolic process,BP,
2776,GO:0060759,1,0.510179056364335,0,4,regulation of response to cytokine stimulus,BP,
2777,GO:0060760,1,0.753843485045977,0,1,positive regulation of response to cytokine stimulus,BP,
2778,GO:0060761,1,0.860646174064634,0,1,negative regulation of response to cytokine stimulus,BP,
2779,GO:0060828,1,0.932920109189956,0,1,regulation of canonical Wnt signaling pathway,BP,
2780,GO:0060992,1,0.689883197202292,0,1,response to fungicide,BP,
2781,GO:0061008,1,0.523098508666123,0,2,hepaticobiliary system development,BP,
2782,GO:0061024,1,0.592349499123574,0,2,membrane organization,BP,
2783,GO:0061025,1,0.689785429679809,0,1,membrane fusion,BP,
2784,GO:0061035,1,0.83065676594881,0,1,regulation of cartilage development,BP,
2785,GO:0061036,1,0.83065676594881,0,1,positive regulation of cartilage development,BP,
2786,GO:0061041,1,0.689785429680012,0,1,regulation of wound healing,BP,
2787,GO:0061061,1,0.854431527474896,0,2,muscle structure development,BP,
2788,GO:0061117,1,0.94012643491917,0,1,negative regulation of heart growth,BP,
2789,GO:0061134,1,0.559588252724287,0,3,peptidase regulator activity,MF,
2790,GO:0061135,1,0.593335839232855,0,2,endopeptidase regulator activity,MF,
2791,GO:0061326,1,0.710373855442479,0,1,renal tubule development,BP,
2792,GO:0061337,1,0.97782001583703,0,1,cardiac conduction,BP,
2794,GO:0061383,1,0.94012643491917,0,1,trabecula morphogenesis,BP,
2795,GO:0061384,1,0.94012643491917,0,1,heart trabecula morphogenesis,BP,
2796,GO:0061418,1,0.932920109189956,0,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
2797,GO:0061448,1,0.521935884803836,0,3,connective tissue development,BP,
2799,GO:0061564,1,0.464807221264095,0,3,axon development,BP,
2800,GO:0061695,1,0.944573033403215,0,1,transferase complex, transferring phosphorus-containing groups,CC,
2802,GO:0065003,1,0.109671108690364,0,12,macromolecular complex assembly,BP,
2803,GO:0065005,1,0.982136033016046,0,1,protein-lipid complex assembly,BP,
2807,GO:0070003,1,0.932920109189956,0,1,threonine-type peptidase activity,MF,
2812,GO:0070064,1,0.689785429679705,0,1,proline-rich region binding,MF,
2813,GO:0070085,1,0.610469436077768,0,3,glycosylation,BP,
2814,GO:0070125,1,0.62680772179944,0,3,mitochondrial translational elongation,BP,
2815,GO:0070126,1,0.862856117640713,0,2,mitochondrial translational termination,BP,
2816,GO:0070129,1,0.728032091145752,0,1,regulation of mitochondrial translation,BP,
2817,GO:0070161,1,0.859997101743051,0,1,anchoring junction,CC,
2818,GO:0070195,1,0.689785429679705,0,1,growth hormone receptor complex,CC,
2820,GO:0070227,1,0.753843485045977,0,1,lymphocyte apoptotic process,BP,
2821,GO:0070228,1,0.753843485045977,0,1,regulation of lymphocyte apoptotic process,BP,
2822,GO:0070229,1,0.753843485045977,0,1,negative regulation of lymphocyte apoptotic process,BP,
2823,GO:0070231,1,0.753843485045977,0,1,T cell apoptotic process,BP,
2824,GO:0070232,1,0.753843485045977,0,1,regulation of T cell apoptotic process,BP,
2825,GO:0070233,1,0.753843485045977,0,1,negative regulation of T cell apoptotic process,BP,
2826,GO:0070235,1,0.753843485045977,0,1,regulation of activation-induced cell death of T cells,BP,
2827,GO:0070236,1,0.753843485045977,0,1,negative regulation of activation-induced cell death of T cells,BP,
2830,GO:0070268,1,0.71008138889583,0,1,cornification,BP,
2831,GO:0070271,1,0.11210318477857,0,11,protein complex biogenesis,BP,
2833,GO:0070293,1,0.689785429679797,0,1,renal absorption,BP,
2834,GO:0070296,1,0.860646174064634,0,1,sarcoplasmic reticulum calcium ion transport,BP,
2835,GO:0070302,1,0.944573033403215,0,1,regulation of stress-activated protein kinase signaling cascade,BP,
2836,GO:0070304,1,0.944573033403215,0,1,positive regulation of stress-activated protein kinase signaling cascade,BP,
2837,GO:0070371,1,0.784178026257555,0,2,ERK1 and ERK2 cascade,BP,
2838,GO:0070372,1,0.784178026257555,0,2,regulation of ERK1 and ERK2 cascade,BP,
2839,GO:0070374,1,0.784178026257555,0,2,positive regulation of ERK1 and ERK2 cascade,BP,
2840,GO:0070402,1,0.886430651618205,0,1,NADPH binding,MF,
2841,GO:0070405,1,0.982136033016046,0,1,ammonium ion binding,MF,
2842,GO:0070482,1,0.679639001511281,0,4,response to oxygen levels,BP,
2843,GO:0070509,1,0.860646174064634,0,1,calcium ion import,BP,
2844,GO:0070513,1,0.838088519544645,0,1,death domain binding,MF,
2845,GO:0070525,1,0.743963160689213,0,2,tRNA threonylcarbamoyladenosine metabolic process,BP,
2846,GO:0070538,1,0.915413777710168,0,1,oleic acid binding,MF,
2848,GO:0070555,1,0.651941289240789,0,2,response to interleukin-1,BP,
2849,GO:0070569,1,0.869799107756487,0,1,uridylyltransferase activity,MF,
2850,GO:0070588,1,0.635004410324262,0,2,calcium ion transmembrane transport,BP,
2851,GO:0070613,1,0.592531454703254,0,2,regulation of protein processing,BP,
2854,GO:0070646,1,0.932920109189956,0,1,protein modification by small protein removal,BP,
2859,GO:0070670,1,0.689785429679685,0,1,response to interleukin-4,BP,
2860,GO:0070696,1,0.944573033403215,0,1,transmembrane receptor protein serine/threonine kinase binding,MF,
2861,GO:0070700,1,0.944573033403215,0,1,BMP receptor binding,MF,
2862,GO:0070704,1,0.689785429679715,0,1,sterol desaturase activity,MF,
2864,GO:0070742,1,0.689785429679914,0,1,C2H2 zinc finger domain binding,MF,
2865,GO:0070777,1,0.689785429679701,0,1,D-aspartate transport,BP,
2866,GO:0070779,1,0.689785429679701,0,1,D-aspartate import,BP,
2867,GO:0070820,1,0.696680402390533,0,1,tertiary granule,CC,
2868,GO:0070838,1,0.635004410324262,0,2,divalent metal ion transport,BP,
2869,GO:0070848,1,0.571539577158986,0,2,response to growth factor,BP,
2870,GO:0070851,1,0.538899387140174,0,3,growth factor receptor binding,MF,
2871,GO:0070857,1,0.689883197202292,0,1,regulation of bile acid biosynthetic process,BP,
2872,GO:0070859,1,0.689883197202292,0,1,positive regulation of bile acid biosynthetic process,BP,
2874,GO:0070900,1,0.743963160689213,0,2,mitochondrial tRNA modification,BP,
2875,GO:0070901,1,0.937272715402406,0,1,mitochondrial tRNA methylation,BP,
2876,GO:0070902,1,0.794342025053001,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
2877,GO:0070925,1,0.689785429679809,0,1,organelle assembly,BP,
2878,GO:0070936,1,0.838088519544645,0,1,protein K48-linked ubiquitination,BP,
2880,GO:0070996,1,0.954275672359452,0,1,type 1 melanocortin receptor binding,MF,
2881,GO:0070997,1,0.518063885559813,0,2,neuron death,BP,
2882,GO:0071071,1,0.636850333607802,0,2,regulation of phospholipid biosynthetic process,BP,
2883,GO:0071073,1,0.915413777710168,0,1,positive regulation of phospholipid biosynthetic process,BP,
2884,GO:0071214,1,0.753843485045977,0,1,cellular response to abiotic stimulus,BP,
2889,GO:0071236,1,0.689883197202292,0,1,cellular response to antibiotic,BP,
2890,GO:0071241,1,0.689883197202292,0,1,cellular response to inorganic substance,BP,
2891,GO:0071248,1,0.689883197202292,0,1,cellular response to metal ion,BP,
2892,GO:0071260,1,0.753843485045977,0,1,cellular response to mechanical stimulus,BP,
2895,GO:0071276,1,0.689883197202292,0,1,cellular response to cadmium ion,BP,
2897,GO:0071312,1,0.689883197202292,0,1,cellular response to alkaloid,BP,
2898,GO:0071320,1,0.689883197202292,0,1,cellular response to cAMP,BP,
2899,GO:0071322,1,0.689883197202292,0,1,cellular response to carbohydrate stimulus,BP,
2900,GO:0071326,1,0.689883197202292,0,1,cellular response to monosaccharide stimulus,BP,
2901,GO:0071331,1,0.689883197202292,0,1,cellular response to hexose stimulus,BP,
2902,GO:0071333,1,0.689883197202292,0,1,cellular response to glucose stimulus,BP,
2904,GO:0071346,1,0.532555188379633,0,3,cellular response to interferon-gamma,BP,
2905,GO:0071347,1,0.651941289240789,0,2,cellular response to interleukin-1,BP,
2906,GO:0071353,1,0.689785429679685,0,1,cellular response to interleukin-4,BP,
2907,GO:0071356,1,0.633366787959991,0,4,cellular response to tumor necrosis factor,BP,
2909,GO:0071363,1,0.571539577158986,0,2,cellular response to growth factor stimulus,BP,
2910,GO:0071371,1,0.689883197202292,0,1,cellular response to gonadotropin stimulus,BP,
2911,GO:0071372,1,0.689883197202292,0,1,cellular response to follicle-stimulating hormone stimulus,BP,
2912,GO:0071373,1,0.689883197202292,0,1,cellular response to luteinizing hormone stimulus,BP,
2914,GO:0071378,1,0.473517862731515,0,2,cellular response to growth hormone stimulus,BP,
2915,GO:0071383,1,0.689883197202292,0,1,cellular response to steroid hormone stimulus,BP,
2916,GO:0071384,1,0.689883197202292,0,1,cellular response to corticosteroid stimulus,BP,
2917,GO:0071385,1,0.689883197202292,0,1,cellular response to glucocorticoid stimulus,BP,
2920,GO:0071407,1,0.689883197202292,0,1,cellular response to organic cyclic compound,BP,
2922,GO:0071436,1,0.97782001583703,0,1,sodium ion export,BP,
2923,GO:0071450,1,0.739171199267924,0,1,cellular response to oxygen radical,BP,
2924,GO:0071451,1,0.739171199267924,0,1,cellular response to superoxide,BP,
2925,GO:0071453,1,0.847856813831993,0,2,cellular response to oxygen levels,BP,
2926,GO:0071456,1,0.847856813831993,0,2,cellular response to hypoxia,BP,
2930,GO:0071548,1,0.689883197202292,0,1,response to dexamethasone,BP,
2931,GO:0071549,1,0.689883197202292,0,1,cellular response to dexamethasone stimulus,BP,
2932,GO:0071550,1,0.630542903290721,0,2,death-inducing signaling complex assembly,BP,
2933,GO:0071553,1,0.690383534494896,0,1,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
2934,GO:0071559,1,0.689883197202292,0,1,response to transforming growth factor beta,BP,
2935,GO:0071560,1,0.689883197202292,0,1,cellular response to transforming growth factor beta stimulus,BP,
2941,GO:0071774,1,0.571539577158986,0,2,response to fibroblast growth factor,BP,
2942,GO:0071822,1,0.0951133492700793,0,13,protein complex subunit organization,BP,
2943,GO:0071825,1,0.677068771719113,0,2,protein-lipid complex subunit organization,BP,
2944,GO:0071826,1,0.860646174064634,0,1,ribonucleoprotein complex subunit organization,BP,
2945,GO:0071827,1,0.677068771719113,0,2,plasma lipoprotein particle organization,BP,
2946,GO:0071830,1,0.982136033016046,0,1,triglyceride-rich lipoprotein particle clearance,BP,
2948,GO:0071855,1,0.954275672359452,0,1,neuropeptide receptor binding,MF,
2949,GO:0071867,1,0.689883197202292,0,1,response to monoamine,BP,
2950,GO:0071868,1,0.689883197202292,0,1,cellular response to monoamine stimulus,BP,
2951,GO:0071869,1,0.689883197202292,0,1,response to catecholamine,BP,
2952,GO:0071870,1,0.689883197202292,0,1,cellular response to catecholamine stimulus,BP,
2953,GO:0071871,1,0.689883197202292,0,1,response to epinephrine,BP,
2954,GO:0071872,1,0.689883197202292,0,1,cellular response to epinephrine stimulus,BP,
2955,GO:0071887,1,0.753843485045977,0,1,leukocyte apoptotic process,BP,
2956,GO:0071897,1,0.739171199267924,0,1,DNA biosynthetic process,BP,
2957,GO:0071900,1,0.538899387139997,0,3,regulation of protein serine/threonine kinase activity,BP,
2958,GO:0071901,1,0.944573033403215,0,1,negative regulation of protein serine/threonine kinase activity,BP,
2959,GO:0071902,1,0.571458039272209,0,2,positive regulation of protein serine/threonine kinase activity,BP,
2961,GO:0071955,1,0.689785429679809,0,1,recycling endosome to Golgi transport,BP,
2962,GO:0072001,1,0.490803375639416,0,3,renal system development,BP,
2963,GO:0072006,1,0.710373855442479,0,1,nephron development,BP,
2964,GO:0072009,1,0.710373855442479,0,1,nephron epithelium development,BP,
2965,GO:0072014,1,0.710373855442479,0,1,proximal tubule development,BP,
2966,GO:0072019,1,0.710373855442479,0,1,proximal convoluted tubule development,BP,
2967,GO:0072073,1,0.710373855442479,0,1,kidney epithelium development,BP,
2968,GO:0072080,1,0.710373855442479,0,1,nephron tubule development,BP,
2969,GO:0072170,1,0.710373855442479,0,1,metanephric tubule development,BP,
2970,GO:0072207,1,0.710373855442479,0,1,metanephric epithelium development,BP,
2971,GO:0072229,1,0.710373855442479,0,1,metanephric proximal convoluted tubule development,BP,
2972,GO:0072234,1,0.710373855442479,0,1,metanephric nephron tubule development,BP,
2973,GO:0072237,1,0.710373855442479,0,1,metanephric proximal tubule development,BP,
2974,GO:0072243,1,0.710373855442479,0,1,metanephric nephron epithelium development,BP,
2977,GO:0072331,1,0.944573033403215,0,1,signal transduction by p53 class mediator,BP,
2978,GO:0072332,1,0.944573033403215,0,1,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
2979,GO:0072338,1,0.689785429679705,0,1,cellular lactam metabolic process,BP,
2980,GO:0072350,1,0.420822871464881,0,3,tricarboxylic acid metabolic process,BP,
2983,GO:0072376,1,0.474390336478735,0,2,protein activation cascade,BP,
2984,GO:0072378,1,0.690927624413754,0,1,blood coagulation, fibrin clot formation,BP,
2987,GO:0072511,1,0.635004410324262,0,2,divalent inorganic cation transport,BP,
2995,GO:0072558,1,0.944573033403215,0,1,NLRP1 inflammasome complex,CC,
2997,GO:0072562,1,0.689996137392405,0,1,blood microparticle,CC,
2999,GO:0072594,1,0.860646174064634,0,1,establishment of protein localization to organelle,BP,
3000,GO:0072604,1,0.944573033403215,0,1,interleukin-6 secretion,BP,
3001,GO:0072606,1,0.944573033403215,0,1,interleukin-8 secretion,BP,
3002,GO:0072608,1,0.944573033403215,0,1,interleukin-10 secretion,BP,
3003,GO:0072676,1,0.711475438092686,0,2,lymphocyte migration,BP,
3004,GO:0072678,1,0.711475438092686,0,2,T cell migration,BP,
3005,GO:0072683,1,0.753843485045977,0,1,T cell extravasation,BP,
3008,GO:0080135,1,0.598998024393074,0,3,regulation of cellular response to stress,BP,
3010,GO:0086036,1,0.97782001583703,0,1,regulation of cardiac muscle cell membrane potential,BP,
3011,GO:0089711,1,0.689785429679701,0,1,L-glutamate transmembrane transport,BP,
3012,GO:0089720,1,0.647680022866411,0,2,caspase binding,MF,
3013,GO:0090066,1,0.633006412739069,0,3,regulation of anatomical structure size,BP,
3014,GO:0090077,1,0.689785429679902,0,1,foam cell differentiation,BP,
3016,GO:0090090,1,0.932920109189956,0,1,negative regulation of canonical Wnt signaling pathway,BP,
3017,GO:0090130,1,0.83065676594881,0,1,tissue migration,BP,
3018,GO:0090132,1,0.83065676594881,0,1,epithelium migration,BP,
3019,GO:0090174,1,0.689785429679809,0,1,organelle membrane fusion,BP,
3020,GO:0090175,1,0.932920109189956,0,1,regulation of establishment of planar polarity,BP,
3022,GO:0090195,1,0.944573033403215,0,1,chemokine secretion,BP,
3023,GO:0090196,1,0.944573033403215,0,1,regulation of chemokine secretion,BP,
3024,GO:0090197,1,0.944573033403215,0,1,positive regulation of chemokine secretion,BP,
3025,GO:0090199,1,0.812567533012029,0,2,regulation of release of cytochrome c from mitochondria,BP,
3026,GO:0090200,1,0.944573033403215,0,1,positive regulation of release of cytochrome c from mitochondria,BP,
3027,GO:0090201,1,0.860646174064634,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
3028,GO:0090205,1,0.689785429679902,0,1,positive regulation of cholesterol metabolic process,BP,
3029,GO:0090207,1,0.739171199267924,0,1,regulation of triglyceride metabolic process,BP,
3030,GO:0090208,1,0.739171199267924,0,1,positive regulation of triglyceride metabolic process,BP,
3031,GO:0090257,1,0.860646174064634,0,1,regulation of muscle system process,BP,
3032,GO:0090263,1,0.932920109189956,0,1,positive regulation of canonical Wnt signaling pathway,BP,
3033,GO:0090276,1,0.94012643491917,0,1,regulation of peptide hormone secretion,BP,
3034,GO:0090277,1,0.94012643491917,0,1,positive regulation of peptide hormone secretion,BP,
3035,GO:0090287,1,0.83065676594881,0,1,regulation of cellular response to growth factor stimulus,BP,
3038,GO:0090322,1,0.739171199267924,0,1,regulation of superoxide metabolic process,BP,
3040,GO:0090484,1,0.90529521320746,0,1,drug transporter activity,MF,
3043,GO:0090533,1,0.97782001583703,0,1,cation-transporting ATPase complex,CC,
3044,GO:0090559,1,0.860646174064634,0,1,regulation of membrane permeability,BP,
3045,GO:0090596,1,0.94012643491917,0,1,sensory organ morphogenesis,BP,
3046,GO:0090630,1,0.689785429679809,0,1,activation of GTPase activity,BP,
3047,GO:0090646,1,0.743963160689213,0,2,mitochondrial tRNA processing,BP,
3048,GO:0097006,1,0.677068771719113,0,2,regulation of plasma lipoprotein particle levels,BP,
3049,GO:0097028,1,0.924359214547204,0,1,dendritic cell differentiation,BP,
3050,GO:0097049,1,0.753843485045977,0,1,motor neuron apoptotic process,BP,
3051,GO:0097060,1,0.689785429679887,0,1,synaptic membrane,CC,
3052,GO:0097089,1,0.79481320556046,0,1,methyl-branched fatty acid metabolic process,BP,
3055,GO:0097164,1,0.375144064968574,0,5,ammonium ion metabolic process,BP,
3058,GO:0097191,1,0.364108237340176,0,6,extrinsic apoptotic signaling pathway,BP,
3059,GO:0097192,1,0.753843485045977,0,1,extrinsic apoptotic signaling pathway in absence of ligand,BP,
3063,GO:0097202,1,0.753843485045977,0,1,activation of cysteine-type endopeptidase activity,BP,
3065,GO:0097296,1,0.630542903290721,0,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
3067,GO:0097305,1,0.6478510588882,0,2,response to alcohol,BP,
3068,GO:0097340,1,0.860646174064634,0,1,inhibition of cysteine-type endopeptidase activity,BP,
3069,GO:0097341,1,0.860646174064634,0,1,zymogen inhibition,BP,
3072,GO:0097421,1,0.739171199267924,0,1,liver regeneration,BP,
3074,GO:0097435,1,0.768372008400137,0,3,supramolecular fiber organization,BP,
3075,GO:0097458,1,0.148904186146058,0,7,neuron part,CC,
3076,GO:0097485,1,0.746221125113029,0,1,neuron projection guidance,BP,
3077,GO:0097502,1,0.982932946886051,0,1,mannosylation,BP,
3078,GO:0097527,1,0.753843485045977,0,1,necroptotic signaling pathway,BP,
3079,GO:0097553,1,0.860646174064634,0,1,calcium ion transmembrane import into cytosol,BP,
3081,GO:0097696,1,0.576634378193675,0,2,STAT cascade,BP,
3083,GO:0097722,1,0.739171199267924,0,1,sperm motility,BP,
3084,GO:0098533,1,0.97782001583703,0,1,ATPase dependent transmembrane transport complex,CC,
3086,GO:0098552,1,0.689785429679902,0,1,side of membrane,CC,
3087,GO:0098573,1,0.695746712093305,0,1,intrinsic component of mitochondrial membrane,CC,
3089,GO:0098589,1,0.630542903290721,0,2,membrane region,CC,
3090,GO:0098590,1,0.689785429679887,0,1,plasma membrane region,CC,
3091,GO:0098599,1,0.745842816697877,0,1,palmitoyl hydrolase activity,MF,
3094,GO:0098655,1,0.452345891917474,0,5,cation transmembrane transport,BP,
3095,GO:0098656,1,0.46235098971295,0,3,anion transmembrane transport,BP,
3096,GO:0098657,1,0.689785429679701,0,1,import into cell,BP,
3097,GO:0098660,1,0.452345891917474,0,5,inorganic ion transmembrane transport,BP,
3098,GO:0098661,1,0.97782001583703,0,1,inorganic anion transmembrane transport,BP,
3099,GO:0098662,1,0.452345891917474,0,5,inorganic cation transmembrane transport,BP,
3100,GO:0098732,1,0.745842816697877,0,1,macromolecule deacylation,BP,
3101,GO:0098734,1,0.745842816697877,0,1,macromolecule depalmitoylation,BP,
3102,GO:0098754,1,0.705783648536025,0,2,detoxification,BP,
3104,GO:0098772,1,0.209290120480736,0,9,molecular function regulator,MF,
3105,GO:0098773,1,0.593711349227464,0,2,skin epidermis development,BP,
3106,GO:0098781,1,0.933624765294581,0,1,ncRNA transcription,BP,
3107,GO:0098794,1,0.689785429679887,0,1,postsynapse,CC,
3108,GO:0098796,1,0.630542903290721,0,2,membrane protein complex,CC,
3109,GO:0098797,1,0.630542903290721,0,2,plasma membrane protein complex,CC,
3110,GO:0098798,1,0.695746712093305,0,1,mitochondrial protein complex,CC,
3111,GO:0098802,1,0.473449921345991,0,2,plasma membrane receptor complex,CC,
3113,GO:0098857,1,0.630542903290721,0,2,membrane microdomain,CC,
3114,GO:0098869,1,0.705783648536025,0,2,cellular oxidant detoxification,BP,
3115,GO:0098878,1,0.473449921345991,0,2,neurotransmitter receptor complex,CC,
3116,GO:0098916,1,0.208030927622597,0,5,anterograde trans-synaptic signaling,BP,
3117,GO:0099080,1,0.4236019288016,0,3,supramolecular complex,CC,
3118,GO:0099081,1,0.4236019288016,0,3,supramolecular polymer,CC,
3119,GO:0099094,1,0.689785429679887,0,1,ligand-gated cation channel activity,MF,
3121,GO:0099512,1,0.4236019288016,0,3,supramolecular fiber,CC,
3122,GO:0099513,1,0.487556612978034,0,2,polymeric cytoskeletal fiber,CC,
3123,GO:0099536,1,0.208030927622597,0,5,synaptic signaling,BP,
3124,GO:0099537,1,0.208030927622597,0,5,trans-synaptic signaling,BP,
3125,GO:0099565,1,0.689785429679887,0,1,chemical synaptic transmission, postsynaptic,BP,
3126,GO:0099568,1,0.689785429679681,0,1,cytoplasmic region,CC,
3127,GO:0099600,1,0.291525629075156,0,4,transmembrane receptor activity,MF,
3130,GO:0102009,1,0.745090050957516,0,1,proline dipeptidase activity,MF,
3131,GO:0102336,1,0.689785429679781,0,1,3-oxo-arachidoyl-CoA synthase activity,MF,
3132,GO:0102337,1,0.689785429679781,0,1,3-oxo-cerotoyl-CoA synthase activity,MF,
3133,GO:0102338,1,0.689785429679781,0,1,3-oxo-lignoceronyl-CoA synthase activity,MF,
3134,GO:0120025,1,0.148904186146058,0,7,plasma membrane bounded cell projection,CC,
3135,GO:0198738,1,0.932920109189956,0,1,cell-cell signaling by wnt,BP,
3136,GO:1900046,1,0.689785429680012,0,1,regulation of hemostasis,BP,
3139,GO:1900180,1,0.860646174064634,0,1,regulation of protein localization to nucleus,BP,
3140,GO:1900274,1,0.933624765294581,0,1,regulation of phospholipase C activity,BP,
3141,GO:1900371,1,0.954275672359452,0,1,regulation of purine nucleotide biosynthetic process,BP,
3142,GO:1900373,1,0.954275672359452,0,1,positive regulation of purine nucleotide biosynthetic process,BP,
3143,GO:1900407,1,0.635004410324262,0,2,regulation of cellular response to oxidative stress,BP,
3144,GO:1900408,1,0.860646174064634,0,1,negative regulation of cellular response to oxidative stress,BP,
3145,GO:1900409,1,0.739171199267924,0,1,positive regulation of cellular response to oxidative stress,BP,
3146,GO:1900542,1,0.954275672359452,0,1,regulation of purine nucleotide metabolic process,BP,
3147,GO:1900544,1,0.954275672359452,0,1,positive regulation of purine nucleotide metabolic process,BP,
3148,GO:1900864,1,0.743963160689213,0,2,mitochondrial RNA modification,BP,
3149,GO:1901019,1,0.739171199267924,0,1,regulation of calcium ion transmembrane transporter activity,BP,
3150,GO:1901021,1,0.739171199267924,0,1,positive regulation of calcium ion transmembrane transporter activity,BP,
3151,GO:1901031,1,0.739171199267924,0,1,regulation of response to reactive oxygen species,BP,
3152,GO:1901033,1,0.739171199267924,0,1,positive regulation of response to reactive oxygen species,BP,
3153,GO:1901052,1,0.689785429679775,0,1,sarcosine metabolic process,BP,
3154,GO:1901053,1,0.689785429679775,0,1,sarcosine catabolic process,BP,
3157,GO:1901137,1,0.410147138477956,0,5,carbohydrate derivative biosynthetic process,BP,
3158,GO:1901184,1,0.746221125113029,0,1,regulation of ERBB signaling pathway,BP,
3159,GO:1901186,1,0.746221125113029,0,1,positive regulation of ERBB signaling pathway,BP,
3160,GO:1901214,1,0.689883197202292,0,1,regulation of neuron death,BP,
3161,GO:1901215,1,0.689883197202292,0,1,negative regulation of neuron death,BP,
3162,GO:1901264,1,0.689785429679902,0,1,carbohydrate derivative transport,BP,
3166,GO:1901317,1,0.739171199267924,0,1,regulation of flagellated sperm motility,BP,
3167,GO:1901318,1,0.739171199267924,0,1,negative regulation of flagellated sperm motility,BP,
3172,GO:1901505,1,0.689785429679902,0,1,carbohydrate derivative transporter activity,MF,
3177,GO:1901570,1,0.658521068639755,0,2,fatty acid derivative biosynthetic process,BP,
3181,GO:1901606,1,0.452313870433698,0,3,alpha-amino acid catabolic process,BP,
3185,GO:1901618,1,0.689785429679902,0,1,organic hydroxy compound transmembrane transporter activity,MF,
3188,GO:1901654,1,0.689883197202292,0,1,response to ketone,BP,
3189,GO:1901655,1,0.689883197202292,0,1,cellular response to ketone,BP,
3192,GO:1901668,1,0.739171199267924,0,1,regulation of superoxide dismutase activity,BP,
3193,GO:1901671,1,0.739171199267924,0,1,positive regulation of superoxide dismutase activity,BP,
3194,GO:1901681,1,0.673238679925827,0,2,sulfur compound binding,MF,
3195,GO:1901685,1,0.955554231038555,0,1,glutathione derivative metabolic process,BP,
3196,GO:1901687,1,0.955554231038555,0,1,glutathione derivative biosynthetic process,BP,
3201,GO:1901861,1,0.854431527474896,0,2,regulation of muscle tissue development,BP,
3202,GO:1901862,1,0.854431527474896,0,2,negative regulation of muscle tissue development,BP,
3203,GO:1901879,1,0.872301952309925,0,1,regulation of protein depolymerization,BP,
3204,GO:1901880,1,0.872301952309925,0,1,negative regulation of protein depolymerization,BP,
3205,GO:1901894,1,0.739171199267924,0,1,regulation of calcium-transporting ATPase activity,BP,
3206,GO:1901896,1,0.739171199267924,0,1,positive regulation of calcium-transporting ATPase activity,BP,
3208,GO:1901987,1,0.932920109189956,0,1,regulation of cell cycle phase transition,BP,
3209,GO:1901988,1,0.932920109189956,0,1,negative regulation of cell cycle phase transition,BP,
3210,GO:1901990,1,0.932920109189956,0,1,regulation of mitotic cell cycle phase transition,BP,
3211,GO:1901991,1,0.932920109189956,0,1,negative regulation of mitotic cell cycle phase transition,BP,
3212,GO:1901998,1,0.689785429679902,0,1,toxin transport,BP,
3213,GO:1902001,1,0.689785429679855,0,1,fatty acid transmembrane transport,BP,
3214,GO:1902041,1,0.630542903290721,0,2,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
3215,GO:1902042,1,0.630542903290721,0,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
3216,GO:1902043,1,0.753843485045977,0,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
3218,GO:1902106,1,0.924359214547204,0,1,negative regulation of leukocyte differentiation,BP,
3220,GO:1902108,1,0.860646174064634,0,1,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3221,GO:1902109,1,0.860646174064634,0,1,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3222,GO:1902115,1,0.689785429679809,0,1,regulation of organelle assembly,BP,
3223,GO:1902175,1,0.860646174064634,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3224,GO:1902176,1,0.860646174064634,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3225,GO:1902221,1,0.929610988847701,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
3226,GO:1902222,1,0.929610988847701,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
3228,GO:1902305,1,0.97782001583703,0,1,regulation of sodium ion transmembrane transport,BP,
3229,GO:1902307,1,0.97782001583703,0,1,positive regulation of sodium ion transmembrane transport,BP,
3230,GO:1902311,1,0.770314150802672,0,1,regulation of copper ion transmembrane transport,BP,
3231,GO:1902475,1,0.689785429679701,0,1,L-alpha-amino acid transmembrane transport,BP,
3232,GO:1902476,1,0.97782001583703,0,1,chloride transmembrane transport,BP,
3234,GO:1902495,1,0.462350989713185,0,3,transmembrane transporter complex,CC,
3235,GO:1902524,1,0.838088519544645,0,1,positive regulation of protein K48-linked ubiquitination,BP,
3237,GO:1902532,1,0.624449676132694,0,3,negative regulation of intracellular signal transduction,BP,
3239,GO:1902554,1,0.944573033403215,0,1,serine/threonine protein kinase complex,CC,
3240,GO:1902555,1,0.937272715402406,0,1,endoribonuclease complex,CC,
3242,GO:1902580,1,0.276408667590097,0,4,single-organism cellular localization,BP,
3243,GO:1902582,1,0.276408667590097,0,4,single-organism intracellular transport,BP,
3244,GO:1902589,1,0.452268049548929,0,5,single-organism organelle organization,BP,
3245,GO:1902593,1,0.860646174064634,0,1,single-organism nuclear import,BP,
3246,GO:1902600,1,0.953244849717105,0,1,hydrogen ion transmembrane transport,BP,
3249,GO:1902656,1,0.860646174064634,0,1,calcium ion import into cytosol,BP,
3252,GO:1902749,1,0.932920109189956,0,1,regulation of cell cycle G2/M phase transition,BP,
3253,GO:1902750,1,0.932920109189956,0,1,negative regulation of cell cycle G2/M phase transition,BP,
3254,GO:1902858,1,0.710373855442479,0,1,propionyl-CoA metabolic process,BP,
3255,GO:1902860,1,0.710373855442479,0,1,propionyl-CoA biosynthetic process,BP,
3256,GO:1902882,1,0.635004410324262,0,2,regulation of response to oxidative stress,BP,
3257,GO:1902883,1,0.860646174064634,0,1,negative regulation of response to oxidative stress,BP,
3258,GO:1902884,1,0.739171199267924,0,1,positive regulation of response to oxidative stress,BP,
3259,GO:1902903,1,0.823602209620197,0,2,regulation of supramolecular fiber organization,BP,
3260,GO:1902904,1,0.872301952309925,0,1,negative regulation of supramolecular fiber organization,BP,
3261,GO:1902905,1,0.944573033403215,0,1,positive regulation of supramolecular fiber organization,BP,
3262,GO:1902911,1,0.944573033403215,0,1,protein kinase complex,CC,
3263,GO:1902914,1,0.838088519544645,0,1,regulation of protein polyubiquitination,BP,
3264,GO:1902916,1,0.838088519544645,0,1,positive regulation of protein polyubiquitination,BP,
3266,GO:1902932,1,0.689785429679902,0,1,positive regulation of alcohol biosynthetic process,BP,
3268,GO:1903010,1,0.739171199267924,0,1,regulation of bone development,BP,
3269,GO:1903011,1,0.739171199267924,0,1,negative regulation of bone development,BP,
3270,GO:1903034,1,0.689785429680012,0,1,regulation of response to wounding,BP,
3273,GO:1903047,1,0.932920109189956,0,1,mitotic cell cycle process,BP,
3274,GO:1903050,1,0.688897299215273,0,2,regulation of proteolysis involved in cellular protein catabolic process,BP,
3275,GO:1903052,1,0.688897299215273,0,2,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
3276,GO:1903169,1,0.739171199267924,0,1,regulation of calcium ion transmembrane transport,BP,
3277,GO:1903173,1,0.748517463788975,0,1,fatty alcohol metabolic process,BP,
3278,GO:1903201,1,0.860646174064634,0,1,regulation of oxidative stress-induced cell death,BP,
3279,GO:1903202,1,0.860646174064634,0,1,negative regulation of oxidative stress-induced cell death,BP,
3280,GO:1903273,1,0.97782001583703,0,1,regulation of sodium ion export,BP,
3281,GO:1903275,1,0.97782001583703,0,1,positive regulation of sodium ion export,BP,
3282,GO:1903276,1,0.97782001583703,0,1,regulation of sodium ion export from cell,BP,
3283,GO:1903278,1,0.97782001583703,0,1,positive regulation of sodium ion export from cell,BP,
3284,GO:1903305,1,0.690322142801083,0,1,regulation of regulated secretory pathway,BP,
3285,GO:1903317,1,0.592531454703254,0,2,regulation of protein maturation,BP,
3286,GO:1903318,1,0.860646174064634,0,1,negative regulation of protein maturation,BP,
3288,GO:1903321,1,0.932920109189956,0,1,negative regulation of protein modification by small protein conjugation or removal,BP,
3290,GO:1903362,1,0.688897299215273,0,2,regulation of cellular protein catabolic process,BP,
3291,GO:1903364,1,0.688897299215273,0,2,positive regulation of cellular protein catabolic process,BP,
3294,GO:1903427,1,0.62863855509776,0,2,negative regulation of reactive oxygen species biosynthetic process,BP,
3301,GO:1903514,1,0.860646174064634,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
3302,GO:1903522,1,0.97782001583703,0,1,regulation of blood circulation,BP,
3303,GO:1903530,1,0.569962745218887,0,4,regulation of secretion by cell,BP,
3304,GO:1903532,1,0.569962745218887,0,4,positive regulation of secretion by cell,BP,
3305,GO:1903533,1,0.860646174064634,0,1,regulation of protein targeting,BP,
3309,GO:1903610,1,0.739171199267924,0,1,regulation of calcium-dependent ATPase activity,BP,
3310,GO:1903611,1,0.739171199267924,0,1,negative regulation of calcium-dependent ATPase activity,BP,
3311,GO:1903624,1,0.739171199267924,0,1,regulation of DNA catabolic process,BP,
3312,GO:1903625,1,0.739171199267924,0,1,negative regulation of DNA catabolic process,BP,
3313,GO:1903627,1,0.739171199267924,0,1,regulation of dUTP diphosphatase activity,BP,
3314,GO:1903629,1,0.739171199267924,0,1,positive regulation of dUTP diphosphatase activity,BP,
3315,GO:1903630,1,0.739171199267924,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
3316,GO:1903631,1,0.739171199267924,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
3317,GO:1903633,1,0.739171199267924,0,1,regulation of leucine-tRNA ligase activity,BP,
3318,GO:1903634,1,0.739171199267924,0,1,negative regulation of leucine-tRNA ligase activity,BP,
3320,GO:1903707,1,0.924359214547204,0,1,negative regulation of hemopoiesis,BP,
3322,GO:1903725,1,0.625017950416306,0,3,regulation of phospholipid metabolic process,BP,
3323,GO:1903726,1,0.982136033016046,0,1,negative regulation of phospholipid metabolic process,BP,
3324,GO:1903727,1,0.915413777710168,0,1,positive regulation of phospholipid metabolic process,BP,
3325,GO:1903779,1,0.97782001583703,0,1,regulation of cardiac conduction,BP,
3326,GO:1903825,1,0.47344992134575,0,2,organic acid transmembrane transport,BP,
3330,GO:1904062,1,0.554568607218397,0,3,regulation of cation transmembrane transport,BP,
3331,GO:1904064,1,0.722399050317903,0,2,positive regulation of cation transmembrane transport,BP,
3332,GO:1904177,1,0.889059397519768,0,1,regulation of adipose tissue development,BP,
3333,GO:1904251,1,0.689883197202292,0,1,regulation of bile acid metabolic process,BP,
3334,GO:1904253,1,0.689883197202292,0,1,positive regulation of bile acid metabolic process,BP,
3335,GO:1904406,1,0.62863855509776,0,2,negative regulation of nitric oxide metabolic process,BP,
3337,GO:1904427,1,0.739171199267924,0,1,positive regulation of calcium ion transmembrane transport,BP,
3338,GO:1904589,1,0.860646174064634,0,1,regulation of protein import,BP,
3341,GO:1904666,1,0.932920109189956,0,1,regulation of ubiquitin protein ligase activity,BP,
3342,GO:1904667,1,0.932920109189956,0,1,negative regulation of ubiquitin protein ligase activity,BP,
3343,GO:1904668,1,0.932920109189956,0,1,positive regulation of ubiquitin protein ligase activity,BP,
3344,GO:1904724,1,0.696680402390533,0,1,tertiary granule lumen,CC,
3346,GO:1904833,1,0.739171199267924,0,1,positive regulation of removal of superoxide radicals,BP,
3347,GO:1904847,1,0.83065676594881,0,1,regulation of cell chemotaxis to fibroblast growth factor,BP,
3348,GO:1904849,1,0.83065676594881,0,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
3349,GO:1904892,1,0.689785429679705,0,1,regulation of STAT cascade,BP,
3350,GO:1904894,1,0.689785429679705,0,1,positive regulation of STAT cascade,BP,
3351,GO:1904949,1,0.97782001583703,0,1,ATPase complex,CC,
3352,GO:1904951,1,0.569962745218887,0,4,positive regulation of establishment of protein localization,BP,
3353,GO:1905037,1,0.689785429679809,0,1,autophagosome organization,BP,
3354,GO:1905039,1,0.47344992134575,0,2,carboxylic acid transmembrane transport,BP,
3355,GO:1905114,1,0.642732733398197,0,2,cell surface receptor signaling pathway involved in cell-cell signaling,BP,
3356,GO:1905330,1,0.932920109189956,0,1,regulation of morphogenesis of an epithelium,BP,
3357,GO:1905348,1,0.937272715402406,0,1,endonuclease complex,CC,
3358,GO:1905368,1,0.932920109189956,0,1,peptidase complex,CC,
3359,GO:1905369,1,0.932920109189956,0,1,endopeptidase complex,CC,
3360,GO:1905709,1,0.860646174064634,0,1,negative regulation of membrane permeability,BP,
3361,GO:1905952,1,0.677068771719113,0,2,regulation of lipid localization,BP,
3362,GO:1905953,1,0.677068771719113,0,2,negative regulation of lipid localization,BP,
3363,GO:1905954,1,0.689785429679902,0,1,positive regulation of lipid localization,BP,
3364,GO:1990001,1,0.860646174064634,0,1,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3365,GO:1990111,1,0.932920109189956,0,1,spermatoproteasome complex,CC,
3366,GO:1990234,1,0.928356987403679,0,2,transferase complex,CC,
3367,GO:1990351,1,0.462350989713185,0,3,transporter complex,CC,
3368,GO:1990481,1,0.794342025053001,0,1,mRNA pseudouridine synthesis,BP,
3369,GO:1990542,1,0.689785429679855,0,1,mitochondrial transmembrane transport,BP,
3370,GO:1990748,1,0.705783648536025,0,2,cellular detoxification,BP,
3371,GO:1990777,1,0.982136033016046,0,1,lipoprotein particle,CC,
3372,GO:1990837,1,0.689785429679797,0,1,sequence-specific double-stranded DNA binding,MF,
3373,GO:1990904,1,0.555459746725411,0,4,ribonucleoprotein complex,CC,
3374,GO:2000021,1,0.860646174064634,0,1,regulation of ion homeostasis,BP,
3376,GO:2000027,1,0.932920109189956,0,1,regulation of organ morphogenesis,BP,
3377,GO:2000058,1,0.932920109189956,0,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3378,GO:2000060,1,0.932920109189956,0,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3379,GO:2000106,1,0.753843485045977,0,1,regulation of leukocyte apoptotic process,BP,
3380,GO:2000107,1,0.753843485045977,0,1,negative regulation of leukocyte apoptotic process,BP,
3384,GO:2000117,1,0.860646174064634,0,1,negative regulation of cysteine-type endopeptidase activity,BP,
3385,GO:2000121,1,0.739171199267924,0,1,regulation of removal of superoxide radicals,BP,
3386,GO:2000142,1,0.689785429679797,0,1,regulation of DNA-templated transcription, initiation,BP,
3387,GO:2000144,1,0.689785429679797,0,1,positive regulation of DNA-templated transcription, initiation,BP,
3388,GO:2000145,1,0.295094985858091,0,5,regulation of cell motility,BP,
3389,GO:2000146,1,0.739171199267924,0,1,negative regulation of cell motility,BP,
3390,GO:2000147,1,0.40348040318604,0,4,positive regulation of cell motility,BP,
3392,GO:2000257,1,0.689996137392405,0,1,regulation of protein activation cascade,BP,
3393,GO:2000278,1,0.739171199267924,0,1,regulation of DNA biosynthetic process,BP,
3394,GO:2000279,1,0.739171199267924,0,1,negative regulation of DNA biosynthetic process,BP,
3396,GO:2000378,1,0.62863855509776,0,2,negative regulation of reactive oxygen species metabolic process,BP,
3398,GO:2000401,1,0.711475438092686,0,2,regulation of lymphocyte migration,BP,
3399,GO:2000403,1,0.711475438092686,0,2,positive regulation of lymphocyte migration,BP,
3400,GO:2000404,1,0.711475438092686,0,2,regulation of T cell migration,BP,
3401,GO:2000406,1,0.711475438092686,0,2,positive regulation of T cell migration,BP,
3402,GO:2000407,1,0.753843485045977,0,1,regulation of T cell extravasation,BP,
3403,GO:2000409,1,0.753843485045977,0,1,positive regulation of T cell extravasation,BP,
3404,GO:2000449,1,0.753843485045977,0,1,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
3405,GO:2000451,1,0.753843485045977,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
3406,GO:2000452,1,0.753843485045977,0,1,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
3407,GO:2000454,1,0.753843485045977,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
3408,GO:2000482,1,0.944573033403215,0,1,regulation of interleukin-8 secretion,BP,
3409,GO:2000484,1,0.944573033403215,0,1,positive regulation of interleukin-8 secretion,BP,
3410,GO:2000544,1,0.83065676594881,0,1,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
3411,GO:2000546,1,0.83065676594881,0,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
3412,GO:2000649,1,0.97782001583703,0,1,regulation of sodium ion transmembrane transporter activity,BP,
3413,GO:2000778,1,0.944573033403215,0,1,positive regulation of interleukin-6 secretion,BP,
3414,GO:2000785,1,0.689785429679809,0,1,regulation of autophagosome assembly,BP,
3416,GO:2001014,1,0.909149134363904,0,1,regulation of skeletal muscle cell differentiation,BP,
3417,GO:2001015,1,0.909149134363904,0,1,negative regulation of skeletal muscle cell differentiation,BP,
3418,GO:2001026,1,0.83065676594881,0,1,regulation of endothelial cell chemotaxis,BP,
3419,GO:2001028,1,0.83065676594881,0,1,positive regulation of endothelial cell chemotaxis,BP,
3423,GO:2001179,1,0.944573033403215,0,1,regulation of interleukin-10 secretion,BP,
3424,GO:2001181,1,0.944573033403215,0,1,positive regulation of interleukin-10 secretion,BP,
3425,GO:2001198,1,0.924359214547204,0,1,regulation of dendritic cell differentiation,BP,
3426,GO:2001199,1,0.924359214547204,0,1,negative regulation of dendritic cell differentiation,BP,
3427,GO:2001233,1,0.364108237340176,0,6,regulation of apoptotic signaling pathway,BP,
3428,GO:2001234,1,0.54111979308309,0,3,negative regulation of apoptotic signaling pathway,BP,
3429,GO:2001235,1,0.555800246372653,0,4,positive regulation of apoptotic signaling pathway,BP,
3430,GO:2001236,1,0.364108237340176,0,6,regulation of extrinsic apoptotic signaling pathway,BP,
3431,GO:2001237,1,0.54111979308309,0,3,negative regulation of extrinsic apoptotic signaling pathway,BP,
3432,GO:2001238,1,0.665258643292366,0,3,positive regulation of extrinsic apoptotic signaling pathway,BP,
3433,GO:2001242,1,0.812567533012029,0,2,regulation of intrinsic apoptotic signaling pathway,BP,
3434,GO:2001243,1,0.860646174064634,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
3435,GO:2001245,1,0.915413777710168,0,1,regulation of phosphatidylcholine biosynthetic process,BP,
3436,GO:2001267,1,0.630542903290721,0,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
3437,GO:2001269,1,0.630542903290721,0,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
1333,GO:0022892,1,0.130786302351893,0,9,substrate-specific transporter activity,MF,
